caffeine and adenosine
caffeine has been researched along with adenosine in 597 studies
Research
Studies (597)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 180 (30.15) | 18.7374 |
1990's | 155 (25.96) | 18.2507 |
2000's | 143 (23.95) | 29.6817 |
2010's | 93 (15.58) | 24.3611 |
2020's | 26 (4.36) | 2.80 |
Authors
Authors | Studies |
---|---|
Browne, RG; Howard, HR; Koe, BK; Lebel, LA; Sarges, R; Seymour, PA | 1 |
Daly, JW | 1 |
Borea, PA; Dalpiaz, A; Gilli, G; Gilli, P; Scatturin, A; Varani, K | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Bearne, SL; Lunn, FA; Roy, AC | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
de Lera Ruiz, M; Lim, YH; Zheng, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Berizzi, A; Bird, L; Culurgioni, S; Navratilova, IH; Olsen, RHJ; Rawlins, PB; Robinson, S; Shepherd, C; Thompson, LEJ; Varzandeh, S | 1 |
Kostopoulos, GK; Phillis, JW | 1 |
Wong, JL; Zady, MF | 1 |
Edstrom, JP; Kirkpatrick, JR; Kostopoulos, GK; Phillis, JW | 1 |
Mitsuda, H; Nakajima, K; Nishikawa, Y | 2 |
Borg, DC; Schmidt, J | 1 |
Hittelman, KJ; Rosak, C | 1 |
Bockaert, J; Perez, M; Premont, J | 1 |
Ozato, K | 1 |
Asano, T; Hidaka, H; Ochiai, Y | 1 |
Buckley, JT | 1 |
Finlayson, LH; Osborne, MP | 1 |
Ehara, T; Goto, M; Yatani, A | 1 |
Chiba, S; Furukawa, Y; Kobayashi, M | 1 |
Chiba, S | 1 |
Lohmann, W; Sapper, H; Schimmack, W | 1 |
Lohmann, W; Schimmack, W | 1 |
Bortot, L; Cutrufo, C; Giachetti, A; Manzini, S | 1 |
David, M; Griesmacher, A; Horvath, G; Mueller, MM; Weigel, G | 1 |
Gadd, GM; Sabie, FT | 1 |
Mustafa, SJ; Ramagopal, MV | 1 |
Henry, JL; Yashpal, K | 1 |
Hara, T; Minematsu, N; Mizuki, Y; Obara, N; Ushijima, I; Yamada, M | 1 |
Holycross, BJ; Jackson, EK | 1 |
Dulloo, AG; Girardier, L; Seydoux, J | 2 |
Adén, U; Fredholm, BB; Johansson, B; Lindström, K; Svenningsson, P | 1 |
Brown, K; Newland, MC | 2 |
Domenici, MR; Frank, C; Sagratella, S; Scotti de Carolis, A; Zeng, YC | 1 |
Arizono, K; Brady, FO; Garrett, SH; Xiong, X | 1 |
Cooper, DR; Coulson, R; Johnson, RA; Olsson, RA; Scheinman, SJ | 1 |
Caporali, MG; Popoli, P; Scotti de Carolis, A | 2 |
Okamoto, K; Yamada, Y; Yoshida, H | 1 |
Huddart, H; Lynch, M | 1 |
Smits, P; Thien, T | 1 |
Nasir, T; Zarrindast, MR | 1 |
Mitsumoto, Y; Mohri, T; Ohkubo, T | 1 |
Guillet, R; Kellogg, CK | 1 |
Andén, NE; Casas, M; Ferré, S; Grabowska-Andén, M; Herrera-Marschitz, M; Ungerstedt, U | 1 |
Holtzman, SG; Mante, S; Minneman, KP | 1 |
Haraguchi, H; Kuribara, H | 1 |
Brownstone, RM; Geiger, JD; Lesiuk, HJ; Peeling, J; Rydzy, M; Saunders, JK; Sutherland, GR | 1 |
Arzubiaga, C; Biaggioni, I; Paul, S; Puckett, A | 1 |
Ammon, HP | 2 |
Holtzman, SG; Mumford, GK | 1 |
Beninger, RJ; Josselyn, SA | 1 |
Holtzman, SG | 2 |
Branch, RA; Brown, NJ; Porter, J; Ryder, D | 1 |
Branch, KR; Jackson, EK; Magee, WD; Oliver, RD; Tofovic, SP | 1 |
Seale, TW; Sekar, KC; Sheldon, RE; Toubas, PL | 1 |
Brechler, V; Garbarz, E; Lotersztajn, S; Pavoine, C; Pecker, F | 1 |
Elphick, M; Godfrey, PP; Powell, T; Taghavi, Z | 1 |
Crews, FT; Garg, LC; Narang, N | 1 |
Mante, S; Minneman, KP | 1 |
Lin, Y; Phillis, JW | 1 |
Haas, HL; Kostopoulos, G; Psarropoulou, C | 1 |
Hasegawa, T | 1 |
Lenders, JW; Smits, P; Thien, T | 1 |
Berman, RF; Lupica, CR; Rosen, JB; Whitcomb, K | 1 |
Contreras, E; Germany, A; Villar, M | 1 |
Ahn, D; Hirsh, JK; Hunt, JM; Silinsky, EM; Solsona, C | 1 |
Barrera, CM; Dohanich, GP; Dunlap, WP; Hunter, RE | 1 |
Centelles, JJ; Franco, R; Kinne, RK | 1 |
Barone, JJ; Grice, HC | 1 |
Biaggioni, I; Feoktistov, I; Hollister, AS; Paul, S; Robertson, D | 1 |
Boyet, S; Dumont, I; Nehlig, A; Pereira de Vasconcelos, A | 1 |
Lautt, WW | 1 |
Durcan, MJ; Morgan, PF | 1 |
Coffin, VL; Spealman, RD | 2 |
Barraco, RA; DeLong, RE; Phillis, JW; Washington, DO | 1 |
DeLander, GE; Hopkins, CJ | 1 |
Dar, MS; Wooles, WR | 1 |
Aitken, RJ; Irvine, S; Mattei, A | 1 |
Boekema, P; De Abreu, R; Smits, P; Thien, T; van 't Laar, A | 1 |
Mersmann, HJ | 1 |
Antunes-Rodrigues, J; Favaretto, AL; López-Jiménez, MA; Picanço-Diniz, DL; Valença, MM | 1 |
Greenblatt, DJ; Kaplan, GB; Leduc, BW; Shader, RI; Thompson, ML | 1 |
Baldwin, HA; File, SE | 1 |
Bedia, E; Donovan, JF; Hammitt, DG; Rogers, PR; Syrop, CH; Williamson, RA | 1 |
O'Regan, MH | 1 |
Adamson, P; Brammer, MJ; Campbell, IC; Hajimohammadreza, I; Mantzouridis, T; Xiang, JZ | 1 |
Diaz, C; Gill, JM; Schiffman, SS | 1 |
McPhee, MD; Whiting, SJ | 1 |
Appalsamy, M; Mosqueda-Garcia, R; Robertson, D; Tseng, CJ | 1 |
Schouten, J; Smits, P; Thien, T | 2 |
Biaggioni, I; Branch, RA; Jackson, EK; Paul, S; Robertson, D | 1 |
Cazzola, G; Dainotti, E; Maraschio, P; Piantanida, M; Tiepolo, L; Tupler, R | 1 |
Clark, M; Post, RM | 1 |
Holycross, BJ; Jackson, EK; Li, P | 1 |
Sosnowski, M; Stevens, CW; Yaksh, TL | 1 |
Lautt, WW; McQuaker, JE | 1 |
Phillis, JW | 3 |
Fujiwara, Y; Kazahaya, Y; Otsuki, S; Sandyk, R; Takeda, T | 1 |
Chisholm, RL; Drummond, IA | 1 |
Dunwiddie, TV | 1 |
DeLong, RE; Phillis, JW | 2 |
Lindblad, S; Rzepczynski, D; Zieve, L | 1 |
Bravo, M; López-Sáez, JF; Pincheira, J | 1 |
Holloway, WR; Thor, DH | 1 |
Fredholm, BB | 3 |
Ahlijanian, MK; Takemori, AE | 3 |
Durston, AJ; Weijer, CJ | 1 |
Goldberg, SR; Katz, JL; Prada, JA | 2 |
Green, RM; Stiles, GL | 1 |
Andersson, KE; Kjellin, G; Persson, CG | 1 |
Beeker, TG; Diaz, C; Schiffman, SS | 1 |
Fredholm, BB; Lindström, K | 2 |
Green, CL; Swanson, TH | 1 |
Daly, JW; Padgett, W; Shamim, MT; Ukena, D | 1 |
Corradetti, R; Pedata, F; Pepeu, G; Vannucchi, MG | 1 |
Biaggioni, IO; Branch, RA; Jackson, EK; Li, P; Ohnishi, A | 1 |
Phillis, JW; Stair, RE | 1 |
Spealman, RD | 1 |
Abla, KA; Carney, JM; Daly, JW; Seale, TW; Shamim, MT | 1 |
Giovannelli, L; Giovannini, MG; Pedata, F; Pepeu, G | 1 |
Jarvis, MF; Williams, M | 2 |
Dugich, MM; Hawkins, M; Porter, NM; Radulovacki, M; Urbancic, M | 1 |
Boyet, S; Collignon, A; Nehlig, A; Pereira de Vasconcelos, A | 1 |
Boulenger, JP; Marangos, PJ; Salem, N; Uhde, TW | 1 |
Smits, P; Thien, T; van 't Laar, A | 1 |
Jackson, EK; Kuan, CJ; Wells, JN | 1 |
Benedetti, M; Frank, C; Sagratella, S; Scotti de Carolis, A | 1 |
Benedetti, M; Popoli, P; Scotti de Carolis, A | 1 |
Finn, IB; Holtzman, SG | 1 |
Conlay, LA; Evoniuk, G; Wurtman, RJ | 1 |
Cheung, WT; Lee, CM; Ng, TB | 1 |
Greene, RW; Haas, HL | 1 |
Clark, RL; Cusick, WA; Eschbach, K; Heyse, JF | 1 |
Gutknecht, AM; Lozeman, FJ; Markovic, J; Stanley, JC | 1 |
Harvey, JA; Winsky, L | 1 |
Barraco, RA; Campbell, WR; Phillis, JW; Shehin, SE; Stair, RE | 1 |
Goldberg, SR; Katz, JL | 1 |
Daly, JW; Evoniuk, G; Jacobson, KA; Shamim, MT; Wurtman, RJ | 1 |
Henry, JL; Salter, MW | 1 |
Buckholtz, NS; Middaugh, LD | 1 |
Ferrario, P; Mantegazza, P; Zambotti, F; Zecca, L; Zonta, N | 1 |
Biaggioni, I; Feely, J; Goldberg, MR; Hollister, AS; Onrot, J; Robertson, D; Shaheen, O; Wilkinson, GR | 1 |
Carney, JM; Coffin, VL | 1 |
Evoniuk, G; von Borstel, RW; Wurtman, RJ | 1 |
Dews, PB; Glowa, JR; Malaspina, S; Sobel, E | 1 |
De Sarno, P; Giovannelli, L; Pedata, F; Pepeu, G | 1 |
González-Fernández, A; Hernández, P; López-Sáez, JF | 1 |
Holloway, FA; Shull, RN | 1 |
Marangos, PJ; Patel, J; Post, RM; Weiss, SR | 1 |
Greene, RW; Haas, HL; Hermann, A | 1 |
Chesielski, L; Kempf, E; Lehmann, A; Maitre, M; Mandel, P | 1 |
Molnár, J; Prágai, B | 1 |
Carmichael, WM | 1 |
Davies, JI; Peers, DG | 1 |
Bygdeman, S; Johnsen, O | 1 |
Haslam, RJ; Rosson, GM | 1 |
Butcher, RW; Hittelman, KJ | 1 |
Kacew, S; Singhal, RL | 1 |
Haslam, RJ | 1 |
Lin, PP | 1 |
Cazenave, JP; Guccione, MA; Mustard, JF; Packham, MA | 1 |
Lackie, JM | 1 |
Fujii, S; Okuda, H; Saito, Y | 1 |
Chapman, RA; Miller, DJ | 1 |
Dryden, EE; Manery, JF; Woo, YT | 1 |
Feldman, JF; Thayer, JP | 1 |
Doctor, RB; Jindal, MN; Kelkar, VV | 1 |
Frantsuzova, SB | 1 |
Brock, N; Pohl, VP | 1 |
Komatsu, Y | 1 |
Nitz, RE; Scholtholt, J; Schraven, E | 1 |
Chiba, S; Hashimoto, K; Kubota, K | 1 |
Kvamme, E; Reichelt, KL; Wedege, E | 1 |
Anderson, SM; Daly, JW; Padgett, W; Weir, RL | 1 |
Caldwell, P; Emmett-Oglesby, MW; Spencer, DG | 1 |
Daly, JW; Sugio, K | 1 |
Mantegazza, P; Tammiso, R; Zambotti, F; Zecca, L; Zonta, N | 1 |
Paul, SM; Skolnick, P | 1 |
Phillis, JW; Wu, PH | 2 |
Schimmel, RJ | 1 |
Hollins, C; Lloyd, H; Stone, TW | 1 |
Annau, Z; Katims, JJ; Snyder, SH | 1 |
Annau, Z; Bruns, RF; Daly, JW; Katims, JJ; Snyder, SH | 1 |
Plagemann, PG; Wohlhueter, RM | 1 |
Sklar, P; Snyder, SH | 1 |
Altman, HJ; Barraco, RA; Coffin, VL; Phillis, JW; Taylor, JA | 1 |
Persons, DL; Shankel, DM | 1 |
Coleman, RA | 1 |
Boulenger, JP; Marangos, PJ; Patel, J | 2 |
Migas, EA | 1 |
Iverson, LL | 1 |
Boulenger, JP; Marangos, PJ; Parma, AM; Patel, J; Post, RM | 1 |
Lal, H; Spencer, DG | 1 |
Deng, JF; Rall, TW; Spyker, DA; Steward, O | 1 |
Butts-Lamb, P; Daly, JW; Padgett, W | 1 |
Kulkarni, SK; Mehta, AK | 1 |
Gilboe, DP; Nuttall, FQ | 1 |
Barber, R; Butcher, RW; Goka, TJ | 1 |
Gould, RJ; Katims, JJ; Murphy, KM; Snyder, SH | 1 |
Pedata, F; Pepeu, G; Spignoli, G | 1 |
Carney, JM; Logan, L | 1 |
DeLong, RE; Phillis, JW; Preston, G | 1 |
Glowa, JR; Spealman, RD | 1 |
Pedata, F; Pepeu, GC; Spignoli, G | 1 |
Elliott, J; Jhamandas, K; Notman, H; Sutak, M | 1 |
Renshaw, AA; von Borstel, RW; Wurtman, RJ | 1 |
Levine, AS; Morley, JE; Oken, MM; Wager-Srdar, SA | 1 |
Collier, HO; Tucker, JF | 1 |
Dragunow, M; Goddard, GV | 1 |
Conlay, LA; von Borstel, RW; Wurtman, RJ | 1 |
Tolkovsky, AM | 1 |
Aller, P; de la Torre, C; González-Fernández, A | 1 |
González-Fernández, A; López-Sáez, JF; Mingo, R | 1 |
Green, RD; Miletich, RS; Radulovacki, M | 1 |
González-Fernández, A; López-Sáez, JF | 1 |
Chelack, BJ; Jiang, ZG; Phillis, JW | 1 |
McGarry, SJ; Williams, AJ | 1 |
Kamphuis, J; Smits, P; Thien, T | 1 |
Danhof, M; Gubbens-Stibbe, JM; Ijzerman, AP; Jacobson, KA; Mathôt, RA; Soudijn, W | 1 |
Cahill, CM; Sawynok, J; White, TD | 1 |
Charest, J; Li, J; Marchand, S | 1 |
Charland, SL; Melko, GP; Stanek, EJ | 1 |
Bayne, CJ; Chen, JH | 1 |
Daly, JW; Jacobson, KA; Nikodijević, O | 1 |
Schiffmann, SN; Vanderhaeghen, JJ | 1 |
Bravo, M; Gallo, C; Lopez-Saez, JF; Navarrete, MH; Pincheira, J | 1 |
Semenov, VV; Studentsova, IA | 1 |
Imaizumi, M; Miyazaki, S; Onodera, K | 1 |
Semenov, VV | 1 |
Behbehani, MM; Dollberg-Stolik, O | 1 |
Etzel, BA; Guillet, R | 1 |
De Abreu, RA; Rongen, GA; Smits, P; Thien, T; Van Belle, H; Ver Donck, K; Willemsen, JJ | 1 |
Cortijo, J; Morcillo, EJ; Orón, JD; Perpiñá, M | 1 |
Inoue, I; Maeda, K; Miwa, M; Morita, H; Nakai, S; Odani, H; Shinzato, T | 1 |
Jacobson, KA; Ji, XD; Kim, HO; Melman, N; Olah, ME; Stiles, GL | 1 |
Daly, JW; Nikodijevic, O; Shi, D; Wong, V | 1 |
Babey, AM; Palmour, RM; Young, SN | 1 |
Delle Donne, KT; Sonsalla, PK | 1 |
Bingmann, D; Moraidis, I | 1 |
Bennett, MR; Larkum, ME; Warren, DA | 1 |
Hunt, JM; Redman, RS; Silinsky, EM | 1 |
Shafaghi, B; Zarrindast, MR | 1 |
Howell, LL; Landrum, AM | 1 |
Cerqueira, MD; Jacobson, AF; Raisys, V; Shattuc, S | 1 |
Jarvis, MF; Martin, GE; Rossi, DJ | 1 |
Aranda, JV; Davis, GM; Lopes, JM; Mullahoo, K | 1 |
Hicks, JL; Salter, MW | 1 |
Bravo, M; Lopez-Saez, JF; Navarrete, MH; Pincheira, J; Rodriguez, M | 1 |
Fukuuchi, Y; Isozumi, K; Itoh, Y; Takeda, H | 1 |
Holtzman, SG; Woolfolk, DR | 1 |
Kuan, CJ; Tarng, JL; Tseng, CJ; Tung, CS | 1 |
Biaggioni, I; Kurunwune, B; Paul, S | 1 |
Krnjević, K; Zhu, PJ | 1 |
Daly, JW; Gallo-Rodriguez, C; Jacobson, KA; Maillard, M; Nikodijević, O; Padgett, WL | 1 |
Howell, LL | 1 |
Ahlberg, S; Brené, S; Fredholm, BB; Johansson, B; Lindefors, N; Persson, H; van der Ploeg, I | 1 |
Fink, JS; Pollack, AE | 1 |
Fisher, CE; Hughes, RN | 1 |
Poon, A; Sawynok, J | 1 |
Bauer, J; Berger, M; Biber, K; Fiebich, BL; Gyufko, K; van Calker, D | 1 |
Shaban, M; Smith, RA; Stone, TW | 1 |
Adeyemo, O; Buchanan, P; Jain, N; Kemp, N; Stone, TW | 1 |
Chern, Y; Ching, YH; Lai, HL; Lee, EH; Lee, YC; Wang, HL | 1 |
Barnes, RC; Carper, HT; Luong, LS; Mandell, GL; Sullivan, GW | 1 |
Hoock, C; Schmidt, H; Steinmetz, J | 1 |
Borbély, AA; Schwierin, B; Tobler, I | 1 |
Jen, SC; Rovainen, CM | 1 |
Fochtmann, L; Francis, A | 1 |
Kaneko, S; Mizuno, K; Okada, M | 1 |
Jackson, EK; Kusaka, H; Pfeifer, CA; Tofovic, SP | 1 |
Ferre, S; Fuxe, K; Popoli, P; Tinner-Staines, B | 1 |
Jacobson, KA; Lin, RC; Von Lubitz, DK | 1 |
Eigler, A; Endres, S; Greten, TF; Haslberger, C; Sinha, B; Sullivan, GW | 1 |
Kaneko, S; Kawata, Y; Kiryu, K; Mizuno, K; Okada, M; Tasaki, H; Wada, K | 1 |
Daly, JW; Evans, SM; Griffiths, RR; Holtzman, SG; Hughes, JR; Strain, EC | 1 |
Bernardi, G; Calabresi, P; Centonze, D; Pisani, A | 1 |
Hespel, P; Richter, EA; Vergauwen, L | 1 |
Fredholm, BB; Georgiev, V; Johansson, B; Lindström, K | 1 |
Snyder, SH | 1 |
Costentin, J; El Yacoubi, M; Heath, JK; Ledent, C; Parmentier, M; Pedrazzini, T; Schiffmann, SN; Vanderhaeghen, JJ; Vassart, G; Vaugeois, JM | 1 |
Chang, YH; Chern, Y; Ching, YH; Conti, M; Lai, HL; Lee, YC | 1 |
Conant, JA; Conlay, LA; deBros, F; Wurtman, R | 1 |
Huddart, H; King, JA; Staff, WG | 1 |
Frobenius, W; Geis, U; Hipp, J; Müller, CE; Pawłowski, M; Sandoval-Ramírez, J; Schobert, U; Suzuki, F | 1 |
Cunha, RA; Gonçalves, ML; Ribeiro, JA | 1 |
Chiang, PH; Lee, JN; Tsai, EM | 1 |
Drazba, JA; Krahl, SE; Liu, YZ; Rivkees, SA; Swanson, TH | 1 |
Akimoto, T; Mashimoto, S; Suetsugi, M; Ushijima, I; Watanabe, K; Yamada, M | 1 |
Job, RF; Minor, TR; Woodson, JC | 1 |
Eikvar, L; Kirkebøen, KA | 1 |
Ando, S; Brooks, SC; Floras, JS; Notarius, CF; Rongen, GA | 1 |
O'Regan, MH; Phillis, JW; Song, D | 1 |
Khandwala, H; Loomis, CW; Zhang, Z | 1 |
Bennett, MR; Brain, KL; Lin, YQ | 1 |
Newland, MC | 1 |
Assmann, H; Illes, P; Nörenberg, W; Richter, M; Wirkner, K | 1 |
Kaneko, S; Okada, M | 1 |
Kaneko, S; Kawata, Y; Kondo, T; Mizuno, K; Murakami, T; Okada, M; Wada, K | 1 |
Hurwitz, R; Lyons, K; Taketa, R | 1 |
Richardt, G; Schreieck, J | 1 |
Dorsa, DM; Ward, RP | 1 |
Esser, MJ; Reid, AR; Sawynok, J | 1 |
Kaplan, GB; Weisberg, SP | 1 |
Bultynck, G; Casteels, R; De Smedt, H; De Smet, P; Maes, K; Missiaen, L; Parys, JB; Sienaert, I; Zizi, M | 1 |
Dixon, DA; Fenix, LA; Kim, DM; Raffa, RB | 1 |
Angel, M; Biaggioni, I; Cavalcante, J; Christman, B; Costa, F; Haile, V; Sulur, P | 1 |
Adair, TH; Anand, V; Brady, AL; Gu, JW; Kelly, WC; Moore, MC | 1 |
Dassesse, D; Goldberg, I; Schiffmann, SN; Vanderhaeghen, JJ; Vanderwinden, JM | 1 |
Fallahi, M; Mirnajafi-Zadeh, J; Palizvan, MR; Pourgholami, MH; Rostampour, M | 1 |
Kopf, SR; Melani, A; Pedata, F; Pepeu, G | 1 |
Blazev, R; Lamb, GD | 1 |
Ichikawa, S; Kitamura, S; Kuwana, Y; Nakamura, J; Shiozaki, S; Yamada, K | 1 |
Baldo, BA; Koob, GF; Markou, A | 1 |
Asano, A; Fraser, LR; Fujiwara, T; Funahashi, H; Nagai, T; Niwa, K | 1 |
Chrousos, GP; Crane, ML; Elenkov, IJ; Kino, T; Link, AA; McGuire, JL; Wilder, RL; Worth, JA | 1 |
Liu, XJ; Reid, A; Sawynok, J | 1 |
Borgeat, P; Bourgoin, SG; Harbour, D; Naccache, PH; Thibault, N | 1 |
Costentin, J; El Yacoubi, M; Ledent, C; Parmentier, M; Vaugeois, JM | 1 |
Aguirre-Bañuelos, P; Castañeda-Hernández, G; Granados-Soto, V; López-Muñoz, FJ; Pérez-Urizar, J | 1 |
Chad, JE; Pivovarov, AS; Walker, RJ | 1 |
Gean, PW; Lu, KT; Wu, SP | 1 |
Capasso, A | 1 |
Materi, LM; Rasmusson, DD; Semba, K | 1 |
Li, SN; Wong, PT | 1 |
Clowes, P; Majd-Ardekani, J; Menash-Bonsu, V; Nunan, TO | 1 |
Dixon, AK; Freeman, TC; Lee, K; Preston, Z; Richardson, PJ; Widdowson, L | 1 |
Adén, U; Fredholm, BB; Herlenius, E; Tang, LQ | 1 |
Dassesse, D; Ledent, C; Meunier, JC; Parmentier, M; Schiffmann, SN | 1 |
Chilian, WM; Jones, DW; Merkus, D; Nishikawa, Y; Stepp, DW | 1 |
Fathollahi, Y; Khalili, M; Semnanian, S | 1 |
Davies, DG; Fowler, JC; Gervitz, LM; Lutherer, LO; Pirch, JH | 1 |
Beilstein, MA; Chen, JF; Cuellar, B; Fink, JS; Grandy, DK; Hackett, E; Impagnatiello, F; Low, MJ; Moratalla, R; Ongini, E; Rubinstein, M; Schwarzschild, MA | 1 |
Fredholm, BB; Irenius, E; Kull, B; Schulte, G | 1 |
Funahashi, H; Nagai, T | 1 |
Chung, ES; Dobson, JG; Fenton, RA; Lorbar, M; Meyer, TE; Norton, GR; Perlini, S; Woodiwiss, AJ | 1 |
Dunwiddie, TV; Masino, SA | 1 |
Belluscio, L; Corvol, JC; Fienberg, AA; Girault, JA; Hervé, D; Jaber, M; Le Moine, C; Ledent, C; Studler, JM | 1 |
Dziubina, A; Gołembiowska, K | 1 |
Ashihara, H; Crozier, A; Kato, A; Koshiishi, C; Yama, S | 1 |
Betsholtz, C; Dunwiddie, TV; Escorihuela, RM; Fernández-Teruel, A; Fredholm, BB; Giménez-Llort, L; Halldner, L; Hårdemark, A; Herlenius, E; Johansson, B; Masino, SA; Poelchen, W; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
Atchison, DJ; Floras, JS; Notarius, CF; Rongen, GA | 1 |
Hleihel, W; Huchet-Cadiou, C; Léoty, C; Talon, S | 1 |
Carcillo, JA; Jackson, EK; Tofovic, SP; Zacharia, L | 1 |
Emala, CW; Lee, HT | 1 |
Hamann, M; Richter, A | 1 |
Antle, MC; Mistlberger, RE; Steen, NM | 1 |
Persson, PB | 1 |
Grbović, L; Pesić, S; Prostran, M; Radenković, M | 1 |
Curtis, SM; Dulhunty, AF; Gallant, EM; Haarmann, C; Laver, D; Pace, S | 1 |
Costentin, J; El Yacoubi, M; Ledent, C; Ongini, E; Parmentier, M; Vaugeois, JM | 1 |
Adén, U; Herlenius, E; Lagercrantz, H; Tang, LQ | 1 |
Shearman, LP; Weaver, DR | 1 |
Green, TA; Schenk, S | 1 |
Ashihara, H; Crozier, A; Kato, M; Ye, CX; Zheng, XQ | 1 |
Nguyen, TT; White, PJ | 1 |
Flood, AJ; Headrick, JP; Willems, L | 1 |
Deutsch, M; Fixler, D; Shainberg, A; Tirosh, R; Zinman, T | 1 |
Aslantas, A; Dokmeci, I; Firat, Z; Karadag, HC; Tamer, M; Ulugol, A | 1 |
Bibb, JA; Fienberg, AA; Fisone, G; Fredholm, BB; Greengard, P; Kim, Y; Lindskog, M; Nairn, AC; Pozzi, L; Svenningsson, P | 1 |
Büyükokuroğlu, ME; Demirezer, LO; Güvenalp, Z | 1 |
Boix, F; Hilgenfeldt, U; Knardahl, S; Rosenborg, L | 1 |
Carrega, L; Devaux, C; Fund-Saunier, O; Guieu, R; Peragut, JC; Pham, T; Saadjian, A; Sauze, N | 1 |
Da Silva, AL; Dall'Igna, OP; de Oliveira, RV; Dietrich, MO; Hoffmann, A; Lara, DR; Souza, DO | 1 |
Brenner, M; Danielczyk, W; Deckert, J; Durany, N; Jellinger, K; Paulus, W; Ransmayr, G; Riederer, P; Tatschner, T; Zöchling, R | 1 |
Antoniou, K; Ferré, S; Fuxe, K; Goldberg, SR; Justinova, Z; Karcz-Kubicha, M; Müller, CE; Pezzola, A; Popoli, P; Quarta, D; Reggio, R; Solinas, M; Terasmaa, A | 1 |
Blay, J; Butler, JJ; Hoskin, DW; Mader, JS; Watson, CL; Zhang, H | 1 |
Berrino, L; Capuano, A; De Novellis, V; Filippelli, A; Mazzeo, F; Rossi, F; Stella, L; Vitelli, MR | 1 |
Floras, JS; Notarius, CF; Rongen, GA | 1 |
O'Regan, MH; Phillis, JW | 1 |
TETZNER, KH | 1 |
DAVOREN, PR; SUTHERLAND, EW | 1 |
RIZACK, MA | 1 |
DEGUBAREFF, T; SLEATOR, W | 1 |
Brodmann, M; Lischnig, U; Lueger, A; Pilger, E; Stark, G | 1 |
Abo-Salem, OM; Bilkei-Gorzo, A; Filipek, B; Hayallah, AM; Müller, CE; Zimmer, A | 1 |
Lorist, MM; Tops, M | 1 |
Morelli, M | 1 |
Fredholm, BB; Svenningsson, P | 1 |
Costentin, J; El Yacoubi, M; Vaugeois, JM | 1 |
Chen, JF | 1 |
Goulart, EC; Kaster, MP; Rodrigues, AL; Rosa, AO; Rosso, MM; Santos, AR | 1 |
Aqel, RA; Baldwin, SA; Iskandrian, AE; Trimm, JR; Zoghbi, GJ | 1 |
Bach-Rojecky, L | 1 |
Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW | 1 |
Cass, CE; Lang, TT; Young, JD | 1 |
Bodineau, L; Frugière, A; Gaytan, S; Gros, F; Saadani-Makki, F | 1 |
Batista, LC; Prediger, RD; Takahashi, RN | 1 |
Goto, W; Hirao, M; Ikeda, T; Kobayashi, T; Oku, H; Sugiyama, T | 1 |
Borycz, J; Ciruela, F; Ferré, S; Franco, R; Goldberg, SR; Hockemeyer, J; Lluis, C; Patkar, K; Quarta, D; Solinas, M; Woods, AS | 1 |
Funahashi, H; Romar, R | 1 |
Burchert, W; Fricke, E; Horstkotte, D; Wielepp, JP | 1 |
Ferré, S; Goldberg, SR; Karcz-Kubicha, M; Müller, CE; Schindler, CW; Tella, SR; Thorndike, EB | 1 |
Alexander West, G; Britz, GW; Groysman, L; Jensen, EM; Kung, DK; Meno, JR; Ngai, AC; Nguyen, TS; Winn, HR | 1 |
Prediger, RD; Takahashi, RN | 1 |
Dall'Igna, OP; de Oliveira, RV; Lara, DR; Neto, PF; Santos Gomes, MW; Schuh, JF; Souza, DO; Tort, AB | 1 |
Kogi, K; Konno, T; Nagai, A; Nakahata, N; Uchibori, T | 2 |
de Leeuw, PW; Houben, AJ; Koster, D; Kroon, AA; Postma, CT; Smits, P; van Engelshoven, JM; Wierema, TK | 1 |
Hoexter, MQ; Mello, LE; Rosa, PS; Tufik, S | 1 |
Brailoiu, E; Cooper, RL; Dropic, AJ | 1 |
Bertolasi, V; Ferretti, V; Pretto, L; Tabrizi, MA | 1 |
Antoniou, K; Bekris, E; Ferré, S; Goldberg, SR; Hyphantis, T; Marselos, M; Müller, CE; Panlilio, L; Papadopoulou-Daifoti, Z; Papathanasiou, G | 1 |
Becker, J; Ghisolfi, ES; Lara, DR; Luersen, G; Martins, FF; Ramos, FL; Schuch, A; Strimitzer, IM | 1 |
Aguilar, E; Bové, J; Cortés, R; Marin, C; Mengod, G; Serrats, J | 1 |
Ely, MR; Motl, RW; O'connor, PJ; Puetz, T; Tubandt, L | 1 |
Abraham, EH; Cho, SY; Engles, JM; Hilton, J; Polster, J; Wahl, RL | 1 |
Aqel, R; Blackmon, L; Heo, J; Htay, T; Iskandrian, AE; Zoghbi, GJ | 1 |
Chan, ES; Chen, JF; Cronstein, BN; Delano, DL; Desai, A; Fernandez, P; Friedman, SL; Montesinos, MC; Pillinger, MH; Reiss, AB; Schwarzschild, MA; Yee, H | 1 |
Conde, SV; Gonzalez, C; Obeso, A; Rigual, R; Rocher, A; Vicario, I | 1 |
da Silva, AL; Dall'Igna, OP; Hoffmann, A; Lara, DR; Souza, DO | 1 |
Arendash, GW; Cracchiolo, JR; Jackson, EK; Rezai-Zadeh, K; Schleif, W; Shippy, D; Tan, J; Zacharia, LC | 1 |
Bayes-Genis, A; Casadó, V; Cinca, J; Ciruela, F; Franco, R; Hove-Madsen, L; Llach, A; Lluis, C; Prat-Vidal, C | 1 |
Aubel, B; Bourgoin, S; Farré, A; Hamon, M; Kayser, V | 1 |
Achermann, P; Adam, M; Dürr, R; Gottselig, JM; Khatami, R; Landolt, HP; Rétey, JV | 1 |
Akundi, RS; Back, SA; Craig, A; Luo, NL; Ren, J; Ribeiro, I; Rivkees, SA | 1 |
Bishnoi, M; Chopra, K; Kulkarni, SK | 1 |
Chen, HH; Pan, HZ | 1 |
Bibb, JA; Galdi, S; Greene, RW; Hendrick, J; Sahin, B; Snyder, GL | 1 |
Borycz, J; Cunha, RA; Ferré, S; Goldberg, SR; Köfalvi, A; Melani, A; Panlilio, L; Pedata, F; Pereira, MF; Rodrigues, RJ | 1 |
Bangalore, S; Messerli, FH; Parkar, S | 1 |
Bakker, SJ; Bosselaar, M; Heine, RJ; Riksen, NP; Rongen, GA; Smits, P; Tack, CJ | 1 |
Daré, E; Fredholm, BB; Johansson, B; Tiselius, C; Valen, G; Yang, JN | 1 |
Gu, R; Li, W; Shan, H; Wang, J; Wang, WH; Xu, Y; Yang, B; Zhang, Y | 1 |
Baraldi, PG; Benini, A; Borea, PA; Gessi, S; Leung, E; Maclennan, S; Merighi, S; Mirandola, P; Simioni, C; Varani, K | 1 |
Shapiro, RE | 1 |
Franke, B; Riksen, NP; Rongen, GA; Smits, P; van den Broek, P | 1 |
Bishnoi, M; Kulkarni, SK; Singh, K | 1 |
Furukawa, K; Ishii, N; Kataoka, K; Nagao, K; Tsuru, H | 1 |
Cohen-Williams, ME; Grzelak, ME; Higgins, GA; Hodgson, RA; Pond, AJ; Varty, GB | 1 |
Antoniou, K; Borycz, J; Ciruela, F; Ferre, S; Franco, R; Goldberg, SR; Justinova, Z; Lluis, C; Quarta, D; Quiroz, C; Solinas, M | 1 |
Benko, I; Brugós, L; Cseppento, A; Deák, G; Edes, I; Galajda, Z; Gesztelyi, R; Kovács, P; Roszer, T; Sipka, S; Szentmiklósi, AJ; Szilasi, M; Zsuga, J | 1 |
Desfrere, L; Gressens, P; Olivier, P; Schwendimann, L; Verney, C | 1 |
Ferré, S | 1 |
Ramkumar, V; Toth, LA; Xie, X | 1 |
Binfaré, RW; Budni, J; Lobato, KR; Rodrigues, AL; Rosa, AO; Santos, AR | 1 |
Badner, J; Childs, E; de Wit, H; Deckert, J; Hohoff, C; Xu, K | 1 |
Coskun, C; Mutlu, D; Savci, V; Suzer, O; Yalcin, M; Yilmaz, MS | 1 |
McGeoch, RJ; Oldroyd, KG | 1 |
Landolt, HP | 1 |
Bhaskara, S; Chandrasekharan, MB; Ganguly, R | 1 |
Edelman, GM; Jing, J; Jones, FS; Stevens, A; Stonehouse, AH | 1 |
Benedek, G; Horvath, G; Kekesi, G; Nagy, E; Tuboly, G | 1 |
Batuca, JR; Conde, SV; Gonzalez, C; Monteiro, EC; Obeso, A | 1 |
Kjaergaard, J; Lukashev, D; Ohta, A; Sitkovsky, MV | 1 |
Balkin, TJ; Grugle, NL; Killgore, DB; Killgore, WD; Muckle, AE | 1 |
Burbiel, CE; Knittel, J; Müller, CE; Töpfer, M; Verspohl, EJ | 1 |
Cullen, PK; Furst, S; Minor, TR; Rowe, M | 1 |
Anagnostopoulos, C; Donovan, J; Harbinson, M; Loong, CY; Reyes, E; Underwood, SR | 1 |
Andretic, R; Greenspan, RJ; Han, KA; Jones, FS; Kim, YC | 1 |
Franco, R | 1 |
Koh, HC; Lee, CB | 1 |
Baghdoyan, HA; Lydic, R; Van Dort, CJ | 1 |
Chaimovitz, C; Douvdevani, A; Kachko, L; Nakav, S; Rogachev, B; Vorobiov, M; Zlotnik, M | 1 |
Chestley, T; Duckworth, ML; Mizuno, T; Parkinson, FE; Xiong, W; Zamzow, CR | 1 |
Boerman, OC; Dekker, D; Meijer, P; Oyen, WJ; Rongen, GA; Scheffer, GJ; Smits, P; van den Broek, PH; Wouters, CW | 1 |
Hollander, E | 1 |
Capasso, A; Gallo, C | 1 |
Kern, MJ; Salcedo, J | 1 |
Belikoff, B; Hatfield, S; Lukashev, D; Ohta, A; Sitkovsky, M | 1 |
Rose'Meyer, RB | 1 |
Jalali, A; Kawa, K; Larsen, C; Trevitt, J | 1 |
Boison, D; Li, T; Shen, HY | 1 |
Buntine, P; Cabalag, MS; Knott, JC; Meyer, A; Smit, D; Taylor, DM | 1 |
Hoffman, AF; Kawamura, M; Laaris, N; Lupica, CR; Masino, SA | 1 |
Ribeiro, JA; Sebastião, AM | 1 |
Bryant, SM; Karydes, HC | 1 |
Groszmann, RJ; Mehal, WZ; Ripoll, C; Zipprich, A | 1 |
Cressey, D | 1 |
Venton, BJ; Xu, Y | 1 |
Beconi, MT; Breininger, E; Cetica, PD | 1 |
de Rooij, M; Meijer, P; Rongen, GA; Scheffer, GJ; Smits, P; van den Broek, PH; Wouters, CW | 1 |
Carta, AR; Kachroo, A; Morelli, M; Schwarzschild, MA | 1 |
Boison, D | 1 |
Porkka-Heiskanen, T | 1 |
Díaz-Muñoz, M; Salín-Pascual, R | 1 |
Bauer, A; Elmenhorst, D; Garibotto, V; Prescher, A | 1 |
Lautt, WW; Ming, Z | 1 |
Franke, B; Peters, WH; Pickkers, P; Ramakers, BP; Riksen, NP; Smits, P; van den Broek, P; van der Hoeven, JG | 1 |
Rivkees, SA; Wendler, CC | 2 |
Hayaishi, O; Huang, ZL; Urade, Y | 1 |
Hirasawa, H | 1 |
Antonucci, I; Bucciarelli, T; De Caterina, R; Prontera, T; Renda, G; Ruggieri, B; Stuppia, L; Tatasciore, A; Zimarino, M | 1 |
Baskar, R; Jaiswal, P; Soldati, T; Thewes, S | 1 |
Hage, FG; Iskandrian, AE | 2 |
Barnett, AG; Fraser, JF; Johnson, LP; Khafagi, FA; Lee, JC; McHenry, CM; Walters, DL; Warnholtz, CR; Wilson, MG | 1 |
Agarwal, A; Agarwal, M; Agarwal, MK; Chakrabarti, A; Glick, A; Gupta, K; Sharma, JP; Wald, DN; Yang, J; Zhang, Y | 1 |
Belzowzki, A; Bergren, D; Brugler, A; Hillman, BG; Hillman, KC; Hillman, SR; Kuss, B; Ngo, BT; Pisarri, T; Rendell, MS; Thompson, SL; Turner, SA | 1 |
Conde, SV; Gonzalez, C; Monteiro, EC; Obeso, A; Ribeiro, MJ; Rigual, R | 1 |
Chatterjee, D; Chiu, GS; Darmody, PT; Freund, GG; Johnson, RW; Meling, DD; Walsh, JP | 1 |
Cidral-Filho, FJ; Martins, DF; Mazzardo-Martins, L; Santos, AR; Stramosk, J | 1 |
Deboer, T; Ferrari, MD; Meijer, JH; Van den Maagdenberg, AM; van Diepen, HC | 1 |
Martins, DF; Mazzardo-Martins, L; Piovezan, AP; Santos, AR; Soldi, F; Stramosk, J | 1 |
Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Wardas, J | 1 |
Meeusen, R; Roelands, B; Spriet, LL | 1 |
Bruner, RC; Choi, DS; Nam, HW | 1 |
Dayanim, S; Grewal, S; Londhe, VA; Lopez, B; Maisonet, TM | 1 |
Arheden, H; Carlsson, M; Ekelund, U; Hedén, B; Jögi, J; Markenroth Bloch, K; Ståhlberg, F | 1 |
Dierckx, RA; Elsinga, PH; Ishiwata, K; Khanapur, S; Meerlo, P; Paul, S; Sijbesma, JW; van Waarde, A | 1 |
Landolt, HP; Urry, E | 1 |
Pohanka, M | 1 |
Marczinski, CA | 1 |
Bakuradze, T; Baum, M; Eirich, M; Eisenbrand, G; Erk, T; Habermeyer, M; Montoya, GA; Richling, E | 1 |
Edvinsson, L; Haanes, KA | 1 |
Bilos, A; Deinum, J; Donders, AR; Riksen, NP; Rongen, GA; van den Berg, TN | 1 |
Matsuda, T; Matsumoto, H; Mikuri, M; Nakatsuma, K; Shimada, T; Ushimaru, S; Yamazaki, T | 1 |
Huang, YG; Shen, L; Xu, L; Zhang, YG | 1 |
Hanff, TC; Minor, TR | 1 |
Chang, CJ; Chen, SA; Chen, YC; Chen, YH; Chen, YJ; Kao, YH; Lin, YK; Lu, YY; Tsai, WC; Yang, LY | 1 |
Hiromura, M; Honda, S; Inoue, K; Kosako, K; Kuroki, H; Shiratani, T; Soeda, S; Toda, A; Uchiyama, H | 1 |
Boehm, SL; Fritz, BM | 1 |
Braun, OÖ; Christersson, C; Grove, EL; Halvorsen, S; James, SK; Lindholm, D; Storey, RF; Varenhorst, C | 1 |
Kawada, T; Matsuda, T; Matsumoto, H; Mikuri, M; Shimada, T; Takahashi, H; Takahashi, N; Ushimaru, S; Yamazaki, T | 1 |
Costa, G; Morelli, M; Simola, N | 1 |
Bajaj, NS; Hage, FG; Saab, R | 2 |
Brito, R; Calaza, KC; Paes-de-Carvalho, R; Pereira-Figueiredo, D; Socodato, R | 1 |
Jouret, F; Marx, B; Scuvée, É; Scuvée-Moreau, J; Seutin, V | 1 |
Faingold, CL; Kommajosyula, SP; Randall, M | 1 |
Kuijpers, D; Oudkerk, M; Prakken, NH; van der Harst, P; van Dijkman, PR; Vliegenthart, R | 1 |
Leiner, T | 1 |
Chuang, HC; Chuang, LT; Ho, SC; Li, YT; Wu, JJ; Yang, TT | 1 |
Fredholm, BB; Wang, Y; Yang, J | 1 |
Aho, V; Ikonen, HMK; Panula, P; Porkka-Heiskanen, T; Puttonen, HAJ; Salminen, T; Vainikka, M; Wigren, HK | 1 |
Kaandorp, TAM; Kuijpers, D; Oudkerk, M; van der Harst, P; van Dijk, R; van Dijkman, PRM; Vliegenthart, R | 1 |
Ateş, N; Dede, F; Eraldemir, FC; Karadenizli, S; Özsoy, ÖD; Şahin, D | 1 |
Bai, X; He, J; Li, T; Qiao, H; Xu, J; Ye, X; Zhang, J; Zhang, W | 1 |
Aires, ID; Ambrósio, AF; Baqi, Y; Boia, R; Cunha, RA; Elvas, F; Madeira, MH; Müller, CE; Rodrigues-Neves, AC; Santiago, AR; Szabó, EC; Tomé, ÂR; Tralhão, P | 1 |
Kaandorp, TAM; Kuijpers, D; Oudkerk, M; van Assen, M; van der Harst, P; van Dijk, R; van Dijkman, PRM; Vliegenthart, R | 1 |
Abu-Zaid, E; Birkmeier, S; Greulich, S; Kaesemann, P; Mahrholdt, H; Sechtem, U; Seitz, A; Vecchio, F | 1 |
Crespo, M; León-Navarro, DA; Martín, M | 1 |
Álvarez-Bagnarol, Y; Ayala-Santiago, C; Canela, EI; Casadó, V; Clemens, S; Cruz-Reyes, N; Díaz-Ríos, M; Ferré, S; Molina-Castro, GC; Moreno, E; Rivera-Oliver, M | 1 |
Andersson, J; Braun, OÖ; Heller, S; Henriksson, P; James, S; Lauermann, J; Lindholm, D; Öhagen, P; Varenhorst, C | 1 |
Fathalla, AM; Moustafa, AA; Soliman, AM | 1 |
de Paula Soares-Rachetti, V; Dos Santos, MKF; Gavioli, EC; Lobão-Soares, B; Rosa, LS | 1 |
Cardoso, AM; Carvalho, FB; Duarte, MMF; Gutierres, JM; Morsch, VM; Oliveira, L; Pillat, MM; Schetinger, MRC; Spanevello, RM; Stefanello, N; Ulrich, H; Vieira, JM | 1 |
Anastasiadi, RM; Berti, F; Di Tommaso, D; Peressi, M; Pividori, M; Redivo, L; Resmini, M | 1 |
Byrne, C; Forman, JL; Hasbak, P; Hurry, PK; Kjaer, A; Schmedes, A; Wissenberg, M | 1 |
Gilbert, N | 1 |
Cai, Q; Cao, T; Li, B; Li, H; Ma, T; Tian, Y; Xu, Y | 1 |
Babar, AK; Bui, L; DeGolovine, A; Gould, KL; Johnson, NP; Kitkungvan, D; Kumar, S; Madjid, M; Nacimbene, A; Patel, MB; Roby, AE; Vejpongsa, P | 1 |
Byrne, C; Hasbak, P; Kjaer, A | 1 |
Abdalla, FH; Bernardes, VM; Braun, JBS; Casali, EA; Castilhos, LG; da Cruz, IBM; de Andrade, CM; de Oliveira, JS; Leal, DBR; Manzoni, AG; Passos, DF; Ruchel, JB | 1 |
Bekeredjian, R; Chatzitofi, M; Greulich, S; Kaesemann, P; Löbig, S; Mahrholdt, H; Sechtem, U; Seitz, A; Tauscher, G | 1 |
Chong, JW; Lee, JC; Luis, SA | 1 |
Huang, CL; Lin, A; Lin, CT; Shih, CT; Tsai, YC; Wu, CC | 1 |
Gom, RC; Phillips, TJ; Teskey, GC; Wolff, MD | 1 |
Calzavara, MB; Camerini, BA; de Mattos Hungria, F; Ramos, AC; Suiama, MA | 1 |
Dong, M; Hu, K; Mo, H; Tang, S; Xiong, M; Zeng, Z; Zhao, D; Zhu, J | 1 |
Adachi, LNS; Assumpção, JAF; Battastini, AMO; Caumo, W; Cioato, SG; de Oliveira, C; de Souza, A; Medeiros, LF; Rozisky, JR; Scarabelot, VL; Silva, RS; Torres, ILS | 1 |
Cai, Z; Huang, R; Li, Y; Ma, Y; Pan, L; Wu, H; Wu, X | 1 |
Chen, JF; Schwarzschild, MA | 1 |
Banks, MI; Grady, SM; Jaeckel, ER; Krause, BM; Murphy, CA; Sanders, RD; Sultan, ZW | 1 |
Brito, R; Calaza, KC; Cunha-Rodrigues, MC; Nascimento, AA; Pereira-Figueiredo, D | 1 |
Hosonuma, M; Inoue, K; Kondo, S; Masaki, R; Matsumoto, H; Ogura, K; Oishi, Y; Okada, N; Sakai, K; Sato, S; Sekimoto, T; Shinke, T; Sumida, A; Takahashi, H; Tanaka, H; Tsujita, H; Tsukamoto, S | 1 |
Berman, NK; Cronstein, BN; Honig, S; Pillinger, MH | 1 |
Ishibashi, K; Ishii, K; Ishiwata, K; Miura, Y; Toyohara, J; Wagatsuma, K | 1 |
Byrne, C; Hasbak, P; Hurry, PK; Kjær, A; Lassen, ML; Schmedes, AV; Sheykhzade, M; Wissenberg, M | 1 |
Deboer, T; Landolt, HP; Reichert, CF | 1 |
Cai, X; Chen, J; Gyabaah, AT; Huang, ZL; Li, Y; Li, Z; Ma, C; Shi, H; Tu, Y; Yu, C | 1 |
Songy, B | 1 |
Li, Z; Liu, J; Lopez, A; Qin, K; Zhang, P | 1 |
Farinha-Ferreira, M; Rei, N; Ribeiro, JA; Sebastião, AM; Valente, CA; Vaz, SH | 1 |
Chen, JF; Choi, DS; Cunha, RA | 1 |
Agostinho, P; Canas, PM; Carvalho, RA; Cunha, RA; Ferreira, SG; Gaspar, I; Lopes, CR; Lopes, JP; Oliveira, A; Rodrigues, MS; Santos, J; Silva, HB; Simões, AP; Szabó, E; Tomé, ÂR | 1 |
Vellapandian, C; Yerragopu, AK | 1 |
Hok, L; Vianello, R | 1 |
Florén Lind, S; Frick, A; Grönbladh, A; Meurling, E; Stam, F; Zelleroth, S | 1 |
Ding, Y; Huang, PJ; Li, AZ; Liu, J; Xie, Y | 1 |
Dieckmann, T; Evans, NM; Huang, PJ; Li, AZ; Liu, J; Lu, C | 1 |
Gaber, M; Ghareeb, D; Hamed, A; Hamed, M; Mohamed, TM; Nofal, MS | 1 |
Reviews
54 review(s) available for caffeine and adenosine
Article | Year |
---|---|
Adenosine receptors: targets for future drugs.
Topics: Adenosine; Adenosine Triphosphate; Animals; Humans; Ligands; Receptors, Cell Surface; Receptors, Purinergic; Structure-Activity Relationship; Xanthines | 1982 |
Adenosine A2A receptor as a drug discovery target.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Biochemical mechanism of caffeine tolerance.
Topics: Adenosine; Animals; Caffeine; Drug Tolerance; Humans | 1991 |
The physiological role of adenosine in the central nervous system.
Topics: Adenosine; Adenylyl Cyclases; Analgesia; Animals; Behavior, Animal; Benzodiazepines; Brain Chemistry; Caffeine; Central Nervous System; Cerebrovascular Circulation; Drug Interactions; Electrophysiology; Ethanol; Humans; Locomotion; Narcotics; Neural Conduction; Neural Inhibition; Neurotransmitter Agents; Receptors, Cell Surface; Receptors, Purinergic; Sleep; Synapses; Time Factors; Vasodilation | 1985 |
Effects of enprofylline and theophylline may show the role of adenosine.
Topics: Adenosine; Animals; Asthma; Brain; Bronchodilator Agents; Caffeine; Diuresis; Fatty Acids, Nonesterified; Gastric Acid; Heart; Humans; Kidney; Kinetics; Lung; Natriuresis; Phosphodiesterase Inhibitors; Receptors, Cell Surface; Receptors, Purinergic; Respiration; Seizures; SRS-A; Theophylline; Vasoconstriction; Vasodilation; Xanthines | 1986 |
Nifedipine: more than a calcium channel blocker.
Topics: Adenosine; Animals; Benzodiazepines; Biological Transport; Caffeine; Coronary Disease; Humans; Nifedipine; Receptors, Cell Surface; Receptors, Purinergic | 1986 |
Adenosine antagonists as potential therapeutic agents.
Topics: Adenosine; Animals; Caffeine; Central Nervous System; Humans; Receptors, Purinergic; Species Specificity; Xanthines | 1988 |
Coffee and the human cardiovascular system.
Topics: Adenosine; Blood Pressure; Caffeine; Cardiovascular System; Cholesterol; Coffee; Heart Diseases; Humans; Lipoproteins; Risk Factors | 1987 |
Cyclic nucleotides in higher plants?
Topics: Adenine; Adenosine; Adenylyl Cyclases; Caffeine; Cyclic AMP; Gibberellins; Phosphoric Diester Hydrolases; Plant Growth Regulators; Plants; Protein Kinases; Theophylline | 1974 |
[New aspects of the mechanism of the central nervous system stimulating effect of caffeine].
Topics: Adenosine; Aminobutyrates; Animals; Brain; Caffeine; Calcium; Cyclic AMP; Habituation, Psychophysiologic; Humans; Mice; Naloxone; Phosphodiesterase Inhibitors; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Opioid; Receptors, Purinergic; Xanthines | 1984 |
The mechanism(s) of action of the benzodiazepines.
Topics: Adenosine; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Caffeine; Carbolines; Cats; Cattle; Diazepam; gamma-Aminobutyric Acid; Humans; Molecular Weight; Muscle Relaxation; Neurotransmitter Agents; Niacinamide; Purines; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Neurotransmitter; Seizures; Sleep Wake Disorders | 1981 |
The role of adenosine and its nucleotides in central synaptic transmission.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine; Adenosine Deaminase; Adenosine Triphosphatases; Animals; Axonal Transport; Behavior, Animal; Benzodiazepines; Brain; Caffeine; Morphine; Nucleotidases; Receptors, Cell Surface; Receptors, Purinergic; Synapses | 1981 |
Adenosine receptor interactions and anxiolytics.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Anti-Anxiety Agents; Benzodiazepines; Caffeine; Diazepam; Humans; Motor Activity; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Purinergic | 1983 |
Xanthine interference with dipyridamole-thallium-201 myocardial imaging.
Topics: Adenosine; Animals; Caffeine; Coronary Disease; Dipyridamole; Dogs; False Negative Reactions; Heart; Humans; Male; Pentoxifylline; Radionuclide Imaging; Thallium Radioisotopes; Xanthine; Xanthines | 1995 |
Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.
Topics: Adenosine; Animals; Awards and Prizes; Brain; Caffeine; Humans; Neurotransmitter Agents; Pharmacology; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Societies, Scientific | 1995 |
[Receptor mediated effects of adenosine and caffeine].
Topics: Adenosine; Caffeine; Humans; Myocardial Ischemia; Myocardial Reperfusion Injury; Receptors, Purinergic P1 | 1998 |
Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists.
Topics: Adenosine; Animals; Caffeine; Clinical Trials as Topic; Drug Interactions; Humans; Mutation; Neurotransmitter Agents; Receptors, Dopamine D2; Receptors, Purinergic P1; Schizophrenia | 1999 |
The role and regulation of adenosine in the central nervous system.
Topics: Adenosine; Animals; Arousal; Caffeine; Central Nervous System; Humans; Neurons; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Sleep | 2001 |
Caffeine, fatigue, and cognition.
Topics: Adenosine; Attention; Caffeine; Central Nervous System Stimulants; Cognition; Dopamine; Electroencephalography; Fatigue; Humans; Reaction Time | 2003 |
Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Caffeine; Central Nervous System Stimulants; Humans; Neuroprotective Agents; Palliative Care; Parkinson Disease; Parkinson Disease, Secondary; Rats | 2003 |
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Corpus Striatum; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Humans; Mice; Nerve Tissue Proteins; Parkinson Disease; Phosphoproteins; Phosphorylation; Pyrimidines; Receptor, Adenosine A2A; Receptors, Dopamine D2; Signal Transduction; Triazoles | 2003 |
The adenosine A(2A) receptor as an attractive target for Parkinson's disease treatment.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Brain; Caffeine; Dopamine; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Receptor, Adenosine A2A; Treatment Failure | 2003 |
Caffeine and headaches.
Topics: Adenosine; Brain; Caffeine; Drug Combinations; Drug Synergism; Headache Disorders; Headache Disorders, Secondary; Humans; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome | 2007 |
Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
Topics: Adenosine; Animals; Brain; Caffeine; Central Nervous System Stimulants; Corpus Striatum; Dimerization; Humans; Models, Biological; Motor Activity; Receptor, Adenosine A1; Receptor, Adenosine A2A | 2008 |
An update on the mechanisms of the psychostimulant effects of caffeine.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Humans; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1 | 2008 |
Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Corpus Striatum; Dopamine; Humans; Locomotion; Models, Biological; Parkinson Disease; Parkinsonian Disorders; Receptors, Dopamine; Receptors, Purinergic P1; Rodentia; Signal Transduction | 2007 |
Pharmacological options for inducing maximal hyperaemia during studies of coronary physiology.
Topics: Adenosine; Adenosine Triphosphate; Animals; Caffeine; Coronary Stenosis; Dobutamine; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Nitroprusside; Papaverine; Vasodilator Agents | 2008 |
Sleep homeostasis: a role for adenosine in humans?
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Homeostasis; Humans; Receptors, Purinergic P1; Sleep | 2008 |
Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia.
Topics: Adenosine; Animals; Caffeine; CD8-Positive T-Lymphocytes; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppressive Agents; Immunotherapy; Mice; Models, Biological; Neoplasms; Receptor, Adenosine A2A; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 2008 |
[Coffee and cancer].
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Anticarcinogenic Agents; Caffeine; Cell Transformation, Neoplastic; Coffee; Female; Humans; Lymphocyte Activation; Male; Mice; Mice, Transgenic; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, Adenosine A2; Theobromine; Theophylline | 2008 |
Effects of caffeine and theophylline on coronary hyperemia induced by adenosine or dipyridamole.
Topics: Adenosine; Animals; Caffeine; Coronary Circulation; Coronary Disease; Dipyridamole; Drug Administration Schedule; Drug Interactions; Echocardiography, Doppler; Humans; Hyperemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Theophylline; Time Factors; Vasodilator Agents | 2009 |
The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells.
Topics: Acute Lung Injury; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Disease Models, Animal; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Mice; Mice, Mutant Strains; Oxygen; Oxygen Consumption; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Respiratory Distress Syndrome; T-Lymphocytes, Regulatory | 2009 |
Caffeine and adenosine.
Topics: Adenosine; Animals; Caffeine; Cognition; Humans; Learning; Mental Disorders; Models, Biological; Nervous System Diseases; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2010 |
Pathophysiological roles for purines: adenosine, caffeine and urate.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Caffeine; Dopamine; Humans; Neuroprotective Agents; Parkinson Disease; Purines; Receptor, Adenosine A2A; Uric Acid | 2010 |
Methylxanthines, seizures, and excitotoxicity.
Topics: Adenosine; Animals; Caffeine; Humans; Neurotoxins; Seizures; Theophylline; Xanthines | 2011 |
Methylxanthines and sleep.
Topics: Adenosine; Animals; Caffeine; Humans; Receptor, Adenosine A1; Receptors, Adenosine A2; Sleep | 2011 |
Purine molecules as hypnogenic factors role of adenosine, ATP, and caffeine.
Topics: Adenosine; Adenosine Triphosphate; Animals; Caffeine; Central Nervous System Stimulants; Humans; Hypnotics and Sedatives; Neurotransmitter Agents; Purines; Sleep; Structure-Activity Relationship; Synaptic Transmission | 2010 |
Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection.
Topics: Adenosine; Animals; Caffeine; Embryo, Mammalian; Female; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Infant, Premature; Leukomalacia, Periventricular; Nerve Fibers, Myelinated; Neuroprotective Agents; Oligodendroglia; Pregnancy; Protein Isoforms; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Respiration | 2011 |
The role of adenosine in the regulation of sleep.
Topics: Adenosine; Adenosine Triphosphate; Animals; Caffeine; Extracellular Space; Gene Expression; Humans; Mice; Mice, Knockout; Neurons; Neurotransmitter Agents; Nucleoside Transport Proteins; Preoptic Area; Prostaglandin D2; Purinergic P1 Receptor Agonists; Rats; Receptor, Adenosine A1; Receptor, Adenosine A2A; Sleep; Sleep Disorders, Circadian Rhythm; Subarachnoid Space; Synaptic Transmission; Wakefulness | 2011 |
Adenosine signaling in striatal circuits and alcohol use disorders.
Topics: Adenosine; Alcohol Drinking; Alcohol-Related Disorders; Animals; Caffeine; Choice Behavior; Corpus Striatum; Dopamine Antagonists; Ethanol; Humans; Mice; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Dopamine; Receptors, Purinergic P1; Signal Transduction | 2013 |
Adenosine, caffeine, and performance: from cognitive neuroscience of sleep to sleep pharmacogenetics.
Topics: Adenosine; Attention; Caffeine; Humans; Neurosciences; Pharmacogenetics; Psychomotor Performance; Sleep; Sleep Deprivation | 2015 |
The effects of caffeine on the cholinergic system.
Topics: Acetylcholine; Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Cholinergic Agents; Cholinesterases; Cytokines; Humans; Receptors, Cholinergic | 2014 |
Regulatory effect of caffeine on the acute and the chronic pain and its possible mechanisms.
Topics: Adenosine; Caffeine; Central Nervous System Stimulants; Chronic Pain; Humans; Pain | 2014 |
[Mechanisms of caffeine-induced diuresis].
Topics: Adenosine; Animals; Caffeine; Diuresis; Diuretics; Humans; Kidney Tubules; Receptors, Purinergic P1; Signal Transduction; Sodium | 2016 |
Low, but not high, dose caffeine is a readily available probe for adenosine actions.
Topics: Adenosine; Caffeine; Dose-Response Relationship, Drug; Humans | 2017 |
Long-term consequences of disrupting adenosine signaling during embryonic development.
Topics: Adenosine; Animals; Caffeine; DNA Methylation; Embryonic Development; Epigenesis, Genetic; Humans; Mice; Receptors, Purinergic P1; Signal Transduction | 2017 |
Adenosine role in brain functions: Pathophysiological influence on Parkinson's disease and other brain disorders.
Topics: Adenosine; Brain Diseases; Caffeine; Dopamine; Humans; Parkinson Disease | 2018 |
Craving espresso: the dialetics in classifying caffeine as an abuse drug.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Craving; Dopamine; Humans; Illicit Drugs | 2018 |
The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.
Topics: Adenosine; Alzheimer Disease; Caffeine; Humans; Protein Isoforms; Purinergic Agonists; Purinergic Antagonists; Receptors, Purinergic; Signal Transduction | 2021 |
Do caffeine and more selective adenosine A
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Disease Models, Animal; Humans; Neuroprotective Agents; Parkinson Disease; Receptor, Adenosine A2A | 2020 |
Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.
Topics: Adenosine; Brain; Caffeine; Central Nervous System; Glucose; Humans; Ischemia; Neuroprotective Agents; Oxygen; Receptors, Purinergic P1; Retina | 2022 |
Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives.
Topics: Adenosine; Caffeine; Circadian Rhythm; Humans; Sleep; Sleep Deprivation; Wakefulness | 2022 |
Striatopallidal adenosine A
Topics: Adenosine; Caffeine; Cognition; Corpus Striatum; Dopamine; Glutamates; Goals; Humans; Receptor, Adenosine A2A | 2023 |
Trials
24 trial(s) available for caffeine and adenosine
Article | Year |
---|---|
Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine.
Topics: Adenosine; Adult; Blood Pressure; Caffeine; Catecholamines; Diazoxide; Drug Synergism; Drug Tolerance; Female; Humans; Infusions, Intravenous; Male; Pulse; Purinergic Antagonists; Renin; Time Factors | 1991 |
Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system.
Topics: Adenosine; Adult; Aldosterone; Blood Pressure; Caffeine; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Male; Oxygen Consumption; Random Allocation | 1987 |
Cardiovascular effects of two xanthines and the relation to adenosine antagonism.
Topics: Adenosine; Adult; Aldosterone; Blood Pressure; Caffeine; Double-Blind Method; Epinephrine; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Nausea; Norepinephrine; Random Allocation; Renin; Xanthines | 1989 |
Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeine.
Topics: Adenosine; Adult; Anxiety; Caffeine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Psychological Tests; Random Allocation | 1987 |
Respiratory stimulant effects of adenosine in man after caffeine and enprofylline.
Topics: Adenosine; Adult; Bronchodilator Agents; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Respiration; Respiratory Function Tests; Stimulation, Chemical; Xanthines | 1987 |
Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation.
Topics: Adenosine; Adult; Caffeine; Double-Blind Method; Female; Humans; Male; Pain; Pain Measurement; Transcutaneous Electric Nerve Stimulation | 1995 |
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection.
Topics: Adenosine; Adult; Blood Pressure; Caffeine; Carrier Proteins; Cross-Over Studies; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Heart Rate; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Male; Membrane Proteins; Middle Aged; Norepinephrine; Nucleoside Transport Proteins; Piperazines; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Antagonists; Reference Values; Systole; Vasodilation | 1995 |
Role of adenosine in dialysis-induced hypotension.
Topics: Adenosine; Aged; Caffeine; Female; Humans; Hypotension; Hypoxanthine; Hypoxanthines; Inosine; Male; Middle Aged; Models, Biological; Norepinephrine; Renal Dialysis; Sympathetic Nervous System; Vascular Resistance; Vasodilation; Xanthine; Xanthines | 1994 |
Adenosine challenge and boost protocols: new tools for myocardial perfusion imaging.
Topics: Adenosine; Caffeine; Cardiac Output; Coronary Disease; Dipyridamole; Exercise Test; Heart; Humans; Radionuclide Imaging | 1999 |
Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure.
Topics: Adenosine; Blood Pressure; Caffeine; Exercise Test; Female; Hand Strength; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Ischemia; Isometric Contraction; Isotonic Contraction; Male; Middle Aged; Muscle, Skeletal; Purinergic P1 Receptor Antagonists; Reflex; Sympathetic Nervous System | 2001 |
Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adult; Caffeine; Coronary Artery Disease; Hemodynamics; Humans; Hyperemia; Infusions, Intravenous; Injections, Intra-Arterial; Male; Middle Aged; Pilot Projects; Vasodilator Agents | 2004 |
Caffeine modulates P50 auditory sensory gating in healthy subjects.
Topics: Adenosine; Adult; Analysis of Variance; Caffeine; Central Nervous System Stimulants; Electroencephalography; Electrooculography; Evoked Potentials, Auditory; Feeding Behavior; Female; Humans; Male; Receptors, Purinergic P1 | 2006 |
Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity.
Topics: Adenosine; Adult; Brain; Caffeine; Cross-Over Studies; Electroencephalography; Humans; Individuality; Male; Polysomnography; Psychomotor Performance; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Sleep Deprivation; Sleep Stages | 2006 |
Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo.
Topics: Adenosine; Autonomic Nervous System; Blood Flow Velocity; Blood Pressure; Caffeine; Compliance; Cross-Over Studies; Fat Emulsions, Intravenous; Fatty Acids, Unsaturated; Forearm; Humans; Insulin; Pulse; Receptors, Purinergic P1; Vasodilation; Vasodilator Agents | 2007 |
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
Topics: Adenosine; Administration, Oral; Annexin A5; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorobenzenes; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intra-Arterial; Male; Nitroprusside; Pyrimidines; Radionuclide Imaging; Regional Blood Flow; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Time Factors; Up-Regulation; Vasodilation; Vasodilator Agents | 2009 |
Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.
Topics: 5'-Nucleotidase; Adenosine; Blood Flow Velocity; Brachial Artery; Caffeine; Central Nervous System Stimulants; Female; Fluorobenzenes; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intra-Arterial; Ischemia; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Up-Regulation; Vasodilator Agents; Young Adult | 2010 |
Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury.
Topics: Adenosine; AMP Deaminase; Caffeine; Double-Blind Method; Endotoxemia; Escherichia coli; Humans; Immunity, Innate; Inflammation; Kidney; Lipopolysaccharides; Male; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2011 |
Genetic determinants of blood pressure responses to caffeine drinking.
Topics: Adenosine; Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Caffeine; Coffee; Double-Blind Method; Epinephrine; Humans; Male; Plant Extracts; Polymorphism, Genetic; Receptor, Adenosine A2A; Receptors, Adrenergic, alpha-2; Young Adult | 2012 |
Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis.
Topics: Adenosine; Blood Flow Velocity; Caffeine; Coronary Artery Disease; Coronary Circulation; Drug Interactions; Exercise Test; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Perfusion Imaging; Reproducibility of Results; Sensitivity and Specificity; Vasodilator Agents | 2012 |
Submaximal adenosine-induced coronary hyperaemia with 12 h caffeine abstinence: implications for clinical adenosine perfusion imaging tests.
Topics: Adenosine; Adult; Blood Flow Velocity; Caffeine; Coronary Circulation; Drug Administration Schedule; Drug Interactions; Female; Humans; Magnetic Resonance Angiography; Male; Myocardial Perfusion Imaging; Reproducibility of Results; Sensitivity and Specificity; Vasodilation; Vasodilator Agents | 2015 |
The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study.
Topics: Adenosine; Caffeine; Dipyridamole; Double-Blind Method; Eplerenone; Forearm; Hemodynamics; Humans; Hyperemia; Male; Nitroprusside; Regional Blood Flow; Spironolactone; Treatment Outcome; Young Adult | 2014 |
Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.
Topics: Acute Coronary Syndrome; Adenosine; Caffeine; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Electrocardiography; Purinergic P1 Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2015 |
Caffeine and incidence of dyspnea in patients treated with ticagrelor.
Topics: Adenosine; Aged; Caffeine; Drug Monitoring; Dyspnea; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Patient Reported Outcome Measures; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2018 |
Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Caffeine; Cardiovascular Diseases; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles | 2019 |
Other Studies
519 other study(ies) available for caffeine and adenosine
Article | Year |
---|---|
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Cats; Cell Membrane; Cerebral Cortex; Chemical Phenomena; Chemistry; Corpus Striatum; Male; Molecular Structure; Motor Activity; Purinergic Antagonists; Quinoxalines; Rats; Receptors, Purinergic; Sleep; Structure-Activity Relationship; Triazoles | 1990 |
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
Topics: Estradiol; Female; Humans; In Vitro Techniques; Male; Metribolone; Pregnenediones; Prostate; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Thermodynamics; Uterus | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids.
Topics: Carbon-Nitrogen Ligases; Enzyme Inhibitors; Escherichia coli; Kinetics; Methylation; Structure-Activity Relationship; Uric Acid; Xanthines | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Surface Plasmon Resonance Screening to Identify Active and Selective Adenosine Receptor Binding Fragments.
Topics: | 2022 |
Adenosine as a putative transmitter in the cerebral cortex. Studies with potentiators and antagonists.
Topics: Action Potentials; Adenine Nucleotides; Adenosine; Animals; Blood Pressure; Caffeine; Cerebral Cortex; Dose-Response Relationship, Drug; Hexobendine; Male; Neurotransmitter Agents; Papaverine; Rats; Receptors, Drug; Structure-Activity Relationship; Theophylline | 1975 |
Kinetics and mechanism of carbon-8 methylation of purine bases and nucleosides by methyl radical.
Topics: Adenine; Adenosine; Caffeine; Guanine; Guanosine; Hot Temperature; Hydrogen-Ion Concentration; Hypoxanthines; Inosine; Kinetics; Methods; Methylation; Photochemistry; Purine Nucleosides | 1977 |
Effects of adenosine and adenine nucleotides on synaptic transmission in the cerebral cortex.
Topics: 1-Methyl-3-isobutylxanthine; Action Potentials; Adenine Nucleotides; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Monophosphate; Animals; Brain; Caffeine; Cerebral Cortex; Male; Neural Inhibition; Neurons; Rats; Synapses; Synaptic Transmission; Theophylline | 1979 |
Relationship between accumulation of guanine ribonucleotidyl-(3'-5')-adenosine and formation of riboflavin.
Topics: Adenosine; Ascomycota; Caffeine; Depression, Chemical; Dinucleoside Phosphates; Escherichia coli; Glucose; Guanine Nucleotides; Neurospora crassa; Riboflavin; Saccharomyces cerevisiae; Saccharomycetales; Stimulation, Chemical | 1977 |
Free radicals from purine nucleosides after hydroxyl radical attack.
Topics: Adenine; Adenosine; Caffeine; Deoxyadenosines; Electron Spin Resonance Spectroscopy; Free Radicals; Guanosine; Hydroxylation; Imidazoles; Inosine; Purine Nucleosides; Radiation Effects | 1976 |
Formation of guanine ribonucleotidyl-(3'-5')-adenosine in a flavinogenic strain of Eremothecium ashbyii.
Topics: Adenosine; Ascomycota; Caffeine; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Chromatography, Paper; Culture Media; Dinucleoside Phosphates; Guanine Nucleotides; Phosphoric Diester Hydrolases; Riboflavin; Ribonucleases; Saccharomycetales | 1976 |
Characterization of lipolytic responses of isolated white adipocytes from hamsters.
Topics: Adenosine; Adipose Tissue; Adrenocorticotropic Hormone; Animals; Caffeine; Catecholamines; Cricetinae; Dose-Response Relationship, Drug; Glycerol; Insulin; Lipid Mobilization; Male; Nicotinic Acids; Norepinephrine; Phentolamine; Propranolol; Prostaglandins E | 1977 |
Adenosine-sensitive adenylate cyclase in rat striatal homogenates.
Topics: Adenosine; Adenosine Deaminase; Adenylyl Cyclases; Animals; Caffeine; Corpus Striatum; Cyclic AMP; Kinetics; Male; Rats; Structure-Activity Relationship; Theophylline; Xanthines | 1977 |
Effects of ACTH, adenyl compounds, and methylxanthines on goldfish erythrophores in culture.
Topics: Adenine; Adenine Nucleotides; Adenosine; Adrenocorticotropic Hormone; Animals; Bucladesine; Caffeine; Cells, Cultured; Chromatophores; Cyclic AMP; Cytoplasmic Granules; Dose-Response Relationship, Drug; Goldfish; Kinetics; Microscopy, Phase-Contrast; Pigments, Biological; Theophylline; Xanthines | 1977 |
Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
Topics: Adenosine; Blood Platelets; Caffeine; Chromatography, DEAE-Cellulose; Cyclic AMP; Cyclic GMP; Depression, Chemical; Dipyridamole; Humans; In Vitro Techniques; Kinetics; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Platelet Aggregation; Theophylline | 1977 |
Properties of human erythrocyte phosphatidylinositol kinase and inhibition by adenosine, ADP and related compounds.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Caffeine; Cyclic AMP; Enzyme Activation; Erythrocytes; Guanine Nucleotides; Humans; Kinetics; Mercaptoethanol; Phosphatidylinositols; Phosphotransferases; Polyethylene Glycols; Theophylline | 1977 |
Effect of cyclic-AMP and other compounds on electrical activity of neurohaemal tissue in Carausius.
Topics: Action Potentials; Adenosine; Animals; Bucladesine; Caffeine; Cyclic AMP; Histamine; Insecta; Nervous System; Norepinephrine; Theophylline | 1977 |
Interaction between caffeine and adenosine on the membrane current and tension component in the bullfrog atrial muscle.
Topics: Action Potentials; Adenosine; Animals; Anura; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; Manganese; Myocardial Contraction; Rana catesbeiana | 1979 |
Effects of cardioactive substances on the post-stimulation potentiation of contractility in the isolated dog atrium.
Topics: Adenosine; Animals; Caffeine; Chlorides; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Manganese; Myocardial Contraction; Ouabain; Pentobarbital; Propranolol; Tetrodotoxin; Verapamil | 1978 |
Differences in chronotropic and inotropic responses of canine atrial muscle and SA node pacemaker activity to adenosine and ACh.
Topics: Acetylcholine; Adenosine; Animals; Atrial Function; Atropine; Caffeine; Depression, Chemical; Dogs; Heart Rate; Myocardial Contraction; Physostigmine; Sinoatrial Node | 1976 |
Stacking interactions of nucleobases: NMR-investigations. II. Self-association of purine-and pyrimidine-derivatives.
Topics: Adenine; Adenosine; Caffeine; Chemical Phenomena; Chemistry; Cytosine; Deuterium; Hypoxanthines; Magnetic Resonance Spectroscopy; Polymers; Purines; Pyrimidines; Thermodynamics; Uracil; Uric Acid; Water | 1975 |
Association of sexual hormones with nucleobases in water: NMR-investigations.
Topics: Adenine; Adenosine; Caffeine; Chemical Phenomena; Chemistry; Cytosine; Deuterium; Estradiol; Hypoxanthines; Magnetic Resonance Spectroscopy; Purines; Pyrimidines; Testosterone; Thermodynamics; Uracil; Uric Acid; Water | 1975 |
Differential effects of various xanthines on pentylenetetrazole-induced seizures in rats: an EEG and behavioural study.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Caffeine; Electroencephalography; Male; Parasympatholytics; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Theophylline; Xanthines | 1992 |
Functional implications of cAMP and Ca2+ on prostaglandin I2 and thromboxane A2 synthesis by human endothelial cells.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Caffeine; Calcimycin; Calcium; Cells, Cultured; Cyclic AMP; Endothelium, Vascular; Epoprostenol; Humans; Kinetics; Tetradecanoylphorbol Acetate; Thrombin; Thromboxane A2 | 1992 |
Effect of nucleosides and nucleotides and the relationship between cellular adenosine 3':5'-cyclic monophosphate (cyclic AMP) and germ tube formation in Candida albicans.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine Nucleotides; Adenosine; Caffeine; Candida albicans; Cyclic AMP; Theophylline | 1992 |
Analysis of the effects of adenosine in skinned bovine coronary artery.
Topics: Adenosine; Animals; Caffeine; Calcium; Cattle; Coronary Vessels; Dinoprost; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Octoxynol; Polyethylene Glycols; Potassium; Saponins | 1992 |
Adenosine receptor link in an adrenal opioid-induced antinociception in the rat tail-flick test.
Topics: Adenosine; Analysis of Variance; Animals; Caffeine; Male; Nociceptors; Pain Measurement; Rats; Rats, Inbred Strains; Reaction Time; Receptors, Purinergic; Substance P | 1992 |
Effects of lithium and purinergic compounds on the behavioral and physiological aspects of restraint stress in rats.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Defecation; Injections, Intraperitoneal; Injections, Intraventricular; Lithium; Male; Motor Activity; Purines; Rats; Rats, Wistar; Restraint, Physical; Stomach Ulcer; Stress, Psychological | 1992 |
Effects of chronic treatment with caffeine on kidney responses to angiotensin II.
Topics: Adenosine; Angiotensin II; Animals; Caffeine; Drug Administration Schedule; Glomerular Filtration Rate; Kidney; Kidney Function Tests; Male; Perfusion; Rats; Rats, Sprague-Dawley | 1992 |
Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition?
Topics: Adenosine; Adipose Tissue, Brown; Animals; Caffeine; Diet; Dose-Response Relationship, Drug; Drug Synergism; Eating; Ephedrine; Fasting; Hot Temperature; Male; Obesity; Oxygen Consumption; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Theobromine; Xanthines | 1992 |
Evidence that the increase in striatal c-fos following acute high-dose caffeine is not due to direct interaction with striatal adenosine receptors.
Topics: Adenosine; Animals; Caffeine; Corpus Striatum; Dose-Response Relationship, Drug; Genes, fos; Purinergic Antagonists; Quinazolines; Rats; RNA, Messenger; Triazoles; Xanthines | 1992 |
Oral caffeine consumption by rats: the role of flavor history, concentration, concurrent food, and an adenosine agonist.
Topics: Adenosine; Animals; Caffeine; Drinking Behavior; Feeding Behavior; Food; Male; Phenylisopropyladenosine; Quinine; Rats; Taste | 1992 |
Effects of adenosinergic drugs on hypoxia-induced electrophysiological changes in rat hippocampal slices.
Topics: Adenosine; Animals; Caffeine; Dizocilpine Maleate; Electrophysiology; Hippocampus; Hypoxia; In Vitro Techniques; Male; Membrane Potentials; Phenethylamines; Phenylisopropyladenosine; Potassium; Purinergic Antagonists; Rats; Rats, Inbred Strains; Synapses; Xanthines | 1992 |
Purinergic agonist induction of metallothionein.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Cells, Cultured; Cladribine; Deoxyadenosines; Dose-Response Relationship, Drug; Immunoblotting; Liver; Male; Metallothionein; Rats; Rats, Inbred Strains; RNA, Messenger; Theophylline; Time Factors; Transcription, Genetic; Vasodilator Agents | 1992 |
Adenosine stimulates phosphate and glucose transport in opossum kidney epithelial cells.
Topics: Adenosine; Aminoisobutyric Acids; Animals; Biological Transport; Caffeine; Carrier Proteins; Cells, Cultured; Cyclic AMP; Dideoxyadenosine; Epithelium; Glucose; Kidney; Opossums; Phenylisopropyladenosine; Phosphates; Protein Kinase C; Sodium-Phosphate Cotransporter Proteins; Symporters | 1991 |
Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility.
Topics: Adenosine; alpha-Methyltyrosine; Animals; Caffeine; Catecholamines; Dose-Response Relationship, Drug; Male; Methyltyrosines; Mice; Motor Activity; Movement Disorders; Reserpine; Tyrosine 3-Monooxygenase | 1991 |
DC6, a novel type of Dictyostelium discoideum gene regulated by secreted factors but not by cAMP.
Topics: Adenosine; Animals; Blotting, Northern; Caffeine; Cell Differentiation; Cell Fractionation; Cloning, Molecular; Cyclic AMP; Dictyostelium; Gene Expression Regulation, Fungal; Genes, Fungal; RNA | 1991 |
Purinergic modulation of field stimulation responses of rat and human vas deferens smooth muscle.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Electric Stimulation; Guanethidine; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Quinidine; Rats; Receptors, Purinergic; Theophylline; Urinary Bladder; Vas Deferens; Vasodilator Agents | 1991 |
Effects of adenosine on human coronary arterial circulation.
Topics: Adenosine; Caffeine; Coronary Circulation; Dose-Response Relationship, Drug; Humans | 1991 |
Methylxanthine-induced attenuation of pecking in chickens.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Apomorphine; Behavior, Animal; Caffeine; Chickens; Dipyridamole; Female; Male; Theophylline; Xanthines | 1991 |
Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives.
Topics: 2-Chloroadenosine; Adenosine; Affinity Labels; Animals; Biological Transport; Caffeine; Cells, Cultured; Cytarabine; Dipyridamole; Embryo, Mammalian; Hippocampus; Kinetics; Neuroglia; Neurons; Pentoxifylline; Rats; Sodium; Theophylline; Thioinosine; Tritium; Xanthines | 1991 |
Neonatal caffeine exposure alters developmental sensitivity to adenosine receptor ligands.
Topics: Adenosine; Age Factors; Animals; Animals, Newborn; Brain; Caffeine; Kinetics; Ligands; Motor Activity; Phenylisopropyladenosine; Rats; Receptors, Purinergic | 1991 |
Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Bromocriptine; Caffeine; Dopamine; Male; Mice; Motor Activity; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Synapses; Theophylline; Xanthines | 1991 |
Role of adenosine receptors in caffeine tolerance.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Oral; Animals; Binding Sites; Brain; Caffeine; Cyclic AMP; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Male; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Time Factors; Tritium; Xanthines | 1991 |
Behavioral effects of adenosine agonists: evaluation by punishment, discrete shuttle avoidance and activity tests in mice.
Topics: Adenosine; Animals; Avoidance Learning; Caffeine; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Mice, Inbred Strains; Motor Activity; Phenylisopropyladenosine; Punishment; Reinforcement Schedule; Xanthines | 1991 |
The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology.
Topics: Adenosine; Animals; Blood Pressure; Brain Ischemia; Caffeine; Cerebral Cortex; Corpus Striatum; Hippocampus; Histocytochemistry; Magnetic Resonance Imaging; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, Purinergic | 1991 |
Caffeine and theophylline as adenosine receptor antagonists in humans.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Caffeine; Heart Rate; Humans; Male; Platelet Aggregation; Purinergic Antagonists; Receptors, Purinergic; Substance Withdrawal Syndrome; Theophylline | 1991 |
Peripheral mechanisms of thermogenesis induced by ephedrine and caffeine in brown adipose tissue.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Deaminase; Adipose Tissue, Brown; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature Regulation; Caffeine; Culture Techniques; Dose-Response Relationship, Drug; Drug Synergism; Ephedrine; Male; Oxygen Consumption; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Theophylline; Xanthines | 1991 |
Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Discrimination Learning; Dose-Response Relationship, Drug; Drug Administration Schedule; Locomotion; Male; Motor Activity; Rats; Rats, Inbred Strains; Xanthines | 1991 |
Behavioral effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine.
Topics: 2-Chloroadenosine; Adenosine; Animals; Behavior, Animal; Caffeine; Corpus Striatum; Dopamine; Flupenthixol; Male; Microinjections; Rats; Rats, Inbred Strains; Rotation; Stereoisomerism; Stereotyped Behavior | 1991 |
CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Dose-Response Relationship, Drug; Drug Tolerance; Male; Motor Activity; Quinazolines; Rats; Rats, Inbred Strains; Triazoles | 1991 |
Caffeine potentiates vasodilator-induced renin release.
Topics: Adenosine; Analysis of Variance; Animals; Blood Pressure; Caffeine; Chromatography, High Pressure Liquid; Drug Synergism; Hydralazine; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic; Renin; Xanthines | 1991 |
Fetal and newborn lambs differ in their cardiopulmonary responsiveness to adenosine agonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Animals, Newborn; Blood Pressure; Bradycardia; Caffeine; Female; Heart; Heart Rate, Fetal; Hydrogen-Ion Concentration; Phenylisopropyladenosine; Pregnancy; Pulmonary Gas Exchange; Respiration; Sheep; Vasodilator Agents | 1990 |
Activation of Na+/Ca2+ exchange by adenosine in ewe heart sarcolemma is mediated by a pertussis toxin-sensitive G protein.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Calcium; Female; GTP-Binding Proteins; Guanosine; Heart Ventricles; Inosine; Kinetics; Myocardium; Pertussis Toxin; Phenylisopropyladenosine; Sarcolemma; Sheep; Sodium; Virulence Factors, Bordetella | 1990 |
Chronic carbamazepine down-regulates adenosine A2 receptors: studies with the putative selective adenosine antagonists PD115,199 and PD116,948.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Brain Chemistry; Caffeine; Carbamazepine; Clonidine; Cyclic AMP; Down-Regulation; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenylisopropyladenosine; Purines; Receptors, Adrenergic; Sulfonamides; Theophylline; Xanthines | 1990 |
Adenosine and its analogs stimulate phosphoinositide hydrolysis in the kidney.
Topics: Adenosine; Animals; Caffeine; Dose-Response Relationship, Drug; Hydrolysis; In Vitro Techniques; Kidney; Kidney Medulla; Male; Phosphatidylinositols; Rabbits; Receptors, Muscarinic | 1990 |
Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
Topics: Adenosine; Adenosine Deaminase; Animals; Brain Chemistry; Caffeine; Cerebral Cortex; Colforsin; Cyclic AMP; Dipyridamole; Drug Synergism; In Vitro Techniques; Male; Phosphodiesterase Inhibitors; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Purinergic | 1990 |
Chronic caffeine exposure enhances adenosinergic inhibition of cerebral cortical neurons.
Topics: Adenosine; Animals; Caffeine; Cerebral Cortex; Dose-Response Relationship, Drug; Electrophysiology; Male; Neurons; Rats; Rats, Inbred Strains; Reference Values | 1990 |
An electrophysiological study of the ontogenesis of adenosine receptors in the CA1 area of rat hippocampus.
Topics: Action Potentials; Adenosine; Animals; Caffeine; Female; Hippocampus; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic; Thioinosine | 1990 |
Depressive effects of lipid peroxides mediated via a purine receptor. Effect of lipid peroxide on the cortical synaptosomal GTPase activity.
Topics: Adenosine; Animals; Caffeine; Cerebral Cortex; Circadian Rhythm; Down-Regulation; GTP Phosphohydrolases; Lipid Peroxides; Locomotion; Mice; Phenobarbital; Rats; Receptors, Purinergic; Synaptosomes | 1990 |
Caffeine and theophylline attenuate adenosine-induced vasodilation in humans.
Topics: Adenosine; Adolescent; Adult; Bronchodilator Agents; Caffeine; Female; Forearm; Humans; Infusions, Intra-Arterial; Male; Regional Blood Flow; Theophylline; Vasodilation; Xanthines | 1990 |
Adenosine involvement in postictal events in amygdala-kindled rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Amygdala; Animals; Anticonvulsants; Caffeine; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Kindling, Neurologic; Male; Rats; Seizures; Theophylline; Time Factors | 1990 |
Effects of some adenosine analogs on morphine-induced analgesia and tolerance.
Topics: 2-Chloroadenosine; Adenosine; Analgesics; Animals; Caffeine; Drug Synergism; Drug Tolerance; Injections, Intraventricular; Mice; Morphine; Naloxone; Phenylisopropyladenosine | 1990 |
The effects of TMB-8 on acetylcholine release from frog motor nerve: interactions with adenosine.
Topics: Acetylcholine; Adenosine; Animals; Caffeine; Calcium Channel Blockers; Gallic Acid; In Vitro Techniques; Motor Endplate; Motor Neurons; Rana pipiens | 1990 |
Effects of uric acid and caffeine on A1 adenosine receptor binding in developing rat brain.
Topics: Adenosine; Aging; Animals; Binding, Competitive; Brain; Caffeine; Male; Oxonic Acid; Rats; Rats, Inbred Strains; Receptors, Purinergic; Time Factors; Uric Acid | 1990 |
Further characterization of adenosine transport in renal brush-border membranes.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Biological Transport; Caffeine; Hypoxanthine; Hypoxanthines; Kidney Tubules, Proximal; Kinetics; Microvilli; Rats; Rats, Inbred Strains; Sodium; Substrate Specificity | 1990 |
Sixth International Caffeine Workshop, Hong Kong, 7-10 August 1989.
Topics: Adenosine; Animals; Arrhythmias, Cardiac; Bone Development; Caffeine; DNA Replication; Female; Humans; Mental Processes; Pregnancy; Prenatal Exposure Delayed Effects; Reproduction | 1990 |
Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Caffeine; Calcium; Cytosol; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Xanthines | 1990 |
Effects of caffeine, L-phenylisopropyladenosine and their combination on local cerebral blood flow in the rat.
Topics: Adenosine; Animals; Antipyrine; Blood Pressure; Caffeine; Cerebrovascular Circulation; Drug Interactions; Male; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Inbred Strains | 1990 |
Noncompetitive antagonism of adenosine by caffeine on the hepatic and superior mesenteric arteries of anesthetized cats.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Cats; Chloralose; Dose-Response Relationship, Drug; Drug Interactions; Female; Hepatic Artery; Injections, Intravenous; Isoproterenol; Male; Mesenteric Arteries; Pentobarbital | 1990 |
Caffeine-induced seizures: apparent proconvulsant action of N-ethyl carboxamidoadenosine (NECA).
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticonvulsants; Caffeine; Cerebral Ventricles; Dose-Response Relationship, Drug; Male; Mice; Premedication; Receptors, Purinergic; Regression Analysis; Seizures | 1990 |
Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Chlordiazepoxide; Conditioning, Psychological; Male; Phenylisopropyladenosine; Receptors, Cell Surface; Receptors, Purinergic; Saimiri; Theobromine; Theophylline; Xanthines | 1985 |
Behavioral characteristics of centrally administered adenosine analogs.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Caffeine; Dilazep; Dipyridamole; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Motor Activity | 1986 |
Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Analgesia; Animals; Caffeine; Hyperalgesia; Injections, Intraventricular; Injections, Spinal; Male; Mice; Morphine; Naloxone; Nociceptors; Spinal Cord; Theophylline; Xanthines | 1986 |
Effect of chronically administered methylxanthines on ethanol-induced motor incoordination in mice.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Brain; Caffeine; Drug Synergism; Ethanol; Kinetics; Male; Mice; Motor Activity; Receptors, Purinergic; Theophylline; Xanthines | 1986 |
Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adrenergic alpha-Antagonists; Animals; Apomorphine; Avoidance Learning; Caffeine; Clonidine; Diazepam; Discrimination Learning; Male; Norepinephrine; Pentobarbital; Picrotoxin; Rats; Rats, Inbred Strains; Theobromine; Theophylline | 1986 |
Paradoxical stimulation of human sperm motility by 2-deoxyadenosine.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Caffeine; Calcimycin; Colforsin; Cyclic AMP; Deoxyadenosines; Freezing; Humans; Male; Sperm Motility; Spermatozoa; Stimulation, Chemical | 1986 |
Inhibition of porcine adipose tissue lipogenesis by beta-adrenergic agonists.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adipose Tissue; Adrenergic beta-Agonists; Animals; Caffeine; Drug Interactions; Epinephrine; Isoproterenol; Lipids; Male; Propranolol; Swine; Theophylline | 1989 |
Effect of adenosine on gonadotropin and prolactin secretion by hemipituitaries in vitro.
Topics: Adenosine; Animals; Caffeine; Culture Media; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; In Vitro Techniques; Luteinizing Hormone; Male; Pituitary Gland; Prolactin; Rats | 1989 |
The role of the purinergic system in the control of stereotypy: relationship to D-1/D-2 dopamine receptor activity.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Benzazepines; Caffeine; Carbamazepine; Dopamine Antagonists; Drug Interactions; Electroencephalography; Haloperidol; Male; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic; Stereotyped Behavior | 1989 |
Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.
Topics: Adenosine; Animals; Brain; Caffeine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Flumazenil; Male; Mice; Motor Activity; Receptors, GABA-A | 1989 |
Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors.
Topics: 2-Chloroadenosine; Adenosine; Alprazolam; Anxiety; Caffeine; Chlordiazepoxide; Clonidine; Flumazenil; Motor Activity; Muscle Relaxants, Central; Norepinephrine; Propranolol; Receptors, Adrenergic; Receptors, GABA-A; Receptors, Purinergic; Social Behavior | 1989 |
Comparison of motility stimulants for cryopreserved human semen.
Topics: Adenosine; Animals; Caffeine; Calcium; Cricetinae; Cyclic AMP; Deoxyadenosines; Female; Humans; Kallikreins; Male; Pentoxifylline; Relaxin; Semen Preservation; Sperm Motility; Sperm-Ovum Interactions | 1989 |
Xylazine-evoked depression of rat cerebral cortical neurons: a pharmacological study.
Topics: Acetylcholine; Adenosine; Animals; Caffeine; Cerebral Cortex; Depression, Chemical; In Vitro Techniques; Male; Neural Inhibition; Neurons; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Inbred Strains; Thiazines; Xylazine | 1989 |
Alpha 2-adrenergic, kappa-opiate, and P1-purinergic autoreceptors have mutually antagonistic effects: a new regulatory mechanism?
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine; Adrenergic alpha-Antagonists; Analgesics; Animals; Benzofurans; Caffeine; Calcium; Cerebral Cortex; Clonidine; Dioxanes; Fluorescent Dyes; Fura-2; Homeostasis; Idazoxan; Male; Naloxone; Phenylisopropyladenosine; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Purinergic; Synaptosomes | 1989 |
Methyl xanthines enhance taste: evidence for modulation of taste by adenosine receptor.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adult; Animals; Caffeine; Female; Humans; In Vitro Techniques; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Taste; Theobromine; Theophylline; Xanthines | 1985 |
The effect of adenosine and adenosine analogues on methylxanthine-induced hypercalciuria in the rat.
Topics: Adenosine; Animals; Body Weight; Caffeine; Calcium; Diet; Diuresis; Male; Rats; Rats, Inbred Strains; Theobromine; Theophylline; Xanthines | 1989 |
Modulatory effects of adenosine on baroreflex activation in the brainstem of normotensive rats.
Topics: Adenosine; Animals; Blood Pressure; Brain Stem; Caffeine; Cisterna Magna; Heart Rate; Injections; Male; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred Strains; Reflex | 1989 |
Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
Topics: Adenosine; Animals; Caffeine; Drug Synergism; Furosemide; Kidney; Male; Rats; Rats, Inbred Strains; Renin; Xanthines | 1989 |
Differential expression of the ICF (immunodeficiency, centromeric heterochromatin, facial anomalies) mutation in lymphocytes and fibroblasts.
Topics: Adenosine; Caffeine; Centromere; Child, Preschool; Chromosome Aberrations; Chromosomes; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 9; Facial Expression; Female; Fibroblasts; Folic Acid; Humans; Immunologic Deficiency Syndromes; Lymphocytes; Mutation; Thymidine | 1989 |
Carbamazepine, but not caffeine, is highly selective for adenosine A1 binding sites.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Carbamazepine; Cerebellum; Corpus Striatum; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic | 1989 |
Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
Topics: Adenosine; Aldosterone; Angiotensin II; Animals; Blood Pressure; Caffeine; Heart Rate; Male; Rats; Rats, Inbred Strains; Xanthines | 1989 |
Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Autonomic Nervous System; Blood Pressure; Caffeine; Male; Movement; Pain; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Spinal Cord; Urinary Bladder | 1989 |
Methodological approach to pharmacodynamic calculations of vascular responses in vivo.
Topics: Adenosine; Animals; Caffeine; Cats; Dose-Response Relationship, Drug; Hemodynamics; Liver Circulation; Vascular Resistance | 1989 |
Caffeine and premenstrual syndrome.
Topics: Adenosine; Animals; Caffeine; Female; Humans; Premenstrual Syndrome; Rats | 1989 |
Inhibitory effects of carbamazepine on clonidine-induced aggressive behavior in mice.
Topics: Adenosine; Aggression; Animals; Behavior, Animal; Caffeine; Carbamazepine; Clonidine; Haloperidol; Male; Mice; Prazosin; Receptors, Cell Surface; Yohimbine | 1988 |
The effect of caffeine, adenosine, and buffer ionic composition on the induction of cell-surface cAMP binding during starvation of Dictyostelium discoideum.
Topics: Adenosine; Buffers; Caffeine; Cyclic AMP; Dictyostelium; Kinetics; Receptors, Cyclic AMP | 1988 |
The role of adenosine in cerebral vascular regulation during reductions in perfusion pressure.
Topics: Adenosine; Animals; Blood Gas Analysis; Blood Pressure; Caffeine; Cerebrovascular Circulation; Injections, Intraperitoneal; Male; Perfusion; Rats; Rats, Inbred Strains; Vascular Resistance | 1986 |
Inhibitory neuromodulators do not alter the course of experimental hepatic encephalopathy.
Topics: Adenosine; Animals; Caffeine; Cerebral Ventricles; Glycine; Hepatic Encephalopathy; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neurotransmitter Agents; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Strychnine | 1988 |
Fanconi's anemia lymphocytes: effect of caffeine, adenosine and niacinamide during G2 prophase.
Topics: Adenosine; Anemia, Aplastic; Caffeine; Chromosome Aberrations; DNA Repair; Fanconi Anemia; Humans; In Vitro Techniques; Interphase; Lymphocytes; NAD; Niacinamide | 1988 |
Chlorpromazine and trifluoperazine potentiate the action of adenosine on rat cerebral cortical neurons.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Cerebral Cortex; Chlorpromazine; Depression, Chemical; Drug Synergism; Iontophoresis; Male; Rats; Rats, Inbred Strains; Synaptic Transmission; Synaptosomes; Trifluoperazine; Vasodilator Agents | 1985 |
Interactive effects of caffeine, 2-chloroadenosine and haloperidol on activity, social investigation and play fighting of juvenile rats.
Topics: 2-Chloroadenosine; Adenosine; Aggression; Animals; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Male; Motor Activity; Rats; Receptors, Cell Surface; Receptors, Purinergic; Social Behavior | 1985 |
On the mechanism of action of theophylline and caffeine.
Topics: Adenosine; Asthma; Caffeine; Calcium; Cyclic AMP; Humans; Muscle Contraction; Receptors, Cell Surface; Receptors, Purinergic; Theophylline | 1985 |
Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice.
Topics: Adenosine; Analgesics; Animals; Brain; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Humans; Male; Mice; Morphine; Morphine Dependence; Phenylisopropyladenosine; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
Influence of cyclic AMP and hydrolysis products on cell type regulation in Dictyostelium discoideum.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acid Phosphatase; Adenine; Adenosine; Caffeine; Cell Differentiation; Cyclic AMP; Dictyostelium; Electrophoresis, Polyacrylamide Gel; Hydrolysis; Isoenzymes; Spores, Fungal | 1985 |
Effects of caffeine and 8-phenyltheophylline on the actions of purines and opiates in the guinea-pig ileum.
Topics: Adenosine; Animals; Caffeine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Muscle Contraction; Nalorphine; Norepinephrine; Phenylisopropyladenosine; Receptors, Cell Surface; Receptors, Purinergic; Theophylline | 1986 |
Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine.
Topics: Adenosine; Animals; Caffeine; Color; Conditioning, Operant; Food; Male; Phenylisopropyladenosine; Rats; Receptors, Cell Surface; Receptors, Purinergic; Reinforcement Schedule; Stereoisomerism | 1985 |
Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
Topics: Adenosine; Adenylyl Cyclases; Animals; Caffeine; Cerebral Cortex; Cross-Linking Reagents; Guanine Nucleotides; Kinetics; Male; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Purinergic; Substance Withdrawal Syndrome; Time Factors | 1986 |
Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)-adenosine (PIA) in mice.
Topics: Adenosine; Animals; Body Weight; Caffeine; Dose-Response Relationship, Drug; Drinking; Drug Tolerance; Kinetics; Male; Methamphetamine; Mice; Motor Activity; Phenylisopropyladenosine; Receptors, Cell Surface; Receptors, Purinergic | 1986 |
Caffeine intensifies taste of certain sweeteners: role of adenosine receptor.
Topics: Adenosine; Adult; Caffeine; Drug Synergism; Female; Humans; Male; Receptors, Cell Surface; Receptors, Purinergic; Sweetening Agents; Taste | 1986 |
The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.
Topics: Adenosine; Animals; Biological Transport; Caffeine; Cyclic AMP; Drug Synergism; Erythrocyte Membrane; Hippocampus; Humans; Pentoxifylline; Rats; Receptors, Cell Surface; Receptors, Purinergic; Structure-Activity Relationship; Theobromine; Xanthines | 1986 |
Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Adipose Tissue; Adrenal Gland Neoplasms; Animals; Blood Platelets; Caffeine; Humans; Phenylisopropyladenosine; Pheochromocytoma; Rats; Receptors, Cell Surface; Receptors, Purinergic; Structure-Activity Relationship | 1986 |
Chronic caffeine treatment reduces caffeine but not adenosine effects on cortical acetylcholine release.
Topics: Acetylcholine; Adenosine; Animals; Body Weight; Caffeine; Cerebral Cortex; Electric Stimulation; Exploratory Behavior; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic | 1986 |
Adenosine in renin-dependent renovascular hypertension.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic; Renin; Renin-Angiotensin System; Time Factors | 1988 |
Ro 15-1788 both antagonizes and potentiates adenosine-evoked depression of cerebral cortical neurons.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Cerebral Cortex; Evoked Potentials; Flumazenil; Male; Rats; Rats, Inbred Strains | 1987 |
Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Male; Psychomotor Performance; Receptors, Purinergic; Saimiri; Stimulation, Chemical; Theophylline; Xanthines | 1988 |
3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Body Temperature; Caffeine; Male; Mice; Mice, Inbred DBA; Motor Activity; Reference Values; Theobromine; Theophylline | 1988 |
Purinergic modulation of cortical acetylcholine release is decreased in aging rats.
Topics: Acetylcholine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Aging; Animals; Caffeine; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Male; Parietal Lobe; Rats; Rats, Inbred Strains | 1988 |
Differences in adenosine A-1 and A-2 receptor density revealed by autoradiography in methylxanthine-sensitive and insensitive mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Autoradiography; Brain; Caffeine; Male; Mice; Mice, Inbred CBA; Mice, Inbred Strains; Organ Specificity; Receptors, Purinergic; Species Specificity; Tritium | 1988 |
Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; Caffeine; Cerebellum; Cerebral Cortex; Corpus Striatum; Hippocampus; Male; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic | 1988 |
Comparative effects of caffeine and L-phenylisopropyladenosine on local cerebral glucose utilization in the rat.
Topics: Adenosine; Animals; Brain; Caffeine; Carbon Radioisotopes; Drug Synergism; Glucose; Humans; Locomotion; Male; Phenylisopropyladenosine; Rats; Rats, Inbred Strains | 1988 |
Role of endogenous adenosine as a modulator of the renin response to salt restriction.
Topics: Adenosine; Animals; Caffeine; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Male; Potassium; Rats; Rats, Inbred Strains; Receptors, Purinergic; Renal Circulation; Renin; Sodium; Xanthines | 1987 |
Comparative influence of calcium blocker and purinergic drugs on epileptiform bursting in rat hippocampal slices.
Topics: Adenosine; Animals; Caffeine; Calcium; Epilepsy; Hippocampus; In Vitro Techniques; Magnesium; Male; Neurons; Nifedipine; Phenylisopropyladenosine; Pyramidal Tracts; Rats; Rats, Inbred Strains; Verapamil | 1988 |
Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Caffeine; Conditioning, Operant; Drug Interactions; Male; Motor Activity; Phenylisopropyladenosine; Receptors, Purinergic; Saimiri | 1988 |
Anticonvulsant activity of carbamazepine and N6-L-phenylisopropyladenosine in rabbits. Relationship to adenosine receptors in central nervous system.
Topics: Adenosine; Animals; Anticonvulsants; Caffeine; Carbamazepine; Central Nervous System; Drug Interactions; Electroencephalography; Male; Pentylenetetrazole; Phenylisopropyladenosine; Rabbits; Receptors, Purinergic; Seizures | 1988 |
Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Dextroamphetamine; Drug Tolerance; Male; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Theophylline | 1988 |
Endogenous adenosine and hemorrhagic shock: effects of caffeine administration or caffeine withdrawal.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Male; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; Substance Withdrawal Syndrome; Time Factors | 1988 |
Potentiation of the anti-lipolytic effect of 2-chloroadenosine after chronic caffeine treatment.
Topics: 2-Chloroadenosine; Adenosine; Adipose Tissue; Animals; Body Weight; Caffeine; Cell Membrane; Drug Synergism; In Vitro Techniques; Lipolysis; Male; Organ Size; Radioligand Assay; Rats; Rats, Inbred Strains; Xanthines | 1988 |
Endogenous adenosine inhibits hippocampal CA1 neurones: further evidence from extra- and intracellular recording.
Topics: Adenosine; Adenosine Deaminase; Animals; Caffeine; Electrophysiology; Evoked Potentials; Hippocampus; In Vitro Techniques; Male; Neurons; Rats; Rats, Inbred Strains; Thioinosine | 1988 |
Interactions between caffeine and adenosine agonists in producing embryo resorptions and malformations in mice.
Topics: 2-Chloroadenosine; Abnormalities, Drug-Induced; Adenosine; Animals; Body Weight; Caffeine; Drug Administration Schedule; Drug Synergism; Embryo Loss; Female; Fetal Death; Mice; Mice, Inbred Strains; Phenylisopropyladenosine; Pregnancy | 1987 |
Stimulation of glycogenolysis in isolated hepatocytes by adenosine and one of its analogues is inhibited by caffeine.
Topics: Adenosine; Adenosine Deaminase; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Cell Separation; Dose-Response Relationship, Drug; Enzyme Activation; Glucagon; In Vitro Techniques; Liver; Liver Glycogen; Male; Phenylisopropyladenosine; Phosphorylases; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1987 |
An involvement of adenosine in cerebral blood flow regulation during hypercapnia.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Cerebrovascular Circulation; Coformycin; Dipyridamole; Hypercapnia; Male; Pentostatin; Rats; Rats, Inbred Strains | 1987 |
Effects of N6-(L-phenylisopropyl)adenosine, caffeine, theophylline and rolipram on the acquisition of conditioned responses in the rabbit.
Topics: Adenosine; Animals; Caffeine; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Interactions; Female; Male; Phenylisopropyladenosine; Pyrrolidinones; Rabbits; Rolipram; Theophylline | 1987 |
Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Blood Pressure; Caffeine; Cardiovascular System; Clonidine; Cocaine; Dextroamphetamine; Heart Rate; Isomerism; Macaca fascicularis; Male; Phenylisopropyladenosine | 1987 |
Central effects of adenosine analogs on blood pressure and heart rate in the mouse.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Blood Pressure; Caffeine; Heart Rate; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Phenylisopropyladenosine | 1987 |
Psychomotor stimulant effects of caffeine alone and in combination with an adenosine analog in the squirrel monkey.
Topics: Adenosine; Amphetamine; Animals; Behavior, Animal; Caffeine; Chlorpromazine; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Food; Male; Motor Activity; Saimiri | 1987 |
A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Dose-Response Relationship, Drug; Heart Rate; Male; Mice; Mice, Inbred Strains; Nicotine; Receptors, Purinergic | 1987 |
Evidence that adenosine mediates the depression of spinal dorsal horn neurons induced by peripheral vibration in the cat.
Topics: Adenosine; Animals; Bicuculline; Blood Pressure; Caffeine; Cats; Dipyridamole; Injections, Intravenous; Iontophoresis; Naloxone; Neurons; Spinal Cord; Strychnine; Theophylline; Vibration | 1987 |
Effects of caffeine and L-phenylisopropyladenosine on locomotor activity of mice.
Topics: Adenosine; Animals; Caffeine; Cerebral Cortex; Corpus Striatum; Dose-Response Relationship, Drug; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Phenylisopropyladenosine; Time Factors; Tritium | 1987 |
Effects of 2-chloroadenosine on hippocampal GABA content and turnover.
Topics: 2-Chloroadenosine; 4-Aminobutyrate Transaminase; Adenosine; Aminooxyacetic Acid; Animals; Caffeine; gamma-Aminobutyric Acid; Hippocampus; Injections, Intraventricular; Kinetics; Male; Rats; Rats, Inbred Strains | 1986 |
Reduction of liver plasma flow by caffeine and theophylline.
Topics: Adenosine; Adult; Blood Pressure; Caffeine; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Humans; Indocyanine Green; Kinetics; Liver Circulation; Male; Middle Aged; Norepinephrine; Theophylline | 1986 |
Effects of selected analogs of adenosine on schedule-controlled behavior in rats.
Topics: Adenosine; Animals; Caffeine; Chlordiazepoxide; Conditioning, Operant; Drug Interactions; Drug Tolerance; Levorphanol; Male; Phenylisopropyladenosine; Rats; Reaction Time; Reinforcement Schedule | 1986 |
Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.
Topics: Adenosine; Blood Pressure; Brain; Caffeine; Heart Rate; Hemodynamics; Receptors, Purinergic; Theophylline | 1987 |
Behavioral effects of caffeine, (-)N-((R)-1-methyl-2-phenylethyl)-adenosine (PIA), and their combination in the mouse.
Topics: Adenosine; Animals; Caffeine; Conditioning, Operant; Drug Interactions; Food; Light; Male; Mice; Reinforcement Schedule; Sound | 1985 |
Effect of adenosine, adenosine derivatives, and caffeine on acetylcholine release from brain synaptosomes: interaction with muscarinic autoregulatory mechanisms.
Topics: Acetylcholine; Adenosine; Animals; Brain; Caffeine; Cerebral Cortex; Hippocampus; Male; Oxotremorine; Physostigmine; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Synaptosomes | 1986 |
Effect of caffeine and adenosine on G2 repair: mitotic delay and chromosome damage.
Topics: Adenosine; Caffeine; Chromosomes; DNA Repair; Interphase; Mitosis; Plants; Uracil | 1985 |
Effects of caffeine and L-PIA on rats with selective damage of the hippocampal system.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Colchicine; Conditioning, Operant; Dose-Response Relationship, Drug; Hippocampus; Male; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Adenosine antagonists. Lack of effect on the inhibition of kindled seizures in rats by carbamazepine.
Topics: Adenosine; Animals; Caffeine; Carbamazepine; Kindling, Neurologic; Male; Rats; Rats, Inbred Strains; Seizures; Theophylline | 1985 |
Effects of caffeine on hippocampal pyramidal cells in vitro.
Topics: Adenosine; Animals; Caffeine; Calcium; Electric Stimulation; Evoked Potentials; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Neural Conduction; Neurons; Pyramidal Tracts; Rats; Rats, Inbred Strains; Synapses; Tetrodotoxin | 1985 |
Protective effect of adenosine and nicotinamide against audiogenic seizure.
Topics: Acoustic Stimulation; Adenosine; Adenosine Triphosphate; Animals; Blood Pressure; Brain Chemistry; Caffeine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Mice; Mice, Inbred Strains; NAD; Niacinamide; Norepinephrine; Phosphocreatine; Phosphorus Radioisotopes; Time Factors | 1974 |
Repression of alkaline phosphatase synthesis by adenine, adenosine and adenine nucleotides in an adenine auxotroph of Bacillus anthracis.
Topics: Adenine; Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Alkaline Phosphatase; Bacillus anthracis; Caffeine; Chlorpromazine; Culture Media; Dinitrophenols; Enzyme Repression; Inosine Nucleotides; Lyases; Mutation; Phosphates; Theophylline | 1973 |
The determination of nikethamide and other compounds in pharmaceutical dosage forms by thin-layer chromatography.
Topics: Adenosine; Caffeine; Chromatography, Thin Layer; Dosage Forms; Gels; Methods; Niacinamide; Silicon Dioxide; Solvents; Spectrophotometry; Strychnine; Theophylline; Ultraviolet Rays | 1971 |
Significance of the caffeine-like effect of various purines, pyrimidines and derivatives on adipose-tissue phosphodiesterase.
Topics: Adenine; Adenosine; Adipose Tissue; Animals; Caffeine; Deoxyadenosines; Epididymis; Guanosine; Male; Phosphoric Monoester Hydrolases; Purines; Pyrimidines; Rats | 1971 |
Methyl xantines in the inhibition of platelet aggregation.
Topics: Adenosine; Aminophylline; Blood Platelets; Caffeine; Cell Aggregation; Cyclic AMP; Norepinephrine; Tritium; Xanthines | 1971 |
Aggregation of human blood platelets by vasopressin.
Topics: Acetates; Adenosine; Animals; Anticoagulants; Blood Platelets; Caffeine; Carbon Isotopes; Cations, Divalent; Cell Aggregation; Chelating Agents; Citrates; Creatine Kinase; Cyclic AMP; Dogs; Ethylmaleimide; Fibrinogen; Glycols; Hirudins; Humans; Imipramine; Phosphocreatine; Prostaglandins; Rabbits; Serotonin; Swine; Vasopressins | 1972 |
Effects of antilipolytic agents and alpha-adrenergic antagonists on cyclic AMP metabolism in hamster white adipocytes.
Topics: 1-Propanol; Adenosine; Adipose Tissue; Adrenocorticotropic Hormone; Animals; Caffeine; Cricetinae; Cyclic AMP; Epididymis; Epinephrine; Male; Nicotinic Acids; Norepinephrine; Phenoxybenzamine; Phentolamine; Prostaglandins; Pyrazoles; Tritium | 1973 |
Effect of certain halogenated hydrocarbon insecticides on cyclic adenosine 3',5'-monophosphate-3H formation by rat kidney cortex.
Topics: Adenosine; Adenylyl Cyclases; Animals; Caffeine; Chlordan; Cyclic AMP; DDT; Dieldrin; Dose-Response Relationship, Drug; Drug Synergism; Endrin; Heptachlor; Hydrazines; Imidazoles; Insecticides; Kidney Cortex; Male; Phosphoric Diester Hydrolases; Propranolol; Prostaglandins; Rats; Tritium | 1974 |
Interactions of the pharmacological receptors of blood platelets with adenylate cyclase.
Topics: Adenosine; Adenosine Diphosphate; Adenylyl Cyclases; Binding Sites; Blood Platelets; Caffeine; Carbon Radioisotopes; Centrifugation, Density Gradient; Chromatography, Thin Layer; Cyclic AMP; Enzyme Activation; Epinephrine; Humans; Isoproterenol; Papaverine; Platelet Adhesiveness; Prostaglandins; Receptors, Adrenergic; Stimulation, Chemical; Sympatholytics; Time Factors | 1973 |
Inhibition of platelet adherence to a collagen-coated surface by agents that inhibit platelet shape change and clot retraction.
Topics: Adenosine; Adenosine Diphosphate; Animals; Blood Platelets; Caffeine; Carbon Radioisotopes; Chromium Radioisotopes; Clot Retraction; Colchicine; Collagen; Cyclic AMP; Cytochalasin B; Maleimides; Mercuribenzoates; Phosphoric Monoester Hydrolases; Platelet Adhesiveness; Prostaglandins; Serotonin; Sulfhydryl Compounds; Sulfonic Acids; Swine | 1974 |
The aggregation of rabbit polymorphonuclear leucocytes: effects of antimitotic agents, cyclic nucleotides and methyl xanthines.
Topics: Adenine; Adenosine; Animals; Bucladesine; Caffeine; Cell Aggregation; Colchicine; Cyclic AMP; Cyclic GMP; Depression, Chemical; In Vitro Techniques; Leukocytes; Nucleotides, Cyclic; Rabbits; Stimulation, Chemical; Theobromine; Theophylline; Vinblastine; Xanthines | 1974 |
Studies on lipolysis in lipid micelles isolated from adipose tissue.
Topics: Adenosine; Adenosine Monophosphate; Adipose Tissue; Animals; Bucladesine; Caffeine; Colloids; Cyclic AMP; Epididymis; Epinephrine; In Vitro Techniques; Lipid Metabolism; Macromolecular Substances; Male; Phospholipases; Rats; Theophylline | 1974 |
Structure-activity relations for caffeine: a comparative study of the inotropic effects of the methylxanthines, imidazoles and related compounds on the frog's heart.
Topics: Adenosine; Animals; Caffeine; Cyclic AMP; Dose-Response Relationship, Drug; Heart; Heart Atria; Histamine; Histidine; Hydrogen-Ion Concentration; Hypoxanthines; Imidazoles; In Vitro Techniques; Naphazoline; Phentolamine; Pilocarpine; Potassium; Pyridines; Rana pipiens; Solutions; Structure-Activity Relationship; Surface Tension; Theobromine; Theophylline; Tolazoline; Xanthines | 1974 |
Theophylline inhibition of nucleoside transport and its relation to cyclic AMP in skeletal muscle.
Topics: Adenine; Adenosine; Animals; Biological Transport; Bucladesine; Caffeine; Carbon Radioisotopes; Chromatography, Paper; Cyclic AMP; Hypoxanthines; In Vitro Techniques; Inosine; Isoproterenol; Muscle Contraction; Muscles; Nucleosides; Phenytoin; Propranolol; Protein Binding; Purines; Rana pipiens; Ribose; Sorbitol; Theophylline; Tritium; Uridine | 1974 |
Cyclic AMP-induced tyrosinase synthesis in Neurospora crassa.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Bucladesine; Caffeine; Catechol Oxidase; Cyclic AMP; Cycloheximide; Enzyme Induction; Neurospora; Neurospora crassa; Theophylline | 1974 |
Chlorpromazine-induced contracture of frog rectus abdominis muscle.
Topics: Acetylcholine; Adenosine; Animals; Arsenic; Atropine; Caffeine; Chlorpromazine; Choline; Cocaine; Cyanides; Electric Stimulation; Fluorides; Hexamethonium Compounds; In Vitro Techniques; Iodoacetates; Muscle Contraction; Ouabain; Physostigmine; Potassium Chloride; Procaine; Quinine; Sparteine; Stimulation, Chemical; Tubocurarine | 1974 |
[The effect of methylxanthines on catecholamine and adenylate nucleotide concentration in rat myocardium].
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Caffeine; Inosine; Inosine Nucleotides; Myocardium; Phosphorus; Rats; Stimulation, Chemical; Strophanthins; Theobromine; Theophylline; Tyramine; Xanthines | 1974 |
[Comparative investigation on the vitro inhibition of adenosine decomposition by dilazep].
Topics: Adenosine; Adult; Azepines; Benzoates; Caffeine; Cell Membrane Permeability; Dipyridamole; Drug Interactions; Erythrocytes; Ethylenediamines; Humans; In Vitro Techniques; Lidoflazine; Theophylline; Vasodilator Agents | 1974 |
Adenosine uptake by isolated membrane vesicles from Escherichia coli K-12.
Topics: Adenine; Adenosine; Ascorbic Acid; Azides; Biological Transport, Active; Caffeine; Carbon Radioisotopes; Cell Membrane; Chloromercuribenzoates; Escherichia coli; Iodoacetates; Kinetics; Maleimides; Microscopy, Electron; Mutation; Organoids; Phenazines; Ribonucleosides; Time Factors | 1973 |
On the mechanism of the antagonistic action of xanthine derivatives against adenosine and coronary vasodilators.
Topics: Acetamides; Adenosine; Animals; Blood Flow Velocity; Caffeine; Cell Membrane Permeability; Coronary Vessels; Coumarins; Dipyridamole; Dogs; Drug Interactions; Erythrocytes; Female; Glycolates; Humans; Male; Piperazines; Receptors, Drug; Structure-Activity Relationship; Theophylline; Vasodilator Agents; Xanthines; Xylenes | 1972 |
Inhibition of the negative chronotropic action of adenosine by caffeine in the dog.
Topics: Acetylcholine; Action Potentials; Adenosine; Animals; Caffeine; Calcium; Dogs; Female; Heart Rate; Male; Norepinephrine; Pacemaker, Artificial; Sinoatrial Node; Time Factors | 1973 |
Effects of amines on the level of N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in mouse brain tissue slices.
Topics: Acetylcholine; Adenosine; Amines; Amino Acids; Amino Alcohols; Aminobutyrates; Animals; Aspartic Acid; Basal Ganglia; Biogenic Amines; Brain; Caffeine; Cerebellum; Cerebral Cortex; Dipeptides; Dopamine; Edetic Acid; Glutamates; Glycine; Histamine; Medulla Oblongata; Mice; Norepinephrine; Pons; Puromycin; Serotonin; Spermine; Taurine | 1971 |
Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system.
Topics: Adenosine; Animals; Anticonvulsants; Brain; Caffeine; Carbamazepine; Cerebellum; Cerebral Cortex; Cyclic AMP; Phenobarbital; Phenytoin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Theophylline | 1984 |
Tolerance to N6-(L-phenylisopropyl) adenosine. Contribution of behavioral mechanisms and cross-tolerance profile.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Chlorpromazine; Dose-Response Relationship, Drug; Drug Tolerance; Male; Phenylisopropyladenosine; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Purinergic | 1984 |
Adenosine analogs: potentiation of bradykinin-induced plasma exudation in rat skin and prevention by caffeine and theophylline.
Topics: Adenosine; Animals; Bradykinin; Caffeine; Capillary Permeability; Cyproheptadine; Drug Synergism; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Skin; Theophylline | 1984 |
Purine involvement in morphine antinociception.
Topics: 2-Chloroadenosine; Adenosine; Analgesia; Animals; Body Temperature; Bucladesine; Caffeine; Male; Morphine; Phenylisopropyladenosine; Rats; Rats, Inbred Strains | 1984 |
Adenosine mediates sedative action of various centrally active drugs.
Topics: Adenosine; Animals; Antipsychotic Agents; Arousal; Brain; Caffeine; Diazepam; Hypnotics and Sedatives; Phenothiazines; Rats; Receptors, Cell Surface; Receptors, Purinergic; Synapses; Synaptic Transmission; Synaptosomes; Theophylline | 1982 |
Interactions between catecholamines, methyl xanthines and adenosine in regulation of cyclic AMP accumulation in hamster adipocytes.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine Deaminase; Adipose Tissue; Animals; Caffeine; Catecholamines; Cricetinae; Cyclic AMP; Epinephrine; Isoproterenol; Mesocricetus; Norepinephrine; Phentolamine; Theophylline | 1980 |
Methylxanthines modulate adenosine release from slices of cerebral cortex.
Topics: 1-Methyl-3-isobutylxanthine; Adenine; Adenosine; Adenosine Triphosphatases; Aminophylline; Animals; Caffeine; Cerebral Cortex; Cyclic AMP; gamma-Aminobutyric Acid; Male; Mice; Ouabain; Theophylline; Xanthines | 1981 |
Interactions in the behavioral effects of methylxanthines and adenosine derivatives.
Topics: Adenosine; Animals; Blood Pressure; Brain; Caffeine; Cardiac Complexes, Premature; Diazepam; Drug Interactions; Heart Rate; Male; Mice; Mice, Inbred ICR; Motor Activity; Phenylisopropyladenosine; Receptors, Cell Surface; Receptors, Purinergic; Stimulation, Chemical; Xanthines | 1983 |
Inhibition of the transport of adenosine, other nucleosides and hypoxanthine in novikoff rat hepatoma cells by methylxanthines, papaverine, N6-cyclohexyladenosine and N6-phenylisopropyladenosine.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Biological Transport, Active; Caffeine; Cell Line; Hypoxanthine; Hypoxanthines; Liver Neoplasms, Experimental; Papaverine; Phenylisopropyladenosine; Rats; Theophylline; Uridine; Xanthines | 1984 |
Behavioral and molecular actions of caffeine: focus on adenosine.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Anxiety Disorders; Behavior; Caffeine; Child; Cyclic AMP; Diagnosis, Differential; Humans; Male; Phenylisopropyladenosine; Psychomotor Performance; Rats; Receptors, Cell Surface; Receptors, Purinergic; Seizures; Sleep Initiation and Maintenance Disorders; Stimulation, Chemical; Tea; Xanthines | 1984 |
Behavioral interaction of adenosine and methylxanthines on central purinergic systems.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; Caffeine; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Papaverine; Theophylline | 1984 |
Effects of antimutagens on prophage induction in E coli lysogenic for lambda.
Topics: Acriflavine; Adenosine; Aminoacridines; Bacteriophage lambda; Caffeine; DNA Repair; Escherichia coli; Quinacrine; Spermine; Ultraviolet Rays; Virus Activation | 1983 |
Purine antagonists in the identification of adenosine-receptors in guinea-pig trachea and the role of purines in non-adrenergic inhibitory neurotransmission.
Topics: Adenosine; Animals; Caffeine; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Phenoxybenzamine; Phentolamine; Purines; Quinidine; Receptors, Drug; Synaptic Transmission; Trachea; Xanthines | 1980 |
Effects of caffeine and theophylline on adenosine and benzodiazepine receptors in human brain.
Topics: Adenosine; Binding, Competitive; Brain; Caffeine; Diazepam; Humans; Phenylisopropyladenosine; Receptors, Cell Surface; Receptors, Drug; Receptors, GABA-A; Receptors, Purinergic; Theophylline; Xanthines | 1982 |
Adenosine actions and adenosine receptors after 1 week treatment with caffeine.
Topics: Adenosine; Adipose Tissue; Animals; Caffeine; Cyclic AMP; Dose-Response Relationship, Drug; Hippocampus; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Time Factors | 1982 |
[Purinergic effect of ethymisole].
Topics: Adenosine; Adenosine Triphosphate; Adenylyl Cyclases; Animals; Brain; Caffeine; Cyclic AMP; Drug Interactions; Energy Metabolism; Etimizol; Imidazoles; Rats | 1982 |
Coffee and opiate receptors. Another cup of coffee?
Topics: Adenosine; Animals; Caffeine; Coffee; Guinea Pigs; Humans; Naloxone; Receptors, Cell Surface; Receptors, Opioid; Receptors, Purinergic | 1983 |
Chronic caffeine consumption increases the number of brain adenosine receptors.
Topics: Adenosine; Animals; Brain; Caffeine; Diazepam; Diet; Mice; Receptors, Cell Surface; Receptors, Purinergic; Xanthines | 1983 |
Discriminative stimulus properties of L-phenylisopropyl adenosine: blockade by caffeine and generalization to 2-chloroadenosine.
Topics: 2-Chloroadenosine; Adenosine; Animals; Caffeine; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Phenylisopropyladenosine; Rats; Receptors, Cell Surface; Receptors, Purinergic | 1983 |
Reduction in caffeine toxicity by acetaminophen.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Acetaminophen; Acoustic Stimulation; Adenosine; Adult; Animals; Brain; Caffeine; Drug Interactions; Female; Humans; Mice; Seizures | 1982 |
Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.
Topics: 2-Chloroadenosine; Adenosine; Adenylyl Cyclases; Animals; Brain; Caffeine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Theobromine; Theophylline; Xanthines | 1983 |
Evidence for the presence of P1- and P2-purinoceptors in rat caecum.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Animals; Caffeine; Cecum; Cyclic AMP; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Quinidine; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Theophylline | 1983 |
Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies.
Topics: Adenosine; Animals; Brain; Brain Stem; Caffeine; Cerebellum; Female; Male; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Purinergic; Thioinosine; Time Factors | 1984 |
The synergistic action of caffeine or adenosine on glucose stimulation of liver glycogen synthase phosphatase activity.
Topics: Adenine; Adenosine; Animals; Caffeine; Drug Synergism; Enzyme Activation; Glucose; Glycogen-Synthase-D Phosphatase; Liver; Phosphoprotein Phosphatases; Rats | 1984 |
Hormone and methylxanthine action on breast epithelial cells.
Topics: 2-Chloroadenosine; Adenosine; Animals; Breast; Breast Neoplasms; Caffeine; Cell Line; Cyclic AMP; Epithelium; Female; Fibrocystic Breast Disease; Humans; Mice; Terbutaline; Xanthines | 1984 |
Caffeine actions and adenosine.
Topics: Adenosine; Animals; Caffeine; Mice; Motor Activity | 1984 |
Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices.
Topics: Acetylcholine; Adenosine; Aminophylline; Animals; Brain; Caffeine; Dipyridamole; Drug Interactions; Electric Stimulation; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Xanthines | 1984 |
Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants.
Topics: Action Potentials; Adenosine; Animals; Antidepressive Agents, Tricyclic; Caffeine; Cerebral Cortex; Clomipramine; Desipramine; Drug Synergism; Iprindole; Male; Neurons; Nortriptyline; Rats; Rats, Inbred Strains | 1984 |
Antagonism of the behavioral effects of L-phenylisopropyladenosine (L-PIA) by caffeine and its metabolites.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Conditioning, Psychological; Male; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Theophylline; Xanthines | 1984 |
Effects of anoxia on cerebral blood flow in the rat brain: evidence for a role of adenosine in autoregulation.
Topics: Adenosine; Animals; Brain; Caffeine; Cerebrovascular Circulation; Dipyridamole; Homeostasis; Hypoxia; Injections, Intravenous; Male; Papaverine; Rats; Rats, Inbred Strains; Regional Blood Flow | 1984 |
Behavioral effects of caffeine, N6-(L-phenylisopropyl) adenosine and their combination in the squirrel monkey.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Combinations; Electroshock; Food; Male; Phenylisopropyladenosine; Saimiri | 1984 |
Effect of adenosine and caffeine on acetylcholine release from electrically stimulated brain slices.
Topics: Acetylcholine; Adenosine; Animals; Caffeine; Cerebral Cortex; Male; Rats; Rats, Inbred Strains | 1984 |
Antagonism of enkephalin action on acetylcholine release by methylxanthines: lack of a purine link.
Topics: Acetylcholine; Adenosine; Animals; Caffeine; Cerebral Cortex; Enkephalins; Guinea Pigs; In Vitro Techniques; Morphine; Muscle Contraction; Muscle, Smooth; Myenteric Plexus; Rats; Theophylline; Xanthines | 1983 |
Adenosine strongly potentiates pressor responses to nicotine in rats.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Drug Synergism; Electric Stimulation; Male; Nicotine; Phenylephrine; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Theophylline | 1984 |
Thermoregulatory effects of purines and caffeine.
Topics: Adenosine; Animals; Body Temperature Regulation; Caffeine; Drug Interactions; Inosine; Male; Purine Nucleosides; Rats; Rats, Inbred Strains | 1983 |
Novel form of drug-dependence--on adenosine in guinea pig ileum.
Topics: Adenosine; Animals; Caffeine; Guinea Pigs; Humans; Ileum; Morphine Derivatives; Muscle Contraction; Muscle, Smooth; Substance-Related Disorders; Theophylline | 1983 |
Adenosine modulation of amygdala kindling.
Topics: 2-Chloroadenosine; Adenosine; Aminophylline; Amygdala; Animals; Caffeine; Differential Threshold; Kindling, Neurologic; Male; Papaverine; Rats; Rats, Inbred Strains; Seizures | 1984 |
Chronic caffeine consumption potentiates the hypotensive action of circulating adenosine.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Drug Synergism; Male; Rats; Rats, Inbred Strains | 1983 |
2'-Deoxyadenosine functionally uncouples adenylate cyclase from the guanyl nucleotide subunit without altering simultaneous GppNHp occupancy.
Topics: Adenosine; Adenylyl Cyclases; Animals; Caffeine; Cell Line; Cell Membrane; Deoxyadenosines; Enzyme Activation; Glioma; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Hybrid Cells; Kinetics; Macromolecular Substances; Mice; Neuroblastoma | 1980 |
Stimulation of nucleologenesis by adenosine.
Topics: Adenosine; Caffeine; Cell Division; Cell Nucleolus; Cell Nucleus; Chromatin; Densitometry; Plant Cells | 1982 |
ATP level and caffeine efficiency on cytokinesis inhibition in plants.
Topics: 2,4-Dinitrophenol; Adenosine; Adenosine Triphosphate; Caffeine; Cell Division; Dinitrophenols; Fluoroacetates; Nucleosides; Oxygen; Plant Cells; Plants | 1982 |
N6 (L-phenylisopropyl) adenosine (L-PHA) increases slow-wave sleep (S2) and decreases wakefulness in rats.
Topics: Adenosine; Animals; Caffeine; Male; Phenylisopropyladenosine; Rats; Sleep; Wakefulness | 1982 |
Effect of caffeine on G2 repair and its reversion by adenosine.
Topics: Adenosine; Adenosine Triphosphate; Caffeine; Cell Cycle; Chromosome Aberrations; Chromosomes; DNA Repair; Plants; Radiation-Sensitizing Agents; Uracil; Xanthines | 1982 |
Effects of morphine and caffeine on adenosine release from rat cerebral cortex: is caffeine a morphine antagonist.
Topics: Acetylcholine; Adenosine; Animals; Caffeine; Cerebral Cortex; Male; Morphine; Rats; Tritium | 1980 |
Adenosine discriminates between the caffeine and adenine nucleotide sites on the sheep cardiac sarcoplasmic reticulum calcium-release channel.
Topics: Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Animals; Caffeine; Calcium; Calcium Channels; Dose-Response Relationship, Drug; Ion Channel Gating; Magnesium; Myocardium; Ruthenium Red; Ryanodine; Sarcoplasmic Reticulum; Sheep | 1994 |
Vascular effects of pentoxifylline in humans.
Topics: Adenosine; Adult; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Female; Forearm; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Muscle, Smooth, Vascular; Pentoxifylline; Receptors, Purinergic P1; Vasodilation | 1994 |
Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
Topics: Adenosine; Animals; Antihypertensive Agents; Blood Pressure; Caffeine; Drug Evaluation, Preclinical; Drug Interactions; Heart Rate; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats | 1995 |
Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Topics: Adenosine; Analgesics; Animals; Behavior, Animal; Caffeine; Calcium; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Nociceptors; Oligopeptides; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord; Synaptosomes | 1995 |
Hemocyte adhesion in the California mussel (Mytilus californianus): regulation by adenosine.
Topics: Adenosine; Animals; Bivalvia; Caffeine; Cell Adhesion; Cyclic AMP; Hemocytes; Receptors, Purinergic P1 | 1995 |
Locomotor activity in mice during chronic treatment with caffeine and withdrawal.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Caffeine; Dopamine Agents; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Parasympathomimetics; Substance Withdrawal Syndrome; Xanthines | 1993 |
Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Corpus Striatum; Enkephalins; Gene Expression Regulation; Globus Pallidus; Neurons; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Purinergic; Substance P; Substantia Nigra | 1993 |
G2 repair and aging: influence of donor age on chromosomal aberrations in human lymphocytes.
Topics: Adenosine; Adult; Aged; Aging; Caffeine; Cell Cycle; Child, Preschool; Chromosome Aberrations; DNA Repair; Female; Humans; In Vitro Techniques; Infant; Male; Middle Aged; Niacinamide | 1993 |
[Quantitative and qualitative criteria for assessing the efficacy of antimutagens in an experiment].
Topics: 4-Aminobenzoic Acid; Adenosine; alpha-Tocopherol; Animals; Antimutagenic Agents; Benzoates; Bone Marrow; Bone Marrow Cells; Caffeine; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Combinations; Gamma Rays; Humans; Lymphocytes; Magnoliopsida; Mice; Salmonella typhimurium; Seeds; Tocopherols; Vitamin E | 1993 |
Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors.
Topics: Adenosine; Animals; Antihypertensive Agents; Anxiety; Behavior, Animal; Caffeine; Darkness; Drug Interactions; Light; Male; Mice; Phenethylamines; Purinergic P1 Receptor Antagonists; Structure-Activity Relationship; Theophylline; Xanthines | 1994 |
[Mutagenesis, antimutagenesis and the cellular regulatory system].
Topics: Adenosine; Antimutagenic Agents; Caffeine; Colchicine; Cyclic AMP; Mutagenesis; Plant Cells; Plants; Seeds; Theophylline | 1995 |
Partial sciatic nerve ligation results in an enlargement of the receptive field and enhancement of the response of dorsal horn neurons to noxious stimulation by an adenosine agonist.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Caffeine; Causalgia; Electrophysiology; Hyperalgesia; Male; Neurons; Nociceptors; Pain Measurement; Patch-Clamp Techniques; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Stimulation, Chemical; Vasodilator Agents | 1994 |
Effects of neonatal exposure to caffeine on adenosine A1 receptor ontogeny using autoradiography.
Topics: Adenosine; Administration, Oral; Aging; Animals; Animals, Newborn; Autoradiography; Brain; Caffeine; Cerebellum; Female; Hippocampus; Humans; Infant, Newborn; Infant, Premature; Male; Neurons; Organ Specificity; Pyramidal Cells; Rats; Receptors, Purinergic P1; Thalamus; Tritium | 1994 |
Effects of alkylxanthines on contractility of diaphragm fibres isolated from normal and sensitized guinea-pigs.
Topics: Adenosine; Animals; Bronchodilator Agents; Caffeine; Calcium; Culture Media; Dantrolene; Diaphragm; Electric Stimulation; Extracellular Space; Female; Guinea Pigs; Immunization; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; Serum Albumin, Bovine; Theobromine; Theophylline; Verapamil; Xanthines | 1993 |
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Brain; Brain Chemistry; Caffeine; CHO Cells; Cricetinae; Gene Expression; Iodine Radioisotopes; Molecular Structure; Phenethylamines; Phenylisopropyladenosine; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Transfection; Xanthines | 1994 |
Chronic effects of ethanol on central adenosine function of mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; Caffeine; Ethanol; Male; Mice; Motor Activity; Purinergic P1 Receptor Antagonists; Radioligand Assay; Receptors, Purinergic P1; Time Factors | 1994 |
Caffeine and propranolol block the increase in rat pineal melatonin production produced by stimulation of adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Binding, Competitive; Caffeine; Caudate Nucleus; Circadian Rhythm; Male; Melatonin; Pineal Gland; Propranolol; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vasodilator Agents | 1994 |
Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation.
Topics: Adenosine; Animals; Caffeine; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; MPTP Poisoning; Receptors, Purinergic P1; Theophylline; Tyrosine 3-Monooxygenase | 1994 |
Epileptogenic actions of xanthines in relation to their affinities for adenosine A1 receptors in CA3 neurons of hippocampal slices (guinea pig).
Topics: Adenosine; Animals; Caffeine; Calcium; Cyclic AMP; Epilepsy; Guinea Pigs; Hippocampus; In Vitro Techniques; Magnesium; Membrane Potentials; Neurons; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Xanthines | 1994 |
Calcium concentration changes in the calyciform nerve terminal of the avian ciliary ganglion after tetanic stimulation.
Topics: Adenosine; Animals; Caffeine; Calcium; Chick Embryo; Electric Stimulation; Ganglia, Parasympathetic; Long-Term Potentiation; Nerve Endings; Nifedipine; Potassium; Terpenes; Tetany; Thapsigargin | 1994 |
Reduction by intracellular calcium chelation of acetylcholine secretion without occluding the effects of adenosine at frog motor nerve endings.
Topics: Acetylcholine; Adenosine; Animals; Buffers; Caffeine; Calcium; Chelating Agents; Cytoplasm; Drug Interactions; Egtazic Acid; In Vitro Techniques; Intracellular Fluid; Motor Neurons; Nerve Endings; Neuromuscular Junction; Rana pipiens | 1994 |
Effects of adenosine receptor agonists and antagonists on acquisition of passive avoidance learning.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Avoidance Learning; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraperitoneal; Male; Mice; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Theophylline; Vasodilator Agents | 1994 |
Behavioral and pharmacological modulation of respiration in rhesus monkeys.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Cocaine; Humans; Infant, Newborn; Macaca mulatta; Male; Plethysmography; Respiration | 1994 |
Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine.
Topics: Adenosine; Caffeine; Contraindications; Coronary Disease; Dipyridamole; Heart; Hemodynamics; Humans; Immunoenzyme Techniques; Male; Middle Aged; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon | 1994 |
Adenosine agonists reduce conditioned avoidance responding in the rat.
Topics: Adenosine; Animals; Antipsychotic Agents; Avoidance Learning; Binding, Competitive; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Electroshock; Female; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Purinergic; Receptors, Purinergic P1 | 1993 |
Role of adenosine in the hypoxic ventilatory response of the newborn piglet.
Topics: Adenosine; Animals; Animals, Newborn; Caffeine; Cerebrospinal Fluid; Citrates; Dipyridamole; Drug Combinations; Hypoxia; Oxygen; Purinergic P1 Receptor Antagonists; Respiration; Swine; Theophylline | 1994 |
ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord.
Topics: Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Animals; Caffeine; Calcium; Electrophysiology; Extracellular Space; Intracellular Membranes; Neuroglia; Neurons; Rats; Rats, Wistar; Spinal Cord; Suramin; Terpenes; Thapsigargin | 1994 |
Defective G2 repair in Down syndrome: effect of caffeine, adenosine and niacinamide in control and X-ray irradiated lymphocytes.
Topics: Adenosine; Adenosine Triphosphate; Caffeine; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, 21-22 and Y; DNA Repair; Down Syndrome; Humans; Infant; Lymphocytes; Niacinamide | 1994 |
Mechanisms of CBF augmentation during hypoxia in cats: probable participation of prostacyclin, nitric oxide and adenosine.
Topics: Adenosine; Animals; Arginine; Caffeine; Cats; Cerebrovascular Circulation; Epoprostenol; Hypoxia; Indomethacin; Nitric Oxide; omega-N-Methylarginine | 1994 |
Restraint stress potentiates analgesia induced by 5'-N-ethylcarboxamidoadenosine: comparison with morphine.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analgesia; Animals; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Male; Morphine; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Restraint, Physical; Stress, Physiological | 1993 |
Effect of adenosine blockade on plasma renin activity and catecholamines.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Consciousness; Epinephrine; Hydralazine; Kidney; Male; Norepinephrine; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Renin; Renin-Angiotensin System; Secretory Rate; Sodium, Dietary; Theophylline; Xanthines | 1993 |
Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adolescent; Adult; Alprostadil; Blood Platelets; Caffeine; Epoprostenol; Humans; Male; Models, Biological; Purinergic P1 Receptor Antagonists; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Purinergic P1; Sensitivity and Specificity; Substance Withdrawal Syndrome; Up-Regulation | 1993 |
Adenosine release is a major cause of failure of synaptic transmission during hypoglycaemia in rat hippocampal slices.
Topics: Action Potentials; Adenosine; Animals; Caffeine; Cell Hypoxia; Energy Metabolism; Evoked Potentials; Glucose; Glyburide; Hippocampus; Hypoglycemia; Neural Inhibition; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Theophylline; Tolbutamide | 1993 |
8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Caffeine; Locomotion; Male; Mice; Rats | 1993 |
Effects of adenosine agonists on ventilation during hypercapnia, hypoxia and hyperoxia in rhesus monkeys.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Carbon Dioxide; Female; Hypercapnia; Hypoxia; Macaca mulatta; Male; Oxygen; Phenethylamines; Plethysmography; Pyrrolidinones; Receptors, Purinergic; Respiration; Respiratory Function Tests; Rolipram | 1993 |
Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain.
Topics: Adenosine; Animals; Autoradiography; Base Sequence; Blotting, Northern; Brain; Caffeine; Corpus Striatum; Hippocampus; In Situ Hybridization; Male; Molecular Sequence Data; Organ Specificity; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; RNA, Messenger; Xanthines | 1993 |
Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway.
Topics: Adenosine; Adrenergic Uptake Inhibitors; Animals; Caffeine; Dopamine Agonists; Ergolines; Genes, fos; Globus Pallidus; Immunohistochemistry; Male; Neostriatum; Neural Pathways; Phosphodiesterase Inhibitors; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reserpine; Theobromine; Theophylline | 1995 |
Effects of diazepam and cyclohexyladenosine on open-field behavior in rats perinatally exposed to caffeine.
Topics: Adenosine; Animals; Caffeine; Diazepam; Eliminative Behavior, Animal; Emotions; Female; Grooming; Locomotion; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Sex Characteristics | 1996 |
Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration.
Topics: Adenosine; Adenosine Kinase; Adenosine-5'-(N-ethylcarboxamide); Analgesics; Animals; Caffeine; Deoxyadenosines; Enzyme Inhibitors; Formaldehyde; Male; Pentostatin; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1 | 1995 |
Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Antineoplastic Agents; Astrocytoma; Blotting, Northern; Caffeine; Dose-Response Relationship, Immunologic; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; RNA, Messenger; Stereoisomerism; Tumor Cells, Cultured; Xanthines | 1996 |
Purine suppression of proliferation of Sertoli-like TM4 cells in culture.
Topics: Adenosine; Animals; Caffeine; Cell Division; Cells, Cultured; Male; Mice; Purinergic P1 Receptor Antagonists; Purines; Receptors, Purinergic P1; Sertoli Cells; Theobromine; Theophylline | 1995 |
Anxiolytic activity of adenosine receptor activation in mice.
Topics: Adenosine; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Caffeine; Male; Maze Learning; Mice; Motor Activity; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline | 1995 |
Circadian rhythm in the Ca(2+)-inhibitable adenylyl activity of the rat striatum.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Caffeine; Calcium; Circadian Rhythm; Colforsin; Corpus Striatum; Cyclic AMP; Guanosine Diphosphate; Isoenzymes; Male; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley | 1996 |
Methylxanthines with adenosine alter TNF alpha-primed PMN activation.
Topics: Adenosine; Caffeine; Humans; Kinetics; Luminescent Measurements; Neutrophil Activation; Neutrophils; Pentoxifylline; Peroxidase; Superoxides; Tumor Necrosis Factor-alpha | 1995 |
Caffeine-evoked contractures in single slow (tonic) muscle fibres of the frog (Rana temporaria and R. esculenta).
Topics: Adenosine; Administration, Topical; Animals; Caffeine; Cations, Divalent; Dose-Response Relationship, Drug; Gallopamil; Hydrogen-Ion Concentration; Injections; Lanthanum; Muscle Contraction; Muscle Fibers, Skeletal; Osmolar Concentration; Potassium; Rana esculenta; Rana temporaria; Time Factors | 1996 |
Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Electroencephalography; Male; Rats; Rats, Sprague-Dawley; Sleep; Sleep Deprivation; Sleep Stages | 1996 |
An adenosine agonist increases blood flow and density of capillary branches in the optic tectum of Xenopus laevis tadpoles.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Capillaries; Microcirculation; Microscopy, Video; Neovascularization, Physiologic; Nitroglycerin; Regional Blood Flow; Superior Colliculi; Theophylline; Time Factors; Vasodilator Agents; Xenopus laevis | 1994 |
Genetic variation in immediate and delayed postictal refractory period in rats.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Epilepsy; Genetic Variation; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Species Specificity | 1996 |
Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum.
Topics: Adenosine; Animals; Antihypertensive Agents; Caffeine; Camptothecin; Dopamine; Enzyme Inhibitors; Extracellular Space; Irinotecan; Male; Microdialysis; Neostriatum; Phenethylamines; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theobromine; Vasodilator Agents | 1996 |
Central effects of caffeine on renal renin secretion and norepinephrine spillover.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Hydralazine; Injections, Intraventricular; Kidney; Male; Norepinephrine; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Renin; Vasodilator Agents; Xanthines | 1996 |
Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites.
Topics: Adenosine; Animals; Autoradiography; Benzazepines; Binding Sites; Binding, Competitive; Caffeine; Central Nervous System Stimulants; Dopamine Antagonists; Iodine Radioisotopes; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1 | 1996 |
Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
Topics: Adenosine; Animals; Brain Ischemia; Caffeine; Cell Survival; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Female; Gerbillinae; Hippocampus; Laser-Doppler Flowmetry; Neurons; Phenethylamines; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Treatment Outcome | 1995 |
Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis.
Topics: Adenosine; Adenosine Deaminase; Caffeine; Dipyridamole; Humans; Inosine; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha; Xanthines | 1997 |
Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis.
Topics: Adenosine; Animals; Anticonvulsants; Caffeine; Carbamazepine; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Ligands; Male; Microdialysis; Rats; Rats, Wistar; Receptors, Purinergic P1 | 1997 |
Caffeine: a model drug of abuse.
Topics: Adenosine; Animals; Behavior; Caffeine; Dopamine; Humans; Substance-Related Disorders | 1996 |
Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses.
Topics: Adenosine; Animals; Caffeine; Cerebral Cortex; Corpus Striatum; Evoked Potentials; Glipizide; Glucose; Glutamic Acid; Hypoglycemic Agents; In Vitro Techniques; Membrane Potentials; Neurons; Potassium Channel Blockers; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synapses; Theophylline; Tolbutamide; Xanthines | 1997 |
Adenosine exerts a glycogen-sparing action in contracting rat skeletal muscle.
Topics: Adenosine; Animals; Caffeine; Cyclic AMP; Drug Combinations; Glycogen; Glycogen Synthase; Male; Muscle Contraction; Muscle, Skeletal; Phosphorylase a; Rats; Rats, Wistar; Theobromine; Xanthines | 1997 |
A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment.
Topics: Adenosine; Animals; Antihypertensive Agents; Autoradiography; Brain Chemistry; Caffeine; Central Nervous System Stimulants; Cerebellum; Cerebral Cortex; Corpus Striatum; Hippocampus; In Situ Hybridization; Male; Mice; Mice, Inbred Strains; Phenethylamines; Radioligand Assay; Receptors, Purinergic P1; RNA, Messenger; Time Factors; Tritium; Xanthines | 1997 |
Adenosine receptors. Knockouts anxious for new therapy.
Topics: Adenosine; Animals; Caffeine; Drug Therapy; Mice; Mice, Knockout; Pain; Receptors, Purinergic P1 | 1997 |
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.
Topics: Adenosine; Aggression; Animals; Blood Pressure; Brain; Caffeine; Cloning, Molecular; Heart Rate; Humans; Hypertension; Male; Mice; Mice, Knockout; Molecular Sequence Data; Pain; Phenethylamines; Platelet Aggregation; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Restriction Mapping; Sequence Homology, Amino Acid | 1997 |
Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adrenal Gland Neoplasms; Animals; Blotting, Western; Caffeine; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Activation; Enzyme Inhibitors; Isoquinolines; Kinetics; PC12 Cells; Phenethylamines; Pheochromocytoma; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Recombinant Proteins; Sulfonamides | 1997 |
Caffeine alters plasma adenosine levels.
Topics: Adenosine; Animals; Caffeine; Humans; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Sympathomimetics; Tyramine | 1997 |
Purinergic modulation of rat urinary bladder detrusor smooth muscle.
Topics: Adenosine; Adenosine Triphosphate; Animals; Atropine; Caffeine; Electric Stimulation; In Vitro Techniques; Labetalol; Male; Muscle, Smooth; Purinergic Agonists; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Quinidine; Rats; Rats, Wistar; Receptors, Purinergic; Urinary Bladder | 1997 |
Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
Topics: Adenosine; Animals; Binding, Competitive; Brain; Caffeine; Molecular Structure; Phenethylamines; Protein Binding; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Theobromine; Xanthines | 1997 |
Adenosine A2A receptors facilitate 45Ca2+ uptake through class A calcium channels in rat hippocampal CA3 but not CA1 synaptosomes.
Topics: 2-Chloroadenosine; Adenosine; Animals; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Hippocampus; Male; omega-Agatoxin IVA; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Spider Venoms; Synaptosomes; Veratridine; Xanthines | 1997 |
Adenosine-stimulated intracellular calcium increase in cultured human uterine myocyte.
Topics: Adenosine; Adult; Aniline Compounds; Caffeine; Calcium; Cells, Cultured; Female; Fluorescent Dyes; Humans; Middle Aged; Myometrium; Xanthenes | 1998 |
Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum.
Topics: Action Potentials; Adenosine; Animals; Axons; Caffeine; Corpus Callosum; Electrophysiology; Immunohistochemistry; Male; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Synapses; Synaptic Transmission | 1998 |
Stress-dependent antinociceptive effects of carbamazepine: a study in stressed and nonstressed rats.
Topics: Adenosine; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Caffeine; Carbamazepine; Cerebral Ventricles; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intraventricular; Male; Naloxone; Pain; Physical Stimulation; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Restraint, Physical; Stress, Psychological; Time Factors | 1998 |
Inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) mimics the effect of inescapable shock on escape learning in rats.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Analysis of Variance; Animals; Caffeine; Central Nervous System Stimulants; Electroshock; Enzyme Inhibitors; Escape Reaction; Fear; Helplessness, Learned; Male; Neural Inhibition; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reaction Time; Restraint, Physical; Stress, Psychological | 1998 |
Caffeine abstinence augments the systolic blood pressure response to adenosine in humans.
Topics: Adenosine; Adult; Blood Pressure; Caffeine; Heart Rate; Humans; Male; Middle Aged; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome | 1998 |
The role of adenosine in rat coronary flow regulation during respiratory and metabolic acidosis.
Topics: Acidosis; Acidosis, Respiratory; Adenosine; Animals; Caffeine; Coronary Circulation; Hypercapnia; Male; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Theophylline; Triazines; Triazoles | 1998 |
Inhibition of strychnine-allodynia is mediated by spinal adenosine A1- but not A2-receptors in the rat.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Heart Rate; Injections, Spinal; Male; Pain; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Spinal Cord; Strychnine; Xanthines | 1998 |
Calcium in sympathetic boutons of rat superior cervical ganglion during facilitation, augmentation and potentiation.
Topics: Action Potentials; Adenosine; Adrenergic Fibers; Agatoxins; Animals; Caffeine; Calcium; Calcium Channel Blockers; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Central Nervous System Stimulants; Chelating Agents; Egtazic Acid; Enzyme Inhibitors; Ionophores; Kinetics; Nifedipine; omega-Conotoxin GVIA; Peptides; Presynaptic Terminals; Rats; Rats, Wistar; Ryanodine; Spider Venoms; Superior Cervical Ganglion; Synaptic Transmission; Thapsigargin | 1998 |
Quantifying the molecular structure of behavior: separate effects of caffeine, cocaine, and adenosine agonists on interresponse times and lever-press durations.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Phenylisopropyladenosine; Rats; Reaction Time; Reinforcement Schedule; Time Factors; Vasodilator Agents | 1997 |
Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Phenylisopropyladenosine; Rats | 1997 |
Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons.
Topics: Adenosine; Adenylyl Cyclases; Animals; Caffeine; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; In Vitro Techniques; Neostriatum; Neurons; Patch-Clamp Techniques; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Signal Transduction; Theophylline | 1998 |
Pharmacological interactions between magnesium ion and adenosine on monoaminergic system in the central nervous system.
Topics: Adenosine; Animals; Biogenic Monoamines; Caffeine; Carbamazepine; Central Nervous System; Central Nervous System Stimulants; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Hippocampus; Magnesium; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Serotonin; Theobromine; Theophylline; Visual Cortex | 1998 |
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
Topics: Adenosine; Animals; Antihypertensive Agents; Biological Transport; Caffeine; Central Nervous System Stimulants; Fluoxetine; Hippocampus; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quipazine; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Theobromine; Theophylline; Vasodilator Agents | 1999 |
Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart.
Topics: Adenine; Adenosine; Aminoimidazole Carboxamide; Animals; Caffeine; Creatine Kinase; Electrocardiography; Enzyme Inhibitors; Hypoxanthine; Inosine; Male; Myocardial Ischemia; Myocardium; Perfusion; Rats; Rats, Wistar; Reperfusion Injury; Ribonucleosides; Theophylline; Thioinosine; Thiophenes; Time Factors; Ventricular Fibrillation; Xanthines | 1999 |
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Topics: Adenosine; Animals; Antipsychotic Agents; Behavior, Animal; Caffeine; Catalepsy; Clozapine; Corpus Striatum; Cyclic AMP; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Genes, fos; GTP-Binding Protein alpha Subunits, Gs; Haloperidol; Nerve Tissue Proteins; Neurons; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Second Messenger Systems; Serotonin; Serotonin Antagonists; Theophylline | 1999 |
Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine.
Topics: Adenosine; Amitriptyline; Analgesics; Animals; Antidepressive Agents, Tricyclic; Caffeine; Dose-Response Relationship, Drug; Male; Pain; Pain Measurement; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Glutamate; Receptors, Histamine; Receptors, Opioid | 1999 |
Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse.
Topics: Adenosine; Animals; Caffeine; Drug Combinations; Drug Resistance; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Narcotics; Purinergic P1 Receptor Antagonists; Xanthines | 1999 |
Adenine-nucleotide binding sites on the inositol 1,4,5-trisphosphate receptor bind caffeine, but not adenophostin A or cyclic ADP-ribose.
Topics: Adenine; Adenosine; Adenosine Diphosphate Ribose; Animals; Binding Sites; Caffeine; Calcium; Calcium Channels; Cyclic ADP-Ribose; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Inositol 1,4,5-Trisphosphate Receptors; Mice; Models, Genetic; Protein Binding; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Time Factors | 1999 |
Intravascular source of adenosine during forearm ischemia in humans: implications for reactive hyperemia.
Topics: Adenosine; Adult; Caffeine; Female; Forearm; Humans; Hyperemia; Ischemia; Male; Microdialysis; Muscle, Skeletal; Reference Values; Regional Blood Flow; Substance Withdrawal Syndrome; Thromboxanes; Time Factors | 1999 |
Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells.
Topics: Adenosine; Animals; Caffeine; Cell Hypoxia; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Endothelial Growth Factors; Lymphokines; Male; Muscle, Smooth, Vascular; Myocardium; Reference Values; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system.
Topics: Adenosine; Animals; Apoptosis Regulatory Proteins; Caffeine; Cell Count; Central Nervous System Stimulants; DNA-Binding Proteins; Dopamine; Early Growth Response Protein 1; Fluorescent Antibody Technique; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Hydroxydopamines; Image Processing, Computer-Assisted; Immediate-Early Proteins; Immunohistochemistry; In Situ Hybridization; Male; Muscle Proteins; Neostriatum; Neurons; Rats; Rats, Wistar; Receptors, Purinergic P1; Transcription Factors | 1999 |
Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
Topics: Adenosine; Animals; Autoradiography; Binding, Competitive; Brain; Caffeine; In Vitro Techniques; Male; Phenethylamines; Purinergic P1 Receptor Antagonists; Pyrazines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles; Tritium; Xanthines | 1999 |
Anticonvulsant action of 2-chloroadenosine injected focally into the perirhinal cortex in amygdaloid kindled rats.
Topics: 2-Chloroadenosine; Adenosine; Amygdala; Analysis of Variance; Animals; Anticonvulsants; Caffeine; Dose-Response Relationship, Drug; Injections; Kindling, Neurologic; Male; Olfactory Pathways; Rats; Rats, Sprague-Dawley; Reaction Time; Seizures | 1999 |
Adenosine and memory storage: effect of A(1) and A(2) receptor antagonists.
Topics: Adenosine; Animals; Avoidance Learning; Caffeine; Central Nervous System Stimulants; Male; Memory; Mice; Purinergic P1 Receptor Antagonists; Pyrimidines; Triazoles; Xanthines | 1999 |
Adenosine inhibits depolarization-induced Ca(2+) release in mammalian skeletal muscle.
Topics: Adenosine; Adenosine Monophosphate; Animals; Caffeine; Calcium; In Vitro Techniques; Inosine Monophosphate; Magnesium; Muscle Contraction; Muscle Fatigue; Muscle Fibers, Skeletal; Muscle, Skeletal; Rats; Rats, Long-Evans; Sarcoplasmic Reticulum | 1999 |
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Caffeine; Catalepsy; Dopamine Agents; Hypokinesia; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenethylamines; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Reserpine; Theophylline | 1999 |
Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats.
Topics: Adenosine; Animals; Brain; Caffeine; Cocaine; Differential Threshold; Dopamine Uptake Inhibitors; Drug Interactions; Electric Stimulation; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Reaction Time; Receptors, Purinergic P1; Reference Values; Reward; Substance Withdrawal Syndrome; Theobromine | 1999 |
Both fertilization promoting peptide and adenosine stimulate capacitation but inhibit spontaneous acrosome loss in ejaculated boar spermatozoa in vitro.
Topics: Acrosome; Adenosine; Animals; Caffeine; Cells, Cultured; Chlortetracycline; Dose-Response Relationship, Drug; Humans; Male; Mice; Pyrrolidonecarboxylic Acid; Sperm Capacitation; Spermatozoa; Swine; Thyrotropin-Releasing Hormone | 2000 |
Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Caffeine; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Immunologic; Female; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-12; Ligands; Lipopolysaccharides; Male; Monocytes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Signal Transduction | 2000 |
Acute paw oedema induced by local injection of adenosine A(1), A(2) and A(3) receptor agonists.
Topics: Acute Disease; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; Animals; Caffeine; Drug Interactions; Edema; Enzyme Inhibitors; Histamine H1 Antagonists; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrilamine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3 | 1999 |
Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases.
Topics: Adenosine; Adenosine Deaminase; Adenosine-5'-(N-ethylcarboxamide); ADP-Ribosylation Factor 1; Adult; Caffeine; Cell Membrane; Enzyme Activation; GTP Phosphohydrolases; Humans; In Vitro Techniques; Isoenzymes; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenethylamines; Phospholipase D; Protein Kinase C; Protein Kinase C-alpha; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptors, Purinergic P1; rhoA GTP-Binding Protein; Triazoles | 2000 |
The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
Topics: Adenosine; Administration, Oral; Animals; Anxiety; Behavior, Animal; Caffeine; Darkness; Drug Administration Schedule; Injections, Intraperitoneal; Light; Male; Maze Learning; Mice; Mice, Knockout; Neuroprotective Agents; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Reaction Time; Receptor, Adenosine A2A; Triazines; Triazoles; Xanthines | 2000 |
Activation of adenosine A1 receptors facilitates the analgesic effect of ketorolac and ketorolac-caffeine combinations in the rat.
Topics: Adenosine; Analgesics, Non-Narcotic; Animals; Area Under Curve; Caffeine; Central Nervous System Stimulants; Drug Synergism; Female; Ketorolac; Pain Measurement; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar | 1999 |
Involvement of ryanodine receptors in EPYLRFamide-mediated reduction of acetylcholine-induced inward currents in helix lucorum identified neurones.
Topics: Acetylcholine; Adenosine; Adenosine Diphosphate Ribose; Adenosine Triphosphate; Aniline Compounds; Animals; Caffeine; Chelating Agents; Cyclic ADP-Ribose; Dantrolene; Egtazic Acid; Fluorescent Dyes; Helix, Snails; Neurons; Neuropeptides; Ryanodine; Ryanodine Receptor Calcium Release Channel; Xanthenes | 2000 |
Promotion of forskolin-induced long-term potentiation of synaptic transmission by caffeine in area CA1 of the rat hippocampus.
Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Central Nervous System Stimulants; Colforsin; Cyclic AMP; Drug Synergism; Excitatory Postsynaptic Potentials; Hippocampus; Long-Term Potentiation; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Triazoles; Xanthines | 1999 |
Adenosine receptors are involved in the control of acute naloxone-precipitated withdrawal: in vitro evidence.
Topics: Adenosine; Animals; Caffeine; Dipyridamole; Guinea Pigs; Ileum; In Vitro Techniques; Male; Naloxone; Narcotic Antagonists; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2000 |
Inhibition of synaptically evoked cortical acetylcholine release by adenosine: an in vivo microdialysis study in the rat.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Caffeine; Cerebral Cortex; Chromatography, High Pressure Liquid; Dipyridamole; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synapses; Xanthines | 2000 |
The adenosine receptor agonist, APNEA, increases calcium influx into rat cortical synaptosomes through N-type channels associated with A2a receptors.
Topics: Adenosine; Animals; Brain Chemistry; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cerebral Cortex; Dose-Response Relationship, Drug; Male; omega-Conotoxin GVIA; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Synaptosomes; Xanthines | 2000 |
Time for abstention from caffeine before an adenosine myocardial perfusion scan.
Topics: Adenosine; Adult; Aged; Caffeine; Drug Interactions; Exercise Test; False Negative Reactions; Heart; Humans; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Time Factors | 2000 |
Adenosine receptor expression and function in rat striatal cholinergic interneurons.
Topics: Acetylcholine; Adenosine; Adenosine Deaminase; Animals; Baclofen; Bicuculline; Caffeine; Cholinergic Fibers; Corpus Striatum; Dose-Response Relationship, Drug; GABA Antagonists; Gene Expression; Male; Membrane Potentials; Naloxone; Narcotic Antagonists; Neurons; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; RNA, Messenger; Tritium; Xanthines | 2000 |
Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain.
Topics: Adenosine; Animals; Animals, Newborn; Autoradiography; Brain; Caffeine; Female; Gene Expression Regulation, Developmental; In Situ Hybridization; Phenethylamines; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Purinergic P1; Tritium; Xanthines | 2000 |
Regulation of nociceptin mRNA expression in the septum by dopamine and adenosine systems.
Topics: Adenosine; Animals; Caffeine; Denervation; Dopamine; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Neural Pathways; Neurons; Nociceptin; Opioid Peptides; Oxidopamine; Receptor, Adenosine A2A; Receptors, Dopamine; Receptors, Purinergic P1; RNA, Messenger; Septal Nuclei; Stress, Physiological | 2000 |
Adenosine preconditions against endothelin-induced constriction of coronary arterioles.
Topics: Adenosine; Animals; Arterioles; Caffeine; Coronary Circulation; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Microcirculation; Purinergic P1 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents; Xanthines | 2000 |
Caffeine increases paragigantocellularis neuronal firing rate and induces withdrawal signs in morphine-dependent rats.
Topics: Adenosine; Analgesics, Opioid; Animals; Caffeine; Electrophysiology; Male; Medulla Oblongata; Microinjections; Morphine; Morphine Dependence; Neurons; Purinergic P1 Receptor Agonists; Rats; Substance Withdrawal Syndrome; Theophylline | 2001 |
Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo.
Topics: Acid-Base Equilibrium; Adenosine; Animals; Blood Pressure; Caffeine; Carotid Artery, Common; Constriction; Excitatory Postsynaptic Potentials; Heart Rate; Hippocampus; Hypoxia-Ischemia, Brain; Male; Oxygen; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Theophylline | 2001 |
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
Topics: Adenosine; Amphetamines; Animals; Caffeine; Catalepsy; Corpus Striatum; Dopamine Antagonists; Enkephalins; Gene Expression; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic P1; RNA, Messenger | 2001 |
Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.
Topics: Adenosine; Animals; Caffeine; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Inosine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine; Theophylline; Transfection | 2001 |
Regulation of in vitro penetration of frozen-thawed boar spermatozoa by caffeine and adenosine.
Topics: Acrosome Reaction; Adenosine; Animals; Caffeine; Coculture Techniques; Cryopreservation; Culture Media; Cyclic AMP; Female; Fertilization in Vitro; Male; Second Messenger Systems; Semen Preservation; Sperm Capacitation; Spermatozoa; Swine | 2001 |
Antiadrenergic effects of adenosine in pressure overload hypertrophy.
Topics: Adenosine; Adrenergic Antagonists; Adrenergic beta-Agonists; Animals; Blood Pressure; Body Weight; Caffeine; Calcium; Cardiomegaly; Cells, Cultured; Coronary Circulation; Disease Models, Animal; Echocardiography; In Vitro Techniques; Inosine; Isoproterenol; Male; Myocardial Contraction; Myocardium; Organ Size; Perfusion; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley | 2001 |
Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.
Topics: Adenosine; Amphetamine; Animals; Caffeine; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Heterotrimeric GTP-Binding Proteins; Heterozygote; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Neurons; Organ Specificity; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Purinergic P1; RNA, Messenger | 2001 |
Involvement of adenosine in the effect of antidepressants on glutamate and aspartate release in the rat prefrontal cortex.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Antidepressive Agents; Aspartic Acid; Brain; Caffeine; Glutamic Acid; Male; Microdialysis; Rats; Rats, Wistar; Veratridine | 2001 |
A new caffeine biosynthetic pathway in tea leaves: utilisation of adenosine released from the S-adenosyl-L-methionine cycle.
Topics: Adenosine; Adenosylhomocysteinase; Caffeine; Carbon Dioxide; Cell Extracts; Chloroplasts; Homocysteine; Hydrolases; Methionine Adenosyltransferase; Methylation; Plant Leaves; S-Adenosylhomocysteine; S-Adenosylmethionine; Tea; Theobromine | 2001 |
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.
Topics: Adenosine; Animals; Anxiety; Autoradiography; Behavior, Animal; Caffeine; Hippocampus; Hyperalgesia; Hypoxia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Purinergic P1 | 2001 |
Inhibition of caffeine-induced Ca2+ release by adenosine in mammalian skinned slow- and fast-twitch fibres.
Topics: Adenosine; Animals; Caffeine; Calcium; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Male; Muscle Contraction; Muscle, Skeletal; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Vasodilator Agents | 2001 |
Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Blood Pressure; Caffeine; Catecholamines; Cytokines; Endotoxemia; Endotoxins; Enzyme Inhibitors; Heart; Heart Rate; Male; Propranolol; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Renin; Xanthines | 2001 |
Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation.
Topics: Adenosine; Analysis of Variance; Animals; Bucladesine; Caffeine; Kidney; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Reperfusion Injury; Vasodilation; Xanthines | 2001 |
Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.
Topics: Adenosine; Animals; Caffeine; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Female; Male; Mesocricetus; Muscle Contraction; Mutation; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Theobromine; Theophylline; Triazines; Triazoles; Xanthines | 2001 |
Adenosine and caffeine modulate circadian rhythms in the Syrian hamster.
Topics: Adenosine; Animals; Caffeine; Circadian Rhythm; Cricetinae; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Mesocricetus; Motor Activity; Neurons; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Sleep; Sleep Deprivation; Suprachiasmatic Nucleus | 2001 |
Tubuloglomerular feedback in adenosine A1 receptor-deficient mice.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Feedback, Physiological; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Kidney Tubules; Mice; Mice, Knockout; Receptors, Purinergic P1; Renin; Sodium | 2001 |
Characterization of adenosine action in isolated rat renal artery. Possible role of adenosine A(2A) receptors.
Topics: Adenosine; Animals; Caffeine; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Indomethacin; Isotonic Solutions; Male; Models, Animal; Muscle Relaxation; Nitroarginine; Potassium Chloride; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Renal Artery; Tetraethylammonium; Vasodilator Agents; Xanthines | 2000 |
Characteristics of irreversible ATP activation suggest that native skeletal ryanodine receptors can be phosphorylated via an endogenous CaMKII.
Topics: Acid Phosphatase; Adenosine; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Alleles; Animals; Binding, Competitive; Caffeine; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Electrophysiology; Immunoblotting; Ligands; Lipid Bilayers; Muscle, Skeletal; Peptides; Phosphorylation; Protein Kinase C; Rabbits; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Swine; Time Factors | 2001 |
In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261.
Topics: Adenosine; Animals; Binding Sites; Binding, Competitive; Blood-Brain Barrier; Brain; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Triazoles; Tritium | 2001 |
Perinatal respiratory control and its modulation by adenosine and caffeine in the rat.
Topics: Adenosine; Animals; Animals, Newborn; Autoradiography; Brain Stem; Caffeine; Female; In Situ Hybridization; Pregnancy; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Respiration; Spinal Cord | 2002 |
Distinct pharmacological mechanisms leading to c-fos gene expression in the fetal suprachiasmatic nucleus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Dizocilpine Maleate; Female; Gene Expression Regulation; Genes, fos; Image Processing, Computer-Assisted; In Situ Hybridization; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; RNA, Messenger; Suprachiasmatic Nucleus | 2001 |
Dopaminergic mechanism for caffeine-produced cocaine seeking in rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Benzazepines; Caffeine; Central Nervous System Stimulants; Cocaine-Related Disorders; Conditioning, Operant; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Salicylamides; Self Administration; Theophylline; Vasodilator Agents | 2002 |
Theacrine (1,3,7,9-tetramethyluric acid) synthesis in leaves of a Chinese tea, kucha (Camellia assamica var. kucha).
Topics: Adenosine; Alkaloids; Beverages; Caffeine; Camellia; Carbon Radioisotopes; Methylation; Molecular Structure; Plant Leaves; Staining and Labeling; Time Factors; Uric Acid | 2002 |
Chronic caffeine treatment causes changes in cardiac adenosine receptor function in rats.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Central Nervous System Stimulants; Female; Heart Rate; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Stimulation, Chemical | 2002 |
Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Diphosphate; Animals; Caffeine; Coronary Circulation; Heart; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocardial Contraction; Myocardial Reperfusion Injury; Nitroprusside; Perfusion; Phenethylamines; Purinergic P1 Receptor Antagonists; Vasodilator Agents; Xanthines | 2002 |
Differential aspects in ratio measurements of [Ca(2+)](i) relaxation in cardiomyocyte contraction following various drug treatments.
Topics: Adenosine; Algorithms; Animals; Animals, Newborn; Caffeine; Calcium; Cardiotonic Agents; Cells, Cultured; Chelating Agents; Cyclic AMP; Doxorubicin; Electric Stimulation; Enzyme Inhibitors; Indoles; Isoproterenol; Models, Theoretical; Muscle Contraction; Myocardium; Myocytes, Cardiac; Rats; Ryanodine; Thapsigargin | 2002 |
Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats.
Topics: Adenosine; Amitriptyline; Analgesics; Animals; Antidepressive Agents, Tricyclic; Caffeine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Interactions; Female; Hyperalgesia; Neuralgia; Nociceptors; Pain Measurement; Pain Threshold; Peripheral Nerves; Phosphodiesterase Inhibitors; Physical Stimulation; Rats; Rats, Sprague-Dawley | 2002 |
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Dopamine and cAMP-Regulated Phosphoprotein 32; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Phenethylamines; Phosphoproteins; Phosphorylation; Phosphothreonine; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P1; Triazoles | 2002 |
Sedative, anticonvulsant and behaviour modifying effects of Centranthus longiflorus ssp. longiflorus: a study of comparison to diazepam.
Topics: Adenosine; Animals; Anticonvulsants; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Depression; Diazepam; Female; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Mice; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Seizures; Sleep; Swimming; Thiopental; Turkey; Valerianaceae | 2002 |
Contraction-related factors affect the concentration of a kallidin-like peptide in rat muscle tissue.
Topics: Adenosine; Animals; Bradykinin; Caffeine; Dose-Response Relationship, Drug; Electric Stimulation; Hydrogen-Ion Concentration; Kallidin; Male; Microdialysis; Muscle Contraction; Muscle, Skeletal; Osmolar Concentration; Rats; Rats, Wistar | 2002 |
Supraspinal antinociceptive effects of mu and delta agonists involve modulation of adenosine uptake.
Topics: Adenosine; Analgesics, Opioid; Animals; Brain Chemistry; Caffeine; Extracellular Space; Female; Injections; Injections, Intraventricular; Mice; Mice, Inbred C57BL; Pain Measurement; Reaction Time; Receptors, Opioid, delta; Receptors, Opioid, mu; Spinal Cord; Synaptosomes | 2003 |
Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Topics: Adenosine; Animals; Avoidance Learning; Caffeine; Central Nervous System Stimulants; Cognition; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Male; Maze Learning; Memory; Mice; Motor Activity; Postural Balance; Receptors, N-Methyl-D-Aspartate | 2003 |
Up-regulation of striatal adenosine A(2A) receptors in schizophrenia.
Topics: Adenosine; Aged; Aged, 80 and over; Antipsychotic Agents; Cadaver; Caffeine; Control Groups; Corpus Striatum; Female; Humans; Male; Middle Aged; Phenethylamines; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Schizophrenia; Up-Regulation | 2003 |
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
Topics: Adenosine; Amphetamine; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Male; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theophylline; Time Factors; Triazines; Triazoles; Tritium; Xanthines | 2003 |
Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
Topics: Adenosine; Animals; Antibodies, Monoclonal; Caffeine; CD2 Antigens; CD28 Antigens; CD3 Complex; Cell Cycle; Colforsin; Cyclic AMP; Female; Flavins; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phenethylamines; Receptors, Interleukin-2; Receptors, Purinergic P1; Signal Transduction; T-Lymphocytes; Tyrosine | 2003 |
Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Chromatography, High Pressure Liquid; Dopamine; Injections, Subcutaneous; Male; Microdialysis; Morphine; Pyrimidines; Rats; Rats, Wistar; Receptors, Dopamine; Substance Withdrawal Syndrome; Triazoles | 2003 |
Caffeine and coffee tolerance.
Topics: Adenosine; Baroreflex; Blood Pressure; Caffeine; Coffee; Drug Tolerance; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Muscles; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sympathetic Nervous System; Vasomotor System | 2003 |
Effects of adenosine receptor antagonists on pial arteriolar dilation during carbon dioxide inhalation.
Topics: Adenosine; Administration, Inhalation; Animals; Caffeine; Carbon Dioxide; Cerebral Cortex; Cerebral Veins; Cerebrovascular Circulation; Drug Interactions; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Sprague-Dawley; Triazines; Triazoles; Vasodilation; Vasodilator Agents; Xanthines | 2003 |
[Administration of injectable gentisic acid combined preparation].
Topics: Adenosine; Analgesics; Caffeine; Gentisates; Humans; Procaine | 1957 |
THE EFFECT OF L-EPINEPHRINE AND OTHER AGENTS ON THE SYNTHESIS AND RELEASE OF ADENOSINE 3',5'-PHOSPHATE BY WHOLE PIGEON ERYTHROCYTES.
Topics: Adenine Nucleotides; Adenosine; Animals; Birds; Caffeine; Columbidae; Epinephrine; Erythrocytes; Isoproterenol; Magnesium; Norepinephrine; Pharmacology; Phosphates; Probenecid; Research; Sympatholytics | 1963 |
ACTIVATION OF AN EPINEPHRINE-SENSITIVE LIPOLYTIC ACTIVITY FROM ADIPOSE TISSUE BY ADENOSINE 3',5'-PHOSPHATE.
Topics: Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Adipose Tissue; Caffeine; Calcium; Epididymis; Epinephrine; Humans; Lipid Metabolism; Lipolysis; Male; Pharmacology; Phosphates; Rats; Research; Theophylline | 1964 |
EFFECTS OF CAFFEINE ON MAMMALIAN ATRIAL MUSCLE, AND ITS INTERACTION WITH ADENOSINE AND CALCIUM.
Topics: Acetylcholine; Adenosine; Aminohydrolases; Atropine; Caffeine; Calcium; Guinea Pigs; Heart Atria; Myocardium; Nucleosides; Pharmacology; Physostigmine; Research; Reserpine | 1965 |
The effect of caffeine on peripheral vascular resistance in isolated perfused guinea pig hind limbs.
Topics: Adenosine; Animals; Caffeine; Dose-Response Relationship, Drug; Female; Flavins; Guinea Pigs; Hindlimb; Hypoxia; Iliac Artery; Iloprost; Male; Nitrogen; Norepinephrine; Perfusion; Triazines; Triazoles; Vascular Resistance; Vasoconstriction; Vasodilation | 2003 |
Antinociceptive effects of novel A2B adenosine receptor antagonists.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Analgesia; Animals; Caffeine; Drug Synergism; Male; Mice; Morphine; Pain | 2004 |
Adenosine A2A receptors and depression.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Depression; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Haloperidol; Mice; Mice, Knockout; Motor Activity; Neurotransmitter Agents; Parkinsonian Disorders; Purines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles | 2003 |
Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors.
Topics: Adenosine; Animals; Antidepressive Agents; Caffeine; Depressive Disorder; Disease Models, Animal; Female; Male; Mice; Motor Activity; Receptor, Adenosine A1; Receptor, Adenosine A2A; Stress, Psychological; Triazines; Triazoles; Xanthines | 2004 |
Analgesic effect of caffeine and clomipramine: a possible interaction between adenosine and serotonin systems.
Topics: Adenosine; Analgesia; Animals; Caffeine; Clomipramine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Injections, Intraperitoneal; Male; Mice; Pain Measurement; Reaction Time; Serotonin | 2003 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Knockout; Microglia; Multiple Sclerosis; Myelin Sheath; Phenotype; Receptor, Adenosine A1; Recurrence; RNA, Messenger; Severity of Illness Index; Spinal Cord; Up-Regulation | 2004 |
Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
Topics: Adenosine; Biological Transport; Caffeine; Dose-Response Relationship, Drug; Floxuridine; Humans; Membrane Transport Proteins; Molecular Sequence Data; Nicotine; Transfection; Tritium; Tumor Cells, Cultured; Uridine | 2004 |
Involvement of adenosinergic A1 systems in the occurrence of respiratory perturbations encountered in newborns following an in utero caffeine exposure. a study on brainstem-spinal cord preparations isolated from newborn rats.
Topics: Adenosine; Animals; Animals, Newborn; Caffeine; Female; In Vitro Techniques; Medulla Oblongata; Neural Pathways; Pons; Pregnancy; Prenatal Exposure Delayed Effects; Proto-Oncogene Proteins c-fos; Rats; Receptor, Adenosine A1; Respiratory Center; Respiratory Physiological Phenomena; Spinal Cord; Xanthines | 2004 |
Adenosine A1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Caffeine; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Male; Maze Learning; Mice; Receptor, Adenosine A1; Triazines; Triazoles; Xanthines | 2004 |
Effects of adenosine on optic nerve head circulation in rabbits.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine A1 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Animals; Caffeine; Capillaries; Dose-Response Relationship, Drug; Glyburide; Injections; Injections, Intravenous; Optic Disk; Phenethylamines; Potassium Channels; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rabbits; Regional Blood Flow; Stimulation, Chemical; Vasodilation; Vitreous Body; Xanthines | 2004 |
Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Dopamine; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Microdialysis; N-Methylaspartate; Nucleus Accumbens; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Synaptic Transmission; Theophylline | 2004 |
Reduction of the incidence of polyspermic penetration into porcine oocytes by pretreatment of fresh spermatozoa with adenosine and a transient co-incubation of the gametes with caffeine.
Topics: Adenosine; Animals; Caffeine; Cell Culture Techniques; Cells, Cultured; Depression, Chemical; Female; Male; Microscopy, Fluorescence; Phosphodiesterase Inhibitors; Sperm-Ovum Interactions; Spermatozoa; Swine; Time Factors | 2004 |
[Effect of caffeine on myocardial blood flow during pharmacological vasodilation].
Topics: Adenosine; Caffeine; Coronary Circulation; Coronary Disease; Coronary Vessels; Drug Interactions; Humans; Hyperemia; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Vasodilation | 2005 |
Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Blood Pressure; Caffeine; Heart Rate; Injections, Intraperitoneal; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Theophylline; Xanthines | 2005 |
Effect of caffeine on cerebral blood flow response to somatosensory stimulation.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Cerebrovascular Circulation; Electric Stimulation; Injections, Intravenous; Male; Physical Stimulation; Pia Mater; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Somatosensory Cortex; Theophylline; Vasodilation; Vasodilator Agents | 2005 |
Modulation of short-term social memory in rats by adenosine A1 and A(2A) receptors.
Topics: Adenosine; Animals; Behavior, Animal; Brain; Caffeine; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Intraperitoneal; Male; Memory, Short-Term; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Social Behavior; Triazines; Triazoles; Xanthines | 2005 |
Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
Topics: Adenosine; Amphetamine; Animals; Ataxia; Caffeine; Central Nervous System Stimulants; Cognition; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Humans; Locomotion; Male; Mice; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2005 |
2-(1-Hexyn-1-yl)adenosine-induced intraocular hypertension is mediated via K+ channel opening through adenosine A2A receptor in rabbits.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Alkynes; Animals; Antihypertensive Agents; Caffeine; Decanoic Acids; Glyburide; Hydroxy Acids; Hypotonic Solutions; Intraocular Pressure; Male; Ocular Hypertension; Phenethylamines; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rabbits; Receptor, Adenosine A2A; Sodium Chloride; Time Factors; Xanthines | 2005 |
Mechanisms of adenosine-induced renal vasodilatation in hypertensive patients.
Topics: Adenosine; Adult; Blood Pressure; Caffeine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Hypertension; Hypertension, Renovascular; Male; Middle Aged; omega-N-Methylarginine; Renal Circulation; Time Factors; Vasodilation | 2005 |
Consequences of prolonged caffeine administration and its withdrawal on pilocarpine- and kainate-induced seizures in rats.
Topics: Adenosine; Animals; Caffeine; Coffea; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Epilepsy, Temporal Lobe; Kainic Acid; Male; Pilocarpine; Rats; Rats, Wistar; Seizures; Status Epilepticus; Substance Withdrawal Syndrome | 2005 |
Presynaptic mechanism of action induced by 5-HT in nerve terminals: possible involvement of ryanodine and IP3 sensitive 2+ stores.
Topics: Adenosine; Animals; Astacoidea; Caffeine; Calcium Channels; Inositol 1,4,5-Trisphosphate Receptors; Membrane Potentials; Neuromuscular Junction; Presynaptic Terminals; Receptors, Cytoplasmic and Nuclear; Ryanodine; Ryanodine Receptor Calcium Release Channel; Serotonin | 2005 |
A structural study of new potent and selective antagonists to the A2B adenosine receptor.
Topics: Acetamides; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Asparagine; Caffeine; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Histidine; Humans; Hydrogen Bonding; Kinetics; Ligands; Models, Chemical; Models, Molecular; Molecular Conformation; Protein Binding; Theophylline; Xanthines | 2005 |
A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Adenosine A2; Xanthines | 2005 |
Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine; Adrenergic Agents; Animals; Caffeine; Corpus Striatum; Dynorphins; Dyskinesias; Enkephalins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger | 2006 |
Effect of caffeine on leg muscle pain during cycling exercise among females.
Topics: Adenosine; Adolescent; Adult; Analgesics; Bicycling; Caffeine; Double-Blind Method; Exercise Test; Female; Georgia; Humans; Leg; Pain Measurement | 2006 |
In vitro evaluation of adenosine 5'-monophosphate as an imaging agent of tumor metabolism.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Caffeine; Carbon Radioisotopes; Cell Line, Tumor; Female; Humans; Immunophenotyping; In Vitro Techniques; Models, Biological; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Time Factors | 2006 |
Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging.
Topics: Adenosine; Aged; Caffeine; Coffee; Drinking; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Single-Blind Method; Time Factors; Tomography, Emission-Computed, Single-Photon | 2006 |
Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Blotting, Western; Caffeine; Carbon Tetrachloride; Cell Line; Chromatography, High Pressure Liquid; Ethanol; Hepatocytes; Humans; Liver Cirrhosis; Matrix Metalloproteinases, Membrane-Associated; Methotrexate; Mice; Mice, Inbred C57BL; Rats; Receptor, Adenosine A2A; Reverse Transcriptase Polymerase Chain Reaction; Thioacetamide; Triazines; Triazoles | 2006 |
Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors.
Topics: Adenosine; Animals; Caffeine; Carotid Body; Catecholamines; Central Nervous System Stimulants; Chemoreceptor Cells; Dose-Response Relationship, Drug; Female; Hypoxia; Immunohistochemistry; Male; Potassium; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Presynaptic; Respiratory Mechanics; Triazines; Triazoles; Xanthines | 2006 |
Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine.
Topics: Adenosine; Adrenergic Agents; Alzheimer Disease; Amphetamine; Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Glutamine; Injections, Intraventricular; Male; Mice; Motor Activity; Psychotic Disorders | 2004 |
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Brain; Caffeine; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Neuropsychological Tests; Peptide Fragments; Presenilin-1; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Treatment Outcome | 2006 |
Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release.
Topics: Adenosine; Aged; Caffeine; Calcium; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; Female; Heart Atria; Humans; Immunohistochemistry; Isoquinolines; Male; Microscopy, Confocal; Middle Aged; Myocytes, Cardiac; Patch-Clamp Techniques; Phenethylamines; Receptors, Adenosine A2; Reverse Transcriptase Polymerase Chain Reaction; Ryanodine; Sarcoplasmic Reticulum; Sodium-Calcium Exchanger; Stimulation, Chemical; Sulfonamides | 2006 |
Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy.
Topics: Adenosine; Analgesics; Animals; Area Under Curve; Caffeine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hyperalgesia; Male; Oxadiazoles; Pain Measurement; Pain Threshold; Piperazines; Psychomotor Performance; Pyrazoles; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Vocalization, Animal | 2007 |
Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; Caffeine; Cell Differentiation; Cell Lineage; Chronic Disease; Disease Models, Animal; Female; Humans; Hypoxia, Brain; Infant, Newborn; Leukomalacia, Periventricular; Mice; Mice, Inbred C57BL; Nerve Fibers, Myelinated; Neuroprotective Agents; Oligodendroglia; Pregnancy; Receptor, Adenosine A1; Stem Cells | 2006 |
Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Topics: Adenosine; Akathisia, Drug-Induced; Animals; Antioxidants; Behavior, Animal; Brain; Caffeine; Catalase; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Haloperidol; Lipid Peroxidation; Male; Mastication; Maze Learning; Motor Activity; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, Purinergic P1; Stereotyped Behavior; Superoxide Dismutase; Vasodilator Agents | 2006 |
Hyperalgesia, low-anxiety, and impairment of avoidance learning in neonatal caffeine-treated rats.
Topics: Adenosine; Animals; Animals, Newborn; Anxiety; Avoidance Learning; Behavior, Animal; Body Temperature Regulation; Brain; Caffeine; Central Nervous System Stimulants; Female; Hot Temperature; Hyperalgesia; Male; Memory; Motor Activity; Pain Measurement; Pain Threshold; Phenethylamines; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Time Factors | 2007 |
Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.
Topics: Adenosine; Animals; Antihypertensive Agents; Caffeine; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Organ Culture Techniques; Phenethylamines; Phosphodiesterase Inhibitors; Phosphoproteins; Phosphorylation; Presynaptic Terminals; Receptor, Adenosine A2A; Synaptic Membranes; Up-Regulation | 2007 |
Effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on ocular blood flow in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Eye; Flavins; Intraocular Pressure; Male; Rabbits; Regional Blood Flow; Retinal Vessels; Vasodilator Agents; Xanthines | 2007 |
Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Caffeine; Corpus Striatum; Dopamine; Glutamic Acid; Male; Microdialysis; Nucleus Accumbens; Phosphodiesterase Inhibitors; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Adenosine A1; Synaptic Transmission; Theophylline | 2007 |
"One" cup of coffee and nuclear SPECT to go.
Topics: Adenosine; Caffeine; Coffee; Humans; Tomography, Emission-Computed, Single-Photon | 2007 |
Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors.
Topics: Adenosine; Animals; Body Temperature; Caffeine; Central Nervous System Stimulants; Female; Genotype; Heart Rate; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Receptor, Adenosine A1; Sex Characteristics | 2007 |
Adenosine stimulates the basolateral 50 pS K channels in the thick ascending limb of the rat kidney.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenylyl Cyclases; Algorithms; Animals; Bucladesine; Caffeine; Dose-Response Relationship, Drug; Enzyme Activation; Female; Kidney; Male; Patch-Clamp Techniques; Phenethylamines; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Adenosine A2; Stimulation, Chemical; Xanthines | 2007 |
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
Topics: Adenosine; Caffeine; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A2B; Receptor, Adenosine A3; Vascular Endothelial Growth Factor A | 2007 |
The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo.
Topics: Adenosine; Adult; Alleles; AMP Deaminase; Base Sequence; Caffeine; DNA Primers; Female; Genotype; Humans; Male; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Adenosine A2A; Vasodilation | 2007 |
Involvement of adenosinergic receptors in anxiety related behaviours.
Topics: Adenosine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Caffeine; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Female; Male; Maze Learning; Mice; Mice, Inbred Strains; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline | 2007 |
The participation of adenosine receptors in the adenosine 5'-triphosphate-induced relaxation in the isolated rabbit corpus cavernosum penis.
Topics: Acetamides; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Animals; Caffeine; Flavins; Male; Muscle Relaxation; Muscle, Smooth; Penile Erection; Penis; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Purines; Rabbits; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Receptors, Purinergic P2 | 2007 |
The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Amphetamine; Animals; Antipsychotic Agents; Attention; Caffeine; Central Nervous System Stimulants; Choice Behavior; Dopamine; Dose-Response Relationship, Drug; Male; Motor Activity; Phenethylamines; Psychomotor Performance; Purines; Rats; Reaction Time; Reflex, Startle; Xanthines | 2007 |
Modulation of adenosine-induced responses in the guinea-pig trachea during long-term caffeine treatment: possible role of epithelium.
Topics: Adenosine; Animals; Body Weight; Caffeine; Capsaicin; Cromolyn Sodium; Epithelium; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Nitric Oxide; Nitroarginine; Trachea | 2007 |
Transient inhibition of astrocytogenesis in developing mouse brain following postnatal caffeine exposure.
Topics: Adenosine; Animals; Animals, Newborn; Apoptosis; Astrocytes; Behavior, Animal; Body Weight; Brain; Caffeine; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Immunohistochemistry; Injections, Intraperitoneal; Mice; Microtubule-Associated Proteins; Models, Animal; Nerve Growth Factors; Organ Size; Phenethylamines; Pyrimidines; Receptor, Adenosine A2A; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Synaptophysin; Time Factors; Triazoles | 2007 |
Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Aniline Compounds; Animals; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Dipyridamole; Female; Male; Mice; Motor Activity; Nucleoside Transport Proteins; Receptor, Adenosine A1; Receptor, Adenosine A2A; Swimming; Triazines; Triazoles; Xanthines; Zinc | 2008 |
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.
Topics: Adenosine; Adolescent; Adult; Anxiety Disorders; Brain; Brain Chemistry; Caffeine; DNA Mutational Analysis; Dopamine; Dose-Response Relationship, Drug; Female; Genetic Predisposition to Disease; Genetic Testing; Genetic Variation; Genotype; Humans; Male; Phosphodiesterase Inhibitors; Polymorphism, Genetic; Receptor, Adenosine A2A; Receptors, Dopamine D2; Self-Assessment; Young Adult | 2008 |
Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Animals; Antihypertensive Agents; Blood Pressure; Caffeine; Carotid Arteries; Consciousness; Cytidine; Dose-Response Relationship, Drug; Heart Rate; Hypotension; Injections, Intravenous; Injections, Intraventricular; Male; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Theobromine; Theophylline; Time Factors; Triazines; Triazoles; Uridine; Ventricular Function, Left; Ventricular Pressure; Xanthines | 2008 |
Caffeine induction of Cyp6a2 and Cyp6a8 genes of Drosophila melanogaster is modulated by cAMP and D-JUN protein levels.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Bucladesine; Caffeine; Cell Line; Cyclic AMP; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 6; Drosophila melanogaster; Drosophila Proteins; Enzyme Inhibitors; Gene Expression Regulation; Genes, Insect; Intracellular Space; Mixed Function Oxygenases; Models, Genetic; Mutation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-jun; Transcription, Genetic | 2008 |
Caffeine stimulates cytochrome oxidase expression and activity in the striatum in a sexually dimorphic manner.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Base Pairing; Caffeine; Electron Transport Complex IV; Female; Gene Expression Regulation, Enzymologic; Male; Mice; Mice, Inbred C57BL; Neostriatum; PC12 Cells; Phenethylamines; Promoter Regions, Genetic; Rats; RNA, Messenger; RNA, Small Interfering; Sex Characteristics; Time Factors; Transcription, Genetic; Up-Regulation | 2008 |
The antinociceptive interaction of anandamide and adenosine at the spinal level.
Topics: Adenosine; Analgesics; Animals; Arachidonic Acids; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Endocannabinoids; Hot Temperature; Inflammation; Injections, Spinal; Male; Pain; Pain Measurement; Polyunsaturated Alkamides; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Reaction Time | 2009 |
An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.
Topics: 1-Methyl-3-isobutylxanthine; Acetamides; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Carotid Body; Catecholamines; Chemoreceptor Cells; Cyclic AMP; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Purines; Rats; Rats, Wistar; Receptor, Adenosine A2B; Receptors, Dopamine D2; Tritium; Vasodilator Agents | 2008 |
Sex differences in cognitive estimation during sleep deprivation: effects of stimulant countermeasures.
Topics: Adenosine; Adult; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cognition; Cognition Disorders; Dextroamphetamine; Dopamine; Female; Humans; Male; Mental Processes; Modafinil; Neuropsychological Tests; Placebos; Prefrontal Cortex; Sex Characteristics; Sleep Deprivation; Stress, Psychological; Wakefulness; Young Adult | 2008 |
Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
Topics: 3T3-L1 Cells; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Analgesics; Animals; Antineoplastic Agents; Caffeine; Calcium; Calcium Channels; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Insulin; Mice; Potassium Channels; Rats; Rats, Wistar; Receptor, Adenosine A1; Rubidium; Xanthines | 2008 |
Enhancing brain adenosine signaling with the nucleoside transport blocker NBTI (S-(4-nitrobenzyl)-6-theoinosine) mimics the effects of inescapable shock on later shuttle-escape performance in rats.
Topics: Adenosine; Analysis of Variance; Animals; Behavior, Animal; Brain; Caffeine; Electroshock; Escape Reaction; Freezing Reaction, Cataleptic; Male; Nucleoside Transport Proteins; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reaction Time; Signal Transduction; Thioinosine; Xanthines | 2008 |
High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine.
Topics: Adenosine; Aged; Caffeine; Central Nervous System Stimulants; Coffee; Coronary Artery Disease; Coronary Vessels; Drug Interactions; Female; Humans; Hyperemia; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Prospective Studies; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Vasodilation; Vasodilator Agents | 2008 |
Drosophila D1 dopamine receptor mediates caffeine-induced arousal.
Topics: Adenosine; Animals; Arousal; Caffeine; Dopamine; Down-Regulation; Drosophila Proteins; Methamphetamine; Mutation; Neurotransmitter Agents; Organisms, Genetically Modified; Receptors, Dopamine | 2008 |
Modification of the cardiovascular response of posterior hypothalamic adenosine A(2A) receptor stimulation by adenylate cyclase and KATP channel blockade in anesthetized rats.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aminoquinolines; Anesthesia, Inhalation; Animals; Blood Pressure; Bradycardia; Caffeine; Glipizide; Guanylate Cyclase; Heart Rate; Hypothalamus, Posterior; Imines; KATP Channels; Male; Microinjections; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A | 2009 |
Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal.
Topics: Acetylcholine; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Arousal; Behavior, Animal; Caffeine; Chromatography, High Pressure Liquid; Electroencephalography; Electromyography; Male; Mice; Microdialysis; Phenethylamines; Phosphodiesterase Inhibitors; Prefrontal Cortex; Receptor, Adenosine A1; Receptors, Adenosine A2; Spectrum Analysis; Triazines; Triazoles; Xanthines | 2009 |
Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Cells, Cultured; Central Nervous System Stimulants; Chlorhexidine; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Mice; Mice, Knockout; Peritoneal Cavity; Phenethylamines; Vasodilator Agents | 2009 |
Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons.
Topics: Adenosine; Animals; Behavior, Animal; Caffeine; Equilibrative Nucleoside Transporter 1; Ethanol; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Neurons; PC12 Cells; Rats; Receptors, Purinergic P1; Up-Regulation | 2009 |
Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.
Topics: Adenosine; Anorexia; Antidepressive Agents, Second-Generation; Caffeine; Central Nervous System Stimulants; Cyclohexanols; Ethnicity; Gambling; Humans; Psychoses, Substance-Induced; Venlafaxine Hydrochloride | 2009 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |
Adenosine receptor interactions alter cardiac contractility in rat heart.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Caffeine; Depression, Chemical; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flavins; Imines; In Vitro Techniques; Male; Myocardial Contraction; Phenylisopropyladenosine; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Adenosine A2; Stimulation, Chemical | 2010 |
Differential effects of adenosine antagonists in two models of parkinsonian tremor.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Synergism; Jaw; Male; Parkinsonian Disorders; Pimozide; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Tacrine; Theophylline; Tremor; Triazoles | 2009 |
A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; Animals; Caffeine; Cause of Death; Death, Sudden; Disease Models, Animal; Enzyme Inhibitors; Epilepsy; Kainic Acid; Mice; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Risk Factors; Seizures; Survival Analysis; Tubercidin | 2010 |
Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia.
Topics: Adenosine; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Caffeine; Case-Control Studies; Female; Humans; Male; Middle Aged; Surveys and Questionnaires; Tachycardia, Supraventricular; Time Factors | 2010 |
Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
Topics: Adenosine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Benzoxazines; Biophysics; CA1 Region, Hippocampal; Caffeine; Calcium Channel Blockers; Dronabinol; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; In Vitro Techniques; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Picrotoxin; Piperidines; Presynaptic Terminals; Propanolamines; Pyrazoles; Quinoxalines; Receptor, Adenosine A1; Receptor, Cannabinoid, CB1; Xanthines | 2010 |
Adenosine and caffeine-induced paroxysmal supraventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Caffeine; Humans; Tachycardia, Supraventricular | 2010 |
A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Blotting, Western; Caffeine; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hepatic Artery; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Portal Vein; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Theophylline; Vascular Resistance; Vasodilation; Vasodilator Agents | 2010 |
Acupuncture for mice.
Topics: Acupuncture Therapy; Adenosine; Animals; Caffeine; Humans; Mice; Models, Animal; Pain; Pain Management; Pentostatin; Placebo Effect; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2010 |
Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Caffeine; Cattle; Electric Conductivity; Electrochemistry; Enzyme Assays; Kinetics; Oxidation-Reduction; Pentostatin; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Silver; Time Factors | 2010 |
Capacitation inducers act through diverse intracellular mechanisms in cryopreserved bovine sperm.
Topics: Adenosine; Animals; Bicarbonates; Caffeine; Cattle; Chlortetracycline; Cryopreservation; Female; Fertilization in Vitro; Fluorescence; Heparin; Intracellular Fluid; Male; Semen; Semen Analysis; Semen Preservation; Signal Transduction; Sperm Capacitation; Superoxides | 2010 |
Adenosine A(1) receptors in human brain and transfected CHO cells: Inhibition of [(3)H]CPFPX binding by adenosine and caffeine.
Topics: Adenosine; Animals; Binding, Competitive; Brain; Caffeine; CHO Cells; Cricetinae; Cricetulus; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Adenosine A1; Transfection; Tritium; Xanthines | 2011 |
Caffeine-induced natriuresis and diuresis via blockade of hepatic adenosine-mediated sensory nerves and a hepatorenal reflex.
Topics: Adenosine; Animals; Caffeine; Diuresis; Kidney; Liver; Male; Natriuresis; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reflex | 2010 |
What's new in Shock, September 2011?
Topics: Adenosine; Animals; Caffeine; Humans; Myocardial Reperfusion Injury; Neutrophils; Shock; Stem Cells | 2011 |
Regulation of aggregate size and pattern by adenosine and caffeine in cellular slime molds.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Caffeine; Cell Adhesion; Cell Adhesion Molecules; Cell Division; Cell Enlargement; Chemotactic Factors; Cyclic AMP; Cytoplasmic Streaming; Cytosol; Dictyostelium; Glucose; Protozoan Proteins; Signal Transduction | 2012 |
The effect of caffeine on adenosine myocardial perfusion imaging: time to reassess?
Topics: Adenosine; Caffeine; Coronary Artery Disease; Coronary Circulation; Exercise Test; Female; Humans; Male; Myocardial Perfusion Imaging | 2012 |
ATP depletion triggers acute myeloid leukemia differentiation through an ATR/Chk1 protein-dependent and p53 protein-independent pathway.
Topics: Acute Disease; Adenosine; Adenosine Triphosphate; Antibiotics, Antineoplastic; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Caffeine; Cell Cycle Proteins; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Comet Assay; DNA Damage; Doxorubicin; HEK293 Cells; Humans; Leukemia, Myeloid; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Signal Transduction; Staurosporine; Thioinosine; Tumor Suppressor Protein p53 | 2012 |
The effect of vasoactive agents on post-pressure hyperemia.
Topics: Adenosine; Alprostadil; Animals; Area Under Curve; Arterial Pressure; Buffers; Caffeine; Dinoprostone; Dopamine; Epinephrine; Humans; Hyperemia; Microdialysis; NG-Nitroarginine Methyl Ester; Phosphates; Rats; Rats, Wistar; Regional Blood Flow; Skin; Time Factors; Vasoconstrictor Agents | 2012 |
Chronic caffeine intake in adult rat inhibits carotid body sensitization produced by chronic sustained hypoxia but maintains intact chemoreflex output.
Topics: Acclimatization; Adenosine; Animals; Caffeine; Carotid Body; Carotid Sinus; Chemoreceptor Cells; Dopamine; Down-Regulation; Ganglion Cysts; Hypercapnia; Hyperventilation; Hypoxia; Partial Pressure; Pulmonary Ventilation; Rats; Rats, Wistar; Receptors, Purinergic P1; Up-Regulation | 2012 |
Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1.
Topics: Adenosine; Amino Acid Chloromethyl Ketones; Amnesia, Anterograde; Amygdala; Animals; Caffeine; Caspase 1; Caspase Inhibitors; Conditioning, Classical; Cues; Enzyme Activation; Fear; Hypoxia, Brain; Interleukin 1 Receptor Antagonist Protein; Male; MAP Kinase Signaling System; Maze Learning; Mental Recall; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxygen; Receptors, Interleukin-1 Type I; Receptors, Purinergic P1; Recognition, Psychology; Theobromine; Xanthines | 2012 |
Ankle joint mobilization affects postoperative pain through peripheral and central adenosine A1 receptors.
Topics: Adenosine; Analysis of Variance; Animals; Ankle Joint; Caffeine; Clonidine; Disease Models, Animal; Fenclonine; Hyperalgesia; Male; Mice; Morphine; Pain, Postoperative; Receptor, Adenosine A1; Xanthines; Yohimbine | 2013 |
Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice.
Topics: Adenosine; Analysis of Variance; Animals; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Disease Models, Animal; Electroencephalography; Electromyography; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Sleep Deprivation; Sleep Stages; Sleep, REM; Sodium Chloride | 2013 |
High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system.
Topics: Adenine; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Adenosine Deaminase Inhibitors; Animals; Caffeine; Exercise Therapy; Hyperalgesia; Male; Mice; Naloxone; Narcotic Antagonists; Neuralgia; Neurons; Reflex Sympathetic Dystrophy; Swimming; Triazines; Triazoles; Xanthines | 2013 |
Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Corpus Striatum; Dopamine; Dopaminergic Neurons; Glutamic Acid; Hydroxyl Radical; Inflammation; Lipopolysaccharides; Male; Microinjections; Parkinson Disease; Purines; Rats; Receptor, Adenosine A2A | 2013 |
Caffeine, exercise and the brain.
Topics: Adenosine; Attention; Brain; Caffeine; Central Nervous System Stimulants; Dopamine; Exercise; Fatigue; Humans; Motivation; Muscle, Skeletal; Musculoskeletal Pain; Physical Endurance; Plant Extracts; Purinergic P1 Receptor Antagonists | 2013 |
Caffeine induces alveolar apoptosis in the hyperoxia-exposed developing mouse lung.
Topics: Adenosine; Animals; Animals, Newborn; Apoptosis; Bronchoalveolar Lavage; Caffeine; In Situ Nick-End Labeling; Mice; Pulmonary Alveoli; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Signal Transduction | 2014 |
Use of 11C-MPDX and PET to study adenosine A1 receptor occupancy by nonradioactive agonists and antagonists.
Topics: Adenosine; Allosteric Site; Animals; Brain; Caffeine; Carbon Radioisotopes; Ethanol; Heart Rate; Male; Morpholines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Rats; Rats, Wistar; Receptor, Adenosine A1; Xanthines | 2014 |
Combined alcohol and energy drink use: hedonistic motives, adenosine, and alcohol dependence.
Topics: Adenosine; Alcohol Drinking; Alcoholism; Caffeine; Drinking Behavior; Energy Drinks; Ethanol; Humans; Motivation; Philosophy; Pleasure; Purinergic P1 Receptor Antagonists; Reward; Risk Factors; Self Administration | 2014 |
Modulation of 3',5'-cyclic AMP homeostasis in human platelets by coffee and individual coffee constituents.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Adult; Blood Platelets; Caffeine; Coffee; Cyclic AMP; Homeostasis; Humans; Phosphodiesterase Inhibitors; Pyrazines; Signal Transduction | 2014 |
Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine.
Topics: Adenosine; Animals; Caffeine; Intracellular Space; Male; Meningeal Arteries; Migraine Disorders; Purine Nucleotides; Pyrimidine Nucleotides; Rats, Sprague-Dawley; Receptors, Purinergic; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2014 |
Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement.
Topics: Adenosine; Administration, Oral; Aged; Blood Pressure; Caffeine; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Papaverine; Premedication; Prospective Studies | 2014 |
Adenosine signaling in reserpine-induced depression in rats.
Topics: Adenosine; Adrenergic Uptake Inhibitors; Animals; Brain; Caffeine; Depressive Disorder; Dose-Response Relationship, Drug; Flavins; Male; Neuropsychological Tests; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Random Allocation; Rats, Sprague-Dawley; Receptors, Purinergic P1; Reserpine; Swimming; Theophylline | 2015 |
Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
Topics: Action Potentials; Adenosine; Animals; Caffeine; Calcium; Flecainide; Gene Knockdown Techniques; Gene Knockout Techniques; Isoproterenol; Male; Mice; Mice, Knockout; Receptors, Androgen; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2015 |
Effect of adenosine system in the action of oseltamivir on behavior in mice.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Antiviral Agents; Behavior, Animal; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Neuraminidase; Oseltamivir; Phenethylamines; Pyrimidines; Receptors, Adenosine A2; Triazoles; Walking | 2015 |
Adenosinergic regulation of binge-like ethanol drinking and associated locomotor effects in male C57BL/6J mice.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Alcohol Drinking; Animals; Binge Drinking; Caffeine; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Motor Activity; Receptors, Purinergic P1; Sucrose; Xanthines | 2015 |
Is Caffeine Abstention Necessary Before Adenosine-Induced Fractional Flow Reserve Measurement?
Topics: Adenosine; Caffeine; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Papaverine; Prospective Studies; Receptors, Purinergic P1; Vasodilator Agents | 2015 |
Activation of adenosine A₂A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Amphetamine; Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Interpersonal Relations; Male; Morphine; Motivation; Motor Activity; Narcotics; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Reward; Social Behavior; Vocalization, Animal | 2016 |
Caffeine does not significantly reduce the sensitivity of vasodilator stress myocardial perfusion imaging.
Topics: Adenosine; Caffeine; Coronary Circulation; Exercise Test; Myocardial Perfusion Imaging; Vasodilator Agents | 2016 |
Caffeine intake and myocardial perfusion imaging.
Topics: Adenosine; Caffeine; Coronary Circulation; Myocardial Perfusion Imaging; Perfusion | 2016 |
Caffeine exposure alters adenosine system and neurochemical markers during retinal development.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Animals; Caffeine; Chick Embryo; Chickens; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptor, Adenosine A2A; Retina | 2016 |
Susceptibility to seizure-induced sudden death in DBA/2 mice is altered by adenosine.
Topics: Adenosine; Animals; Caffeine; Death, Sudden; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Male; Mice, Inbred DBA; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyrimidines; Receptors, Purinergic P1; Respiration; Respiration Disorders; Seizures; Tubercidin; Xanthines | 2016 |
Caffeine intake inverts the effect of adenosine on myocardial perfusion during stress as measured by T1 mapping.
Topics: Adenosine; Aged; Aged, 80 and over; Caffeine; Case-Control Studies; Coffee; Coronary Circulation; False Negative Reactions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Vasodilator Agents | 2016 |
Hold off on that shot of Java: more evidence that caffeine intake leads to false negative adenosine stress myocardial perfusion.
Topics: Adenosine; Caffeine; Coronary Circulation; Exercise Test; Humans; Myocardial Perfusion Imaging; Predictive Value of Tests; Vasodilator Agents | 2017 |
Characterization of particulate-phase polycyclic aromatic hydrocarbons emitted from incense burning and their bioreactivity in RAW264.7 macrophage.
Topics: Adenosine; Air Pollutants; Air Pollution, Indoor; Alcohols; Aldehydes; Amides; Animals; Caffeine; Environmental Monitoring; Gas Chromatography-Mass Spectrometry; Imidazoles; Ketones; Macrophages; Mice; Molecular Weight; Nitric Oxide; Particulate Matter; Polycyclic Aromatic Hydrocarbons; Smoke; Taiwan; Tumor Necrosis Factor-alpha | 2017 |
Homeostatic response to sleep/rest deprivation by constant water flow in larval zebrafish in both dark and light conditions.
Topics: Adenosine; Animals; Arousal; Caffeine; Circadian Rhythm; Darkness; Homeostasis; Larva; Light; Models, Animal; Phenylalanine; Receptor, Adenosine A1; Reflex, Startle; Rest; Sleep; Sleep Deprivation; Wakefulness; Water Movements; Zebrafish | 2017 |
Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
Topics: Adenosine; Aged; Caffeine; Coffee; Coronary Artery Disease; Coronary Circulation; Female; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Vasodilator Agents | 2017 |
The Effects of Adenosinergic Modulation on Cytokine Levels in a Pentylenetetrazole-Induced Generalized Tonic-Clonic Seizure Model.
Topics: Adenosine; Animals; Brain; Caffeine; Central Nervous System Stimulants; Convulsants; Cytokines; Disease Models, Animal; Drug Interactions; Male; Pentylenetetrazole; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Seizures | 2017 |
Theacrine: A purine alkaloid from Camellia assamica var. kucha with a hypnotic property via the adenosine system.
Topics: Adenosine; Alkaloids; Animals; Caffeine; Camellia; Drug Synergism; Hippocampus; Male; Mice; Pentobarbital; Pyrimidines; Rats; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazoles; Uric Acid; Xanthines | 2017 |
Treatment with A
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Humans; Inflammation; Ischemia; Male; Microglia; Nitrobenzenes; Pyridines; Rats; Receptor, Adenosine A2A; Reperfusion Injury; Retina; Retinal Diseases | 2017 |
Disagreement between splenic switch-off and myocardial T1-mapping after caffeine intake.
Topics: Adenosine; Aged; Caffeine; Case-Control Studies; Coffee; Coronary Circulation; Female; Hemodynamics; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Observer Variation; Predictive Value of Tests; Purinergic P1 Receptor Antagonists; Reproducibility of Results; Spleen; Vasodilator Agents | 2018 |
Effects of caffeine on the detection of ischemia in patients undergoing adenosine stress cardiovascular magnetic resonance imaging.
Topics: Adenosine; Aged; Caffeine; Central Nervous System Stimulants; Coronary Circulation; Electrocardiography; Exercise Test; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Myocardial Ischemia; Predictive Value of Tests; Vasodilator Agents | 2017 |
Cerebellar oxidative stress and fine motor impairment in adolescent rats exposed to hyperthermia-induced seizures is prevented by maternal caffeine intake during gestation and lactation.
Topics: 5'-Nucleotidase; Adenosine; Animals; Caffeine; Cerebellum; Female; Fever; Gait; Lactation; Mothers; Motor Activity; Oxidative Stress; Pregnancy; Rats; Receptor, Adenosine A2A; Seizures; Time Factors | 2018 |
Adenosine A
Topics: Adenosine; Caffeine; Cells, Cultured; Dopamine; Humans; Motor Neurons; Neurons, Efferent; Receptors, Dopamine D1; Spinal Cord; Synaptic Transmission | 2019 |
Caffeine and high intensity exercise: Impact on purinergic and cholinergic signalling in lymphocytes and on cytokine levels.
Topics: Acetylcholinesterase; Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Caffeine; Cell Proliferation; Cytokines; Glucocorticoids; Hydrolysis; Lymphocyte Activation; Lymphocytes; Male; Physical Conditioning, Animal; Rats, Wistar; Receptors, Cholinergic; Receptors, Purinergic; Signal Transduction | 2018 |
Prediction of self-assembly of adenosine analogues in solution: a computational approach validated by isothermal titration calorimetry.
Topics: Adenosine; Caffeine; Calorimetry; Dimerization; Models, Molecular; Molecular Structure; Solvents; Structure-Activity Relationship; Surface Properties; Theophylline; Thermodynamics; Water | 2019 |
Dose-Dependent Effect of Caffeine on Adenosine-Induced Myocardial Stress Perfusion in Rubidium-82 Positron-Emission Tomography/Computed Tomography.
Topics: Adenosine; Administration, Oral; Adult; Caffeine; Coronary Circulation; Dose-Response Relationship, Drug; Female; Healthy Volunteers; Humans; Male; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Random Allocation; Reproducibility of Results; Rubidium Radioisotopes; Vasodilator Agents; Young Adult | 2019 |
The science of tea's mood-altering magic.
Topics: Adenosine; Affect; Alpha Rhythm; Animals; Antioxidants; Behavior; Beta Rhythm; Blood-Brain Barrier; Caffeine; Catechin; Cognition; Dementia; Depression; Exercise; gamma-Aminobutyric Acid; Glutamates; Humans; Hydrocortisone; Life Style; Mental Health; Middle Aged; Stress, Psychological; Tea; Theta Rhythm | 2019 |
Caffeine Treatment Promotes Differentiation and Maturation of Hypoxic Oligodendrocytes via Counterbalancing Adenosine 1 Adenosine Receptor-Induced Calcium Overload.
Topics: Adenosine; Animals; Caffeine; Calcium; Cell Differentiation; Cells, Cultured; China; Homeostasis; Hypoxia; Myelin Sheath; Oligodendroglia; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Calcium-Sensing; Receptors, Purinergic P1 | 2019 |
Effect of Caffeine Ingestion on Relative Myocardial Blood Flow Imaging.
Topics: Adenosine; Caffeine; Positron Emission Tomography Computed Tomography; Rubidium Radioisotopes | 2019 |
The Authors' Reply.
Topics: Adenosine; Caffeine; Positron Emission Tomography Computed Tomography; Rubidium Radioisotopes | 2019 |
Lipotoxicity-associated inflammation is prevented by guarana (
Topics: Adenosine; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperlipidemias; Inflammation; Lymphocytes; Male; Rats; Rats, Wistar; Simvastatin; Theobromine; Theophylline | 2021 |
Impact of caffeine on myocardial perfusion reserve assessed by semiquantitative adenosine stress perfusion cardiovascular magnetic resonance.
Topics: Adenosine; Aged; Caffeine; Coronary Circulation; Female; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Predictive Value of Tests; Prospective Studies; Purinergic P1 Receptor Antagonists; Reproducibility of Results; Vasodilation; Vasodilator Agents | 2019 |
Blood Flow Reserve at Common Caffeine Levels.
Topics: Adenosine; Caffeine; Positron-Emission Tomography; Rubidium Radioisotopes; Tomography | 2019 |
Hypnotic Effects of
Topics: Adenosine; Animals; Caffeine; DNA, Bacterial; Gene Expression; Hypnotics and Sedatives; Limosilactobacillus fermentum; Locomotion; Male; Mice; Mice, Inbred C57BL; Pentobarbital; Real-Time Polymerase Chain Reaction; Signal Transduction; Sleep; Sleep Aids, Pharmaceutical | 2019 |
Caffeine Exacerbates Postictal Hypoxia.
Topics: Adenosine; Animals; CA1 Region, Hippocampal; Caffeine; Dose-Response Relationship, Drug; Hypoxia; Kindling, Neurologic; Male; Oxygen; Phenethylamines; Pyrimidines; Rats; Receptors, Adenosine A2; Seizures; Triazoles | 2019 |
Potential beneficial effects of caffeine administration in the neonatal period of an animal model of schizophrenia.
Topics: Adenosine; Animals; Animals, Newborn; Caffeine; Disease Models, Animal; Locomotion; Male; Motor Activity; Rats; Rats, Inbred SHR; Rats, Wistar; Schizophrenia | 2020 |
Effects of the excitation or inhibition of basal forebrain cholinergic neurons on cognitive ability in mice exposed to chronic intermittent hypoxia.
Topics: Acetylcholine; Adenosine; Animals; Apoptosis; Caffeine; Cholinergic Neurons; Cognition; Endoplasmic Reticulum Stress; Hypoxia, Brain; Male; Maze Learning; Mice; Oxidative Stress | 2020 |
Effects of gestational and breastfeeding caffeine exposure in adenosine A1 agonist-induced antinociception of infant rats.
Topics: Adenosine; Animals; Caffeine; Female; Lactation; Pregnancy; Rats; Rats, Wistar; Receptor, Adenosine A1 | 2020 |
Electrophysiological signatures of acute systemic lipopolysaccharide-induced inflammation: potential implications for delirium science.
Topics: Adenosine; Age Factors; Animals; Caffeine; Cerebral Cortex; Cytokines; Delirium; Disease Models, Animal; Electroencephalography; Electrophysiological Phenomena; Humans; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Piroxicam; Prostaglandins; Wakefulness | 2021 |
Linear concentration-response relationship of serum caffeine with adenosine-induced fractional flow reserve overestimation: a comparison with papaverine.
Topics: Adenosine; Caffeine; Coronary Angiography; Coronary Stenosis; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Papaverine; Predictive Value of Tests; Vasodilator Agents | 2021 |
The effects of caffeine on bone mineral density and fracture risk.
Topics: Adenosine; Adult; Bone Density; Caffeine; Coffee; Fractures, Bone; Humans; Osteoporosis | 2022 |
Adenosine A
Topics: Adenosine; Caffeine; Coffee; Humans; Parkinson Disease; Receptor, Adenosine A2A | 2022 |
Image-derived and physiological markers to predict adequate adenosine-induced hyperemic response in Rubidium-82 myocardial perfusion imaging.
Topics: Adenosine; Biomarkers; Caffeine; Coronary Circulation; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Rubidium Radioisotopes; Tomography, X-Ray Computed; Vasodilator Agents | 2022 |
Caffeine excites medial parabrachial nucleus neurons of mice by blocking adenosine A1 receptor.
Topics: Adenosine; Animals; Apnea; Caffeine; Mice; Neurons; Parabrachial Nucleus; Receptor, Adenosine A1; Receptor, Adenosine A2A | 2022 |
Adenosine-caffeine: the agonist-antagonist couple for vasodilator stress tests.
Topics: Adenosine; Caffeine; Exercise Test; Humans; Vasodilator Agents | 2023 |
General Label-Free Fluorescent Aptamer Binding Assay Using Cationic Conjugated Polymers.
Topics: Adenosine; Aptamers, Nucleotide; Biosensing Techniques; Caffeine; Cations; Hydrocortisone; Polymers | 2022 |
Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine.
Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Brain-Derived Neurotrophic Factor; Caffeine; Disease Models, Animal; Mice; Mice, Transgenic; Receptors, Purinergic P1; Spinal Cord; Superoxide Dismutase; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
Effects of Chronic Caffeine Consumption on Synaptic Function, Metabolism and Adenosine Modulation in Different Brain Areas.
Topics: Adenosine; Animals; Caffeine; Hippocampus; Male; Mice; Prospective Studies; Receptors, Purinergic P1 | 2023 |
Chemoimmunotherapy with doxorubicin and caffeine combination enhanced ICD induction and T-cell infiltration in B16F10 melanoma tumors.
Topics: Adenosine; Animals; Caffeine; Doxorubicin; Immunogenic Cell Death; Melanoma; Mice; T-Lymphocytes; Tumor Microenvironment | 2023 |
Selective Deuteration Improves the Affinity of Adenosine A
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Caffeine; Ligands; Receptor, Adenosine A2A | 2023 |
Acute caffeine differently affects risk-taking and the expression of BDNF and of adenosine and opioid receptors in rats with high or low anxiety-like behavior.
Topics: Adenosine; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Caffeine; Rats; Receptors, Opioid; Receptors, Purinergic P1; Risk-Taking; RNA, Messenger | 2023 |
Cross-Binding of Four Adenosine/ATP Aptamers to Caffeine, Theophylline, and Other Methylxanthines.
Topics: Adenosine; Adenosine Triphosphate; Aptamers, Nucleotide; Caffeine; Theophylline | 2023 |
Cross-Binding of Adenosine by Aptamers Selected Using Theophylline.
Topics: Adenosine; Aptamers, Nucleotide; Caffeine; Nucleotide Motifs; Theophylline | 2023 |
Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Topics: Adenosine; Caffeine; Chitosan; Folic Acid; Humans; Immunotherapy; Methotrexate; Molecular Docking Simulation; Nanoparticles; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment | 2023 |